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Understanding the development of epigenetic patterns that underlie neural 
development and differentiation is an essential foundation for understanding what 
occurs in “abnormal” situations. DNA methylation, in concert with other epigenetic 
regulators, controls the accessibility of transcription factors to DNA and/or their 
function. While extensively studied in neuronal progenitors in vitro, the role of 
methylation/demethylation in neuronal lineage/subtype specification in vivo is not 
known. By profiling two distinct neuronal lineages, and five neuron subtypes in the 
hippocampus and striatum, we uncovered a set of five principles that govern DNA 
methylation-dynamics in neurodevelopment.  By dividing neurodevelopment to three 
alternating methylation and demethylation periods and applying the principles to each 
of these stages, we created a matrix that comprehensively describes the targets, 
genomic contexts, functional consequences and putative mechanisms of 
methylation/demethylation events.  The overarching theme is that the developmental 
methylation program is remarkably similar in the hippocampus and striatum, with 
significant divergence only occurring during subtype specification. Our matrix can be 
cross-referenced with disease-associated methylation changes to specify possible 
events and underlying principles compromised in disease. 
	  	  
Adverse environmental conditions, particularly during early life, are associated 
with increased risk for behavioral and/or psychiatric disorders. However, the 
molecular basis that can potentially link environmental conditions to 
psychopathologies are unknown, complicating diagnosis and therapeutic measures. 
We identified differentially methylated regions (DMRs) in mammalian offspring 
exposed to an adverse maternal environment associated with anxiety in both the 
mother and offspring. We hypothesized the presence of metastable “hotspots” in the 
genome that display an inherent sensitivity to environmental cues. These hotspots 
would enable an adaptive/maladaptive molecular response to multiple environmental 
conditions by modifying appropriate gene expression patterns and cellular phenotypes. 
Using several animal models of early life adversities, which result in a common 
offspring anxiety phenotype, we used genome-wide DNA methylation sequencing to 
detect common environmentally sensitive DMRs (E-DMRs). E-DMRs displayed 
several DNA features including: Exonic enrichment, intermediate methylation, and 
enhancer activity. Interestingly, E-DMRs did not perturb the overall patterning of 
DNA methylation that takes place during neural development. The experience 
dependent variations in DNA methylation at E-DMRs may prime the genome for 
differential transcriptional response to later events. This metaplasticity may be 
especially important in brain regions responsible for processing environmental input to 
elicit a behavioral response.  
 Since maternal conditions impact the offspring during gametogenesis and 
through fetal/early-postnatal life, the resultant phenotype is likely the aggregate of 
consecutive germline and somatic effects; a concept that hasn’t been previously 
	  	  
studied. We dissected a complex maternally-transmitted phenotype, reminiscent of 
comorbid generalized anxiety/depression, to elementary behaviors/domains and their 
transmission mechanisms. We show that four anxiety/stress-reactive traits are 
transmitted via independent iterative-somatic and gametic epigenetic mechanisms 
across multiple generations.  Somatic/gametic transmission alters DNA methylation at 
enhancers within synaptic genes whose functions can be linked to the behavioral-
traits. Traits have generation-dependent penetrance and sex-specificity resulting in 
pleiotropy, often seen in psychiatry. A transmission-pathway based concept can refine 
current inheritance models of psychiatric diseases and facilitate the development of 
better animal models and new therapeutic approaches. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Non-genetic foundation of Psychiatric Disorders  
Psychiatric disorders affect nearly one third of the human population at some 
point in their lives1. However, despite the prevalence of these disorders, little is known 
regarding the underlying causes. The majority of psychiatric disorders cannot be 
traced to genetic abnormalities, and are believed to arise, at least partly, from 
epigenetic changes caused by environmental factors, often during early life2-5.  
The mammalian brain is a complex system with a highly choreographed 
developmental process. The process is guided by distinct stages of gene expression by 
transcription factors, and morphogens6,7. In addition, external factors including 
resources from the mother during early stages of life, such as hormones and cytokines, 
influence neuronal development8-10. Environmental perturbations during early life are 
believed to result in the dysregulation of the developmental process, giving rise to 
abnormal brain structure/function and subsequent behavioral and/or neuropsychiatric 
abnormalities9. Early environmental adversities, such as maternal stress, maternal 
deprivation or maternal infection are associated with increased neurophysiological and 
behavioral abnormalities in adult offspring11-13. Due to the vulnerability of certain 
neuronal systems and circuits during development, different early-life environmental 
adversities often result in similar phenotypes. However, little is known regarding the 
convergence point, whether at the molecular, circuit or behavioral level, that explain 
the observed convergent phenotype14,15. Furthermore, recent studies have 
demonstrated that the behavioral abnormalities can be multigenerationally 
inherited4,9,16-20. 
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The behavioral consequences of early life adversity can most plausibly 
explained by epigenetics. Dysregulation	  of	  key	  epigenetic	  modifiers	  results	  in	  gross	  behavioral	  abnormalities21-­‐23.	  Several	  studies	  have	  shown	  differential	  methylation	  at	  candidate	  genes	  following	  early	  life	  environmental	  adversity,	  and	  adult	  environmental	  changes24-­‐26.	  Moreover, the early-life adversity induced 
behavioral phenomena discussed above, including convergent phenotypes and 
multigenerational transmission, can have an epigenetic origin. Epigenetic 
modifications alter gene expression and phenotype in response to environmental 
perturbations and occur without a change in DNA sequence. Epimutations are based 
on changes in DNA methylation and/or histone modifications, and can remain	  stable	  through	  embryonic	  development	  and	  adult	  life27,28.	  	  
 
1.2 DNA methylation dynamics during neural development 
One limitation in studying the early development of environmentally induced 
behavioral abnormalities is our limited understanding of the epigenetics of neural 
development and differentiation. While many of the morphogens and transcription 
factors have been well studied and documented6,7, little is known regarding the 
epigenetic factors, particularly DNA methylation, one of the most stable epigenetic 
modifications. While the dynamics of DNA methylation from germ cells to 
fertilization and through early embryonic development have been well documented 
and are characterized by distinct waves of methylation and demethylation28,29, the 
dynamics during neural development remains unclear. Recently, epigenetic 
modifications associated with in-vitro development and differentiation of neural 
progenitors to glia and neuronal cells have been described30. We expanded upon these 
data by profiling DNA methylation in vivo and our study is the first to describe the 
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dynamics that take place during distinct stages of neural development in multiple 
regions and lineage subtypes in the brain.  
 
1.3 Link between early life adversity, epimutations, and behavioral 
abnormalities 
Neural development is associated with the formation of epigenetic patterns that 
are essential for proper differentiation31,32. Neural differentiation continues late in 
development, with many regions undergoing differentiation through the late prenatal 
to early postnatal period33,34. Environmental interference within this period often 
results in localized developmental and behavioral abnormalities associated with these 
developing regions, including anxiety35, depression36 and ADHD37. Since these 
psychiatric phenotypes are not due to genetic abnormalities, they are believed to result 
from stable epigenetic changes13. In fact dysregulation of key epigenetic modifiers, 
such as MECP2, results in gross behavioral abnormalities21-23. Additionally, several 
studies have shown differential methylation at candidate genes following early life 
environmental adversity, and adult environmental changes24-26. For instance, maternal 
deprivation in rats results in demethylation of the CRH promoter38. However, no 
studies to date have shown the environmental effect of early life adversity at the global 
level.  
Studies described in Chapters 3 and 4 utilize three animal models of early life 
adversity that result in adult behavioral abnormalities, resembling neuropsychiatric 
disease. These models differ in timing, duration and severity. However, despite some 
differences in the physiological and behavioral phenotypes, all three models are 
associated with increased anxiety. This leads to the question of how such differing 
environmental triggers give rise to a phenotypic convergence on an anxiety phenotype. 
The convergence of non-genetic permanent behavioral abnormalities following early 
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life adversity suggests a common molecular and/or cellular phenotype in neuronal 
tissue. We hypothesized that the convergence of the various early life challenges 
occurs at specific regions in the genome that are inherently sensitive to environmental 
cues through development, particularly in the brain, and which can respond in an 
adaptive manner to modify gene expression and cellular phenotype.  In chapters 3 and 
4 we identified regions that undergo similar epigenetic changes in response to the 
different early life environmental challenges.  
 
1.4  Propagation of epigenetic signatures across multiple generations  
 Several studies have documented the multigenerational inheritance of 
behavioral phenotypes8,16,17,39,40. Transmission can occur either through the germline 
due to epigenetic changes in the gametes, or somatically due to the exposure of the 
offspring to the affected parent. Due to technical difficulties separating the germ-line 
from somatic inheritance, most studies using rodent models have focused on the 
paternal inheritance18,19,41.  
 However, many studies indicate that non-genetic transmission via the maternal 
line may be a more prominent mode of multigenerational inheritance of behavioral 
phenotypes4,39,42,43. Chapter 5 examines the multigenerational transmission of a 
complex maternally transmitted behavioral phenotype, reminiscent of the symptoms of 
anxiety and stress disorders. We show that transmission of the epigenetic signatures 
tracks the propagation of the behavioral phenotype across generations and that the 
individual traits are transmitted via parallel but segregated gametic and somatic 
pathways.  
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CHAPTER 2 
 
PRINCIPLES GOVERNING DNA METHYLATION DURING NEURONAL 
LINEAGE AND SUBTYPE SPECIFICATION 
 
* Sharma A.**, Klein S.L.**, Barboza L., Lodhi N., and Toth M. 2015. Principles 
governing DNA methylation during neuronal lineage and subtype specification. 
Manuscript submitted for review.  
** These authors contributed equally 	  
2.1  Introduction 
 An important question in neuroscience is to understand how neuronal lineages, 
and the large number of neuronal subtypes, are established in the CNS during 
development and how this program is perturbed in neurodevelopmental disorders. 
Neuronal development is driven by a transcriptional program consisting of 
morphogens, their downstream intracellular signaling pathways, and associated 
transcription factors. Accessibility of these factors to DNA, determined by epigenetic 
mechanisms such as DNA methylation, is believed to be a permissive requirement for 
regulation 44. An alternative model is that DNA methylation is secondary to regulation 
but cooperates with other factors to solidify the regulatory state 45,46. Whether a 
causative factor or cooperating partner in gene regulatory changes, DNA methylation 
allows the identification of regulatory regions and provides information on the gene 
regulatory landscape during neuronal lineage and subtype specification. 
 Compared to DNA binding proteins and co-factors, relatively little is known 
regarding the role of DNA methylation in neuronal development. Studies with 
neuronal progenitors, differentiated in vitro from embryonic stem cells (ESCs), 
showed that pluripotency genes are methylated and repressed while a subset of genes, 
which are active in terminally differentiated neurons, become hypomethylated and 
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bivalent 47,48. Surprisingly, few methylation changes, at least in promoters, were found 
during the transition from progenitors to postmitotic neurons 47. Another report 
described hypomethylation at enhancer-like elements and increased expression at 
nearby genes in similar neuronal progenitors 45. However, an in vitro differentiation 
system may not capture the complexities of lineage and neuronal subtype 
diversification and corresponding DNA methylation changes occurring in-vivo. 
Therefore, our aim was to determine genome-wide DNA methylation differences 
between two groups of prototypical neurons, hippocampal glutamatergic and striatal 
GABAegic, and their precursors at single base resolution to assess the contribution of 
DNA methylation to neuronal development. 
 Hippocampal and striatal neurons represent two highly divergent neuronal 
subtypes differing in several fundamental characteristics, including their origin, 
neurotransmitter identify and function. Hippocampal principal neurons, that include 
CA1 and CA3 pyramidal neurons as well as dentate gyrus (DG) granule cells (GCs), 
derive from the most medial domain of the dorsal telencephalon. In contrast, striatal 
projection neurons (medium spiny neurons or MSNs) originate from the ventral 
telencephalon. While hippocampal neurons are involved in spatial learning/memory 
and navigation, MSNs are associated with coordination of movement (dorsal) and 
reward processes (ventral). The hippocampal circuit is often implicated in epileptic 
seizures and hippocampal neurons are one of the first neuronal subtypes affected in 
Alzheimer’s disease. MSNs on the other hand, degenerate in Huntington’s disease and 
are critical in the development of Parkinson’s disease. 
 Differentiation of ESCs to neuron-restricted neuronal progenitors and then to 
subtype specific neurons in the CNS is a gradual process of diversification. ESCs in 
the inner cell mass of the embryonic (E) 3.5 day blastocyst undergo progressive fate 
restriction and sequentially give rise to tissue-specific multipotent progenitor cells, 
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including neural progenitors in the ventricular germinal layer in the E9.5-10.5 
telencephalon (Fig. 2.1A, developmental stage-1). Hippocampal progenitors (HPs) are 
derived from the epithelium of the ventricular germinal layer, while striatal 
progenitors (SP) from the lateral ganglionic eminence 49-51 (Fig. S2.1A). The regional 
specification of these progenitors is regulated by morphogens produced in patterning 
centers. The dorsal telecephalon is patterned by Wnt via the canonical Wnt pathway 
and bone morphogenic proteins, both derived from the cortical hem, an area in the 
dorsal midline in the telencephalon 52,53. Specification of ventral telencephalic 
progenitors is regulated by sonic hedgehog secreted from the rostrocaudal axis of the 
neural tube 54. The graded signaling of dorsal and ventral morphogens is translated 
into regional transcription factor codes 49. For example, in HPs, LEF1/TCF proteins, 
nuclear mediators of Wnt signaling, are required for patterning and proliferation 53. In 
contrast, SP specification is controlled by the homeodomain transcription factor GSH2 
and the proneural basic helix-loop-helix factor MASH1 55,56.  
 The next phase in neuronal development, between E10.5 and 17.5, is 
neurogenesis and early differentiation that produce postmitotic “young” CA (yCA) 
neurons from HPs in the CA region of the hippocampus 57(Fig. 2.1A, developmental 
stage-2, Fig. S2.1B). Neurogenesis of yGCs in the developing DG of the hippocampus 
is delayed, peaking during the first week of postnatal (P) life in rodents (Altman and 
Bayer, 1990a). Propagation/differentiation of SPs occur between E13.5 and E17.5, 
producing postmitotic yMSNs in the developing striatum 58(Fig. S2.1B).  
Final maturation of neurons in both the hippocampus and striatum begins prenatally 
and continues postnatally (Fig. 2.1A, developmental stage-3).  
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2.2  Results 
Alternating waves of gain and loss of methylation in the telencephalon during 
neuronal development  
We determined DNA methylation patterns in two distinct neuronal lineages 
across development; starting with pluripotent stem cells that produce dorsal and 
ventral telencephalic neural progenitors, which in turn differentiate to various 
hippocampal and striatal neurons (Fig. 2.1A). In principle, methylation changes can be 
measured in two “dimensions” during neuronal development; “vertically” through 
discrete steps of development in individual lineages (developmental specific) and 
“horizontally” across lineages/subtypes at each developmental stage (Fig. 2.1B). 
Differences in developmental methylation between lineages create lineage/subtype 
specificity. ESCs, which can be differentiated towards the neuronal fate 59 were used 
as reference. Mouse ESCs, presumably because of their serial propagation in culture, 
have a DNA methylation pattern similar to that of E6.5 epiblasts 29,47, the last of 
pluripotent undifferentiated cells in the embryo 60. Indeed, we found a high 
concordance between methylation in our ESCs and in E6.5 epiblasts 29 at CpG sites 
(Fig. S2.2A). Because of its higher coverage, our ESC dataset was used in all studies. 
Progenitors and young neurons were isolated by microdissection from cryosectioned 
slices of E10.5 and 17.5 brains, respectively (Fig. S2.1A, B). Neuronal cell bodies 
were isolated from cryoslices of DG and CA, regions that have a low number of non-
neuronal cells, from adult brains (Fig. S2.1C, D). MSNs, which are more dispersed in 
the dorsal and ventral striatum, were obtained by fluorescent activated cell soring 
(FACS)(Fig. S2.1AE, F). In addition to minimize contamination by non-neuronal cells 
during sample preparation, the threshold for differential methylation was set to 20% 
(beyond statistical difference) to further minimize that changes in methylation are due 
to the presence of non-neuronal cells. The ten isolated populations of cells, ranging 
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from pluripotent ESCs through neuronal progenitors to young and mature 
postmitotic neurons, were subjected to enhanced reduced representational bisulfite 
sequencing 61, a method that is less biased to CpG rich regions than the traditional 
RRBS but relatively cost effective because up to 90% of reads of full genome 
sequencing are not informative (i.e. have no cytosines). Differentially methylated 
regions (DMRs) were defined as clusters of >4 differentially methylated sites 
(>20%; p<0.01, SLIM-corrected), either at CpG or non-CpG (CpH) dinucleotides, 
with inter CpN distance of <1kb. The size of DMRs ranged between 1,000 and 
1,400 bps and contained 5.7-7.3 differentially methylated sites across 
developmental stages and between neuronal subtypes (Fig. 2.1B).  
We found large-scale changes in methylation, with alternating hyper-, hypo- 
and again hypermethylation, through the three distinct periods of neuronal 
development (Fig. 2.1C). During the establishment of progenitors (up to E10.5, stage-
1), approximately one tenth of the 1.48 and 1.36 million profiled CpG sites were 
differentially methylated within clusters (10.4% and 9.6% of CpGs in HPs and SPs, 
respectively), with relatively few clustered changes at the ~6.5 million profiled non-
CpG sites (0.1%). Most of these changes involved hypermethylation (93.4% and 
92.6% in HPs and SPs, respectively, Fig. 2.1C). During neurogenesis/early 
differentiation (stage-2), as progenitors gave rise to young postmitotic neurons, there 
was a substantial loss of methylation and/or active demethylation, both in the dorsal 
and ventral telencephalon (Fig. 2.1C). Again, changes were almost exclusively at CpG 
sites. Finally, during the third period, as young neurons matured to field specific 
CA1/CA3 pyramidal neurons, GCs and MSNs, methylation again increased (Fig. 
2.1C). Substantially more methylation occurred in the striatal than hippocampal, 
lineage. In contrast to the two previous developmental periods, methylation in this 
period involved not only CpGs but CpH sites as well (23.2% and 33.2% of the 
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methylated CpNs in CA1 neurons and MSN, respectively). CpH methylation took 
place mainly in CpA context, in agreement with previous reports 62-66. In conclusion, 
the neuronal genome undergoes alternating, largely unidirectional changes, at 
consecutive stages of neuronal development.   
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Figure 2.1. Dynamics of DNA methylation during hippocampal and striatal 
neuron development. A. Schematic diagram of the developmental “tree” of 
hippocampal and striatal lineages in the telencephalon. DNA methylation changes 
were studied during three consecutive developmental periods that span the production 
of progenitors in the telencephalon (stage 1), neurogenesis and early differentiation to 
“young” (y) neurons (stage-2) and maturation to subtype specific neurons (stage-3). 
HP and SP, hippocampal and striatal progenitors; yCA, young CA neuron; yGC, GC, 
granule cell; MSN, medium spiny neuron; d, dorsal; v, ventral; CPu, caudate putamen; 
NAc, nucleus accumbens. B. Methylation differences are analyzed vertically, through 
development within lineages and horizontally, across lineages and subtypes. 
Differentially methylated regions (DMRs) are defined as regions with 4 or more 
clustered differentially methylated sites (DMSs). C. Hyper- and hypomethylation at 
CpGs (grey bars) and CpHs (black bars) during the three developmental periods, as 
shown in “A”, in the hippocampal and striatal lineages. D. Extensive overlap between 
lineages during proliferation and early differentiation but diversification in 
differentially methylated sites during maturation. E. Lineage differences in CpG and 
CpH methylation across development and subtype specific methylation differences in 
mature neurons. F. Developmental time course of Tet mRNA levels. G. Inactivation 
of Dnmt3a in developing GCs prevents gain in methylation during GC maturation. T-
cre-, control; T-cre+, cre-induced inactivation of Dnmt3a. 
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Regulation of loss and gain of methylation during neuronal differentiation 
To explain the mostly uniform loss of methylation during the progenitor to 
young neuron transition (stage-2, Fig. 2.1C), we surveyed the expression of all known 
enzymes with confirmed or putative DNA demethylase activity by RNA-Seq. We 
found a 5 and 7-fold increase in apobec2 expression in yCA neurons and yMSNs, 
relative to that in HPs and SPs, respectively. Although the AID/APOBEC family has 
been implicated in demethylation 67, more recently APOBEC2 and other members of 
the APOBEC family have been shown to have no or minimal activity at methylated 
cytosines 68. Consistent with the latter data, differentially methylated sites that were 
hypomethylated in P5 WT yGCs were also hypomethylated in apobec2–/– yGCs, 
indicating no consequence of the absence of the protein on methylation. Alternatively, 
loss of methylation could be due to active demethylation by the ten-eleven 
translocation (TET) family of enzymes via hydroxylation, followed by reversion to 
unmethylated cytosines through iterative oxidation and thymine DNA glycosylase-
mediated base excision repair 69. Expression of Tet1 and Tet2 were high in ESCs but 
declined from the progenitor stage and remained low through neurogenesis and 
maturation. In contrast, expression of Tet3 was initially low in ESCs, higher in 
progenitors and young neurons, and again low in mature neurons. This time course is 
most consistent with loss of methylation between the progenitor and young neuron 
stages and gain in methylation in the preceding and consecutive periods (Fig. 2.1F). 
Finally, passive loss of methylation could also be a contributing factor due to 
proliferation during the progenitor to young neuron transition. Overall, these data 
suggest that both active demethylation via Tet3 and passive demethylation may have a 
role in the substantial loss of methylation during early neuronal differentiation. 
In the next developmental stage, characterized by the transition of young to 
mature neurons in the hippocampus and striatum (stage-3, Fig. 2.1C), there was an 
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overall gain in methylation at both CpG and non-CpG sites. The de novo 
methyltransferase DNMT3a is essential for CpH methylation 65,66,70. Therefore, we 
conditionally inactivated Dnmt3a by tamoxifen inducible nestin-creERT2, from E13.5 
in the hippocampus (75-85% knockdown efficiency), before the young to adult GC 
transition at E17.5. This prevented the developmental gain in methylation in GCs (Fig. 
2.1G), implicating Dnmt3a in the gain of methylation during GC maturation. 
Lineage specific DNA methylation differences are minimal during neuronal 
proliferation and early neuronal differentiation, but substantial during neuronal 
maturation 
A large fraction of the developmentally methylated sites (76% and 88% for HP 
and SP, respectively), mapped to the same CpG sites, with the same direction of 
change, in the two lineages (Fig. 2.1D, Fig. S2.2B). Significant methylation 
differences between HPs and SPs were found at only 1,038 CpG sites (Fig. 2.1E), 
much less than the number of developmentally modified sites (lineage vs. 
developmental ratio of ~1:100). In contrast, lineage diversity at the transcriptome level 
was much greater (lineage vs. developmental specific transcript ratio of ~1:10; i.e. 946 
HP-SP vs. 10,374 ESC-HP/10,640 ESC-SP, RNA-Seq, FDR <0.05). This indicates 
that the neuronal DNA methylation program during progenitor proliferation may only 
minimally contribute to lineage specification.  
During the progenitor to young neuron transition (stage-2), most sites were still 
similarly modified in the two lineages (Fig. 2.1D). Consequently, the number of 
lineage, compared to development specific differentially methylated sites (Fig. 2.1E) 
was still low (~10:1). This is in contrast to the ~1:2 lineage vs. developmental gene 
expression ratio (4,114 yCA-yMSN vs. 9,165 HP-yCA/8,885 SP-yMSN). This 
suggests that DNA hypomethylation during the transition of progenitors to young 
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neurons is still primarily associated with common, lineage-independent, neuronal 
changes. 
In contrast to the previous developmental stages, neural maturation was 
characterized by 3-4 times more methylated sites in the striatum. This resulted in less 
overlap between the lineages (Fig. 2.1D), and consecutively larger diversity across 
lineages (Fig. 2.1E). Modifications at CpHs contributed to these lineage and subtype 
specific methylation changes. As a result, the lineage and developmental methylation 
(Fig. 2.1C and E), similar to the lineage vs. developmental expression changes (CA1-
dMSN vs. yCA-CA1/yMSN-dMSN), were in par. Methylation differences were 
observed not only between hippocampal and striatal mature neurons, but between 
neuronal subtypes within brain regions as well, particularly in the hippocampus (Fig. 
2.1E). This suggests that the DNA methylation program progresses in a field specific 
manner in the hippocampus, while the striatal pattern remains relatively uniform in the 
dorsal and ventral compartments. This is consistent with the successive birth and 
migration of CA3, CA1 and finally GC neurons in the hippocampus. In contrast, the 
dorsal and ventral MSNs, destined to the caudate-putamen and nucleus accumbens, are 
produced and migrate simultaneously 58,71. Taken together, the developmental 
methylation program is remarkably similar initially in the hippocampus and striatum, 
with significant divergence only occurring during neuronal maturation.  
Widespread DNA methylation at partially methylated sites during neuronal 
progenitor proliferation 
Methylation during the establishment of the progenitor pool was targeted to 
sites with an intermediate level of methylation (25-75%) in ESCs (and in E6.5 
epiblasts). Methylation shifted to a higher level in both the dorsal and ventral 
progenitors (Fig. 2.2A). Intermediately methylated sites represents a minority of all 
CpGs in ESCs and epiblasts (Fig. S2.2A), since methylation is bimodal, with most 
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CpG sites either methylated (>75%) or unmethylated (<25%)(Fig. 2.2A; Controls). In 
inbred mice, like those used in our experiments, intermediate methylation reflects cell-
to-cell variability (except at imprinted genes)72,73. Indeed, differentially methylated 
sites on the X-chromosome were also intermediately methylated in male ESCs. 
Intermediate/variable methylation in ESCs and E6.5 epiblasts may represent 
epigenetic mosaicism due to ongoing, yet uncompleted reprogramming at these sites, 
that follows the erasure of methylation marks in the early embryo 28.  
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Figure 2.2. Characteristics of DNA methylation during progenitor proliferation. 
A. Distribution of methylation levels at proliferation specific differentially methylated 
sites (DMSs) across development, as compared to the methylation of all CpG sites 
(Control) in ESC and HP/SP. Sites with intermediate methylation in ESCs (and in 
epiblasts) are preferentially targeted, while genomic CpGs overall show a bimodal 
distribution in ESCs and progenitors (see Controls in frame). The sites with 
intermediate methylation in ESC acquire high methylation level in hippocampal and 
striatal progenitors (HP and SP) and maintain it through neuronal differentiation. In 
oocytes and sperms, as well as in zygotes, CpGs at proliferation specific differentially 
methylated sites have the typical bimodal methylation distribution and are 
demethylated during reprogramming in the inner cell mass (ICM). B. Enrichment and 
depletion of proliferation-related DMSs in genomic features (fold difference, as 
compared to the representation of all profiled CpGs). C. Heat map representation of 
methylation levels emphasizing the permanence of most HP and SP DMSs across 
development. D and F. Genes with differential methylation and expression (mean 
methylation of differentially methylated sites within a gene). Hypermethylation during 
HP and SP proliferation is associated with both gene activation and repression. E, G. 
Hypermethylated/upregulated (red) and hypermethylated/downregulated (blue) genes 
belong to different functional categories in both the dorsal and ventral telencephalon.
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Surveying the genomic location of differentially methylated sites between 
ESCs and progenitors, we noticed their exclusion from CpG rich areas, such CG island 
(CGI) promoters. This is consistent with the known resistance of CGIs to methylation 
47,74. However, ESC-HP/SP differentially methylated sites were enriched in multiple 
other genomic features (Fig. 2.2B). This included a substantial fraction of non-CGI 
promoters (5474 and 4498 in hippocampus and striatum, respectively) and which 
became predominantly methylated (87% and 90% in HP and SP) relative to ESCs. 
Although the enrichment was lower, extensive methylation also occurred at exons, 
introns and intergenic regions in progenitors. Heatmap representation of the 
methylation data indicated that the gain in methylation during progenitor development 
was mostly permanent (Fig. 2.2C). Only 9.6% and 10.2% of the ESC-HP, and 7.5% 
and 14.3% of the ESC-SP differentially methylated sites, were modified again during 
the progenitor to young neuron and young to mature neuron transitions, respectively 
(Fig. S2.3). Only a small fraction of sites (1.9 and 3.5%) were modified in all three 
stages of development in the dorsal and ventral telencephalon.  
In accordance with the genome-wide methylation during proliferation, a large 
number of genes were differentially methylated (8,329 ESC-HP and 7,865 ESC-SP 
genes). Approximately 60% of differentially methylated genes were also differentially 
expressed (DMR x DE genes) and could be divided into four categories according to 
the direction of their methylation and expression change (Fig. 2.2D,F). The majority 
of DMR x DE genes were hypermethylated, consistent with the overall gain in 
methylation during this period (Fig. 2.1C), but were associated with both gene 
activation and repression. Gene ontology analysis by Ingenuity Pathway Analysis 
(IPA) showed that the upregulated/hypermethylated and 
downregulated/hypermethylated groups of genes were enriched in different functional 
categories (Fig. 2.2E,G). Upregulated genes were enriched in the cellular processes of 
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proliferation, neuritogenesis and even neurotransmission. This suggests that aside 
from stage-specific changes, epigenetic and transcriptional changes supporting later 
differentiation processes are also underway. In contrast, downregulated genes were 
solely enriched in apoptotic function. Thus, while there is no global correspondence 
between methylation and expression during progenitor proliferation, within specific 
functional categories methylation correlates with increased or reduced gene 
expression. 
Intronic and intergenic methylation during neuronal differentiation 
Developmental methylation changes, predominantly hypomethylation, during 
the progenitor to young neuron transition (Fig. 2.1A, stage-2) were concentrated in 
introns, and, to a lesser extent, in intergenic areas, while excluded from promoters and 
exons (Fig. 2.3A and Fig. S2.4). The modified sites had predominantly high 
methylation in progenitors, which was drastically shifted to a low methylation level in 
yCA neurons and yMSNs (Fig. 2.3B), as well as in yGCs. While loss of methylation 
during the progenitor to young neuron transition was mostly permanent in the 
hippocampus, a significant fraction of SP-MSN differentially methylated sites were 
remethylated in adult neurons (Fig. 2.3C).  
During the transition from young to mature neurons (Fig. 2.1A, stage-3), 
intron-specific methylation changes were also more abundant (Fig. 2.3E); but instead 
of loss, sites gained methylation, both at CpG and CpH sites (Fig. 2.3F). Introns were 
also the preferred targets during GC development.  
  
	  21	  
Figure 2.3. Characteristics of DNA methylation during neuronal differentiation 
from progenitors to young neurons (A-D) and then from young to mature 
neurons (E-G). A. Enrichment and depletion of young neuron specific differentially 
methylated sites (DMSs) in genomic features (fold difference, as compared to the 
representation of all profiled CpGs). B. Distribution of methylation levels in 10% bins 
at HP-yCA and SP-yMSN DMSs, as well as all profiled CpGs, before (blue) and after 
(red) the developmental transitions. C. Heat map representation of methylation levels 
at HP-yCA and SP-yMSN DMSs through development, illustrating that loss of 
methylation during the progenitor to young neuron transition is mostly permanent, 
except at a fraction of SP-yMSN DMSs that are remethylated in adult neurons. D. 
Selected young neuron specific DMRs have promoter and/or enhancer-like activity in 
transfected neuronal N2A cells (ANOVA: basic vector, F6.14=3.272, P=0.032; 
promoter vector, F6.14=13.594, P<0.0001, LSD posthoc, *p<0.05, **p<0.01, 
***p<0.005, #p<0.01 trend). Luciferase expression is expressed in fold change, 
relative to activities in cells transfected with basic (left panel) and promoter vector 
(right panel). Positive controls are basic vector with EF1 promoter (left panel) and 
promoter vector with CMV enhancer (right panel). E. Enrichment and depletion of 
mature neuron specific DMSs in genomic features (fold difference, as compared to the 
representation of all profiled CpGs). F. Distribution of methylation levels in 10% bins 
at yCA-CA and yMSN-MSN DMSs, as well as at all genomic sites, before (blue) and 
after (red) the developmental transitions, at CpG and CpH sites. G. Selected mature 
neuron specific DMRs have no promoter but significant enhancer-like activity in N2A 
cells (ANOVA: promoter vector, F4.10=27.983, P<0.0001, LSD posthoc, *p<0.05, 
***p<0.005). Luciferase expression is expressed in fold change as indicated in D. An 
intergenic Drosophila control sequence has neither promoter nor enhancer activity. 
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Intronic DMRs exhibit promoter and enhancer activities 
The preferred intronic localization of DMRs suggested alternative promoter 
and/or enhancer function. Therefore, we used luciferase reporter constructs in 
neuronal N2A cells to determine possible promoter and/or enhancer activity. One out 
of the four intronic DMRs (~200 bp), hypomethylated in both yCA neurons and 
yMSNs relative to HPs and SPs, exhibited promoter activity (Gria1, glutamate 
receptor (AMPA) 1), while two enhanced the activity of the EF1 promoter (Grid2, 
glutamate receptor, ionotropic, delta 2 and Gria1, trend only) (Fig. 2.3D). 
Additionally, two selected intronic DMRs, hypermethylated in CA1 neurons and 
dMSNs relative to yCA neurons and yMSNs, exhibited significant enhancer activity 
(Park2, parkin 2 and Crhr1, corticotrophin receptor 1; Fig. 2.3G), but no promoter 
activity. In contrast, an arbitrary 208 bp long intergenic drosophila sequence had 
neither promoter nor enhancer activity. These data indicate that at least some of the 
intronic DMRs associated with the transition of progenitors to young neurons, and 
young to mature neurons, have promoter and/or enhancer activity and could thus 
regulate isoform and/or overall gene expression.  
 
Intersecting DNA methylation and gene expression changes across differentiation 
identifies developmental stage-specific functional gene clusters 
Functional analysis was performed with genes which were differentially 
methylated in intronic/intergenic regions during the progenitor to young neuron 
transition. They exhibited enrichment in a wide range of developmental functions, 
including proliferation, migration, neuritogenesis, and synaptic transmission, in both 
the hippocampal (Fig. S2.5A) and striatal lineages. These functional categories were 
still strongly represented in the next, final maturation stage (Fig. S2.5B). Overall, 
these functional categories aligned with the consecutive steps along neuronal 
	  24	  
differentiation, indicating that many neurodevelopmentally relevant genes undergo 
methylation changes during developmental transitions.  
These developmental categories (from proliferation to neurotransmission) 
were also identified when the analysis was repeated with genes that were both 
differentially methylated and expressed during early differentiation. Consistent with 
the overall loss of methylation during this stage (Fig. 2.1C), the majority of 
corresponding DMRxDE genes were hypomethylated, but split to up- and 
downregulated groups (Fig. 2.4A). Downregulated genes (many of them transcription 
factors) were enriched in brain morphogenesis, in agreement with the closure of major 
morphogenic processes in the brain by the end of neuronal proliferation (Fig. 2.4B). 
Upregulated genes represented functions from neuronal proliferation, through 
migration, and neuritogenesis, to synaptic transmission. This analysis was repeated 
with genes that were DMRxDE during late differentiation/maturation. Though this 
period is characterized by gains in methylation (Fig. 2.1C), a significant fraction of 
DExDMR genes were hypomethylated (Fig. 2.4C). We therefor analyzed all 
combinations of expression and methylation changes by IPA. Although we still 
identified genes enriched in neuronal proliferation and migration functions, they were 
hypermethylated/downregulated, i.e. hyper/down, in contrast to their hypo/up status 
during the previous progenitor to young neuron transition (Fig. 2.4B, D). This switch 
from up- to downregulation reflects the cessation of proliferation and migration in 
both the hippocampal and striatal lineages. Genes associated with ongoing maturation 
processes (neuritogenesis and synaptic transmission) were hypo/up, like in the 
previous developmental stage. Although most of the hypo/up genes during early and 
late differentiation (stage-2 and -3) were different, some of them underwent two 
rounds of changes (red dots in Fig. 2.4C), suggesting a stepwise gene regulatory 
process, presumably to meet different demands during early and late differentiation.   
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Figure 2.4. Intersecting DNA methylation and gene expression changes during 
differentiation identifies developmental stage-specific gene clusters. A. Genes 
differentially methylated during the progenitor to young neuron transition are mostly 
hypomethylated, but can be either up- (hypo/up, red) or downregulated (hypo/down, 
blue). Very few genes are hypermethylated. Numbers in the individual quadrants 
represent Parson expression vs. methylation correlation p values. B. IPA analysis of 
hypo/up and hypo/down genes. Enrichment p values for these two groups of genes for 
highly significant functional categories are displayed in quadrants that correspond to 
their expression/methylation status, as in A. No IPA analysis was performed with 
hyper/up and hyper/down genes because of their low number. Hypo/down genes are 
associated with the early steps of brain formation, while hypo/up genes are enriched in 
a series of neuronal functions that align with the progressive steps of differentiation 
from migration to synaptic transmission. The enrichment score values in the four 
quadrants are connected, thus areas in the individual quadrants reflect the level of 
significance for each group of genes. C. Genes, differentially expressed during the 
young to mature neuron transitions are mostly hypermethylated, especially in the 
striatal lineage, but a substantial number of hypomethylated genes are also present. 
Genes, previously altered during the progenitor to young neuron transition are 
highlighted red (previously hypo/up, A) and blue (previously hypo/down). D. IPA 
analysis of genes distributed to four groups in C, based on their expression and 
methylation. Only highly significant functions are displayed. Hyper/down genes are 
enriched in functions associated with early brain development, progenitor 
proliferation and migration. Hypo/up genes are associated with later differentiation 
processes, from neuritogenesis to synaptic transmission.  
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Taken together, we conclude that differentially methylated genes are enriched 
in neurodevelopmental functions; upregulated genes representing current and 
consecutive stage-specific functions, while downregulated genes representing 
preceding functions that are no longer required. However, these data are only 
associational. Further studies will be needed to demonstrate that, depending on the 
developmental stage, both hypomethylation and hypermethylation can downregulate 
gene expression (i.e. brain formation cluster in stage-2 and -3, Fig. 2.4B, D), as well 
as whether the switch from hypomethylation to hypermethylation at intronic 
sequences can turn activation to repression (i.e. proliferation and migration genes in 
stage-2 and -3).  
 
Neuronal subtype specific DNA methylation and gene expression changes 
Methylation differences between the lineages (hippocampal vs. striatal) 
emerged in substantial numbers, on par with transcriptional changes, during 
maturation (Fig. 2.1E). Therefore, we analyzed genes DMRxDE between CA1 
neurons/GCs and dMSNs by IPA. This analysis identified well known, as well as 
unexpected gene expression and functional differences. As expected, genes with 
higher hippocampal expression (CA1>MSN) were enriched at a higher level in the 
process of spatial learning (Fig. 2.5A, upregulated). In contrast, genes upregulated in 
MSNs (MSN>CA1/GC), were associated with disorders of the basal ganglia, 
Huntington’s disease, and movement disorders, consistent with the specificity of these 
genes and their expression to the striatum. Because hypomethylated genes, within the 
upregulated category, had a higher enrichment value, DNA methylation may inversely 
correlate with expression at many of these neuron-subtype specific genes.  
Neuron-subtype specific DMRxDE genes were also enriched in specific 
cellular functions. Genes, upregulated in hippocampal relative to striatal neurons, were 
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associated with neuritogenesis and synaptic transmission, suggesting more robust 
neuronal plasticity in the hippocampus (Fig. 2.5B). Furthermore, CA1/GC>MSN 
genes were enriched in the processes of long-term potentiation (LTP), long-term 
depression (LTD), and excitatory postsynaptic potential, distinctive functions in the 
hippocampus. In contrast, genes upregulated in MSNs relative to CA1/GC were 
associated with striatal LTD, a process that is different from hippocampal LTD. 
Striatal LTD is postsynaptically induced, but presynaptically expressed, through 
retrograde endocannabinoid signaling 75. Hippocampal LTD is postsynaptic and 
involves internalization of synaptic AMPA receptors 76. In these categories of genes, 
upregulated genes were either hypomethylated or hypermethylated.  
Next, genes upregulated in hippocampal relative to striatal neurons were 
enriched in the molecular function of phosphorylation of proteins (Fig. 2.5C). In 
contrast, genes upregulated in the striatum were enriched in GABA metabolism and 
cAMP synthesis, consistent with the neurotransmitter phenotype of MSNs and the 
Gs/Gi coupling of the striatal dopamine receptors, respectively. Surprisingly, striatal 
upregulated genes were also enriched in membrane lipid synthesis and steroid 
biosynthesis. Besides their role as structural elements, membrane lipids are involved in 
a multitude of signaling processes and de novo steroid biosynthesis of neurons 
(estrogens, progesterone, and androgens) 77. Our data suggest that lipid signaling and 
central steroid biosynthesis could be more prominent in the striatum than in the 
hippocampus.  
Finally, we analyzed genes DExDMR between CA1 neurons and GCs to assess 
if concurrent methylation and expression differences reflect neuron subtype specificity 
within the hippocampus (Fig. S2.5C). This analysis identified genes upregulated in 
GCs relative to CA1 neurons, which were enriched in the biological processes of 
proliferation, migration and neuritogenesis. These functions are consistent with the 
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persistent neurogenesis and neuronal replenishment in GCL throughout life, as 
opposed to the lack of adult neurogenesis in the CA1 layer of the hippocampus. 
Moreover, genes related to the metabolism of phosphatidylinositol membrane lipids 
were upreglated in GCs suggesting a difference in major signaling pathways, such as 
AKT, between GCs and CA1. Finally, sphingolipid metabolism was also a more 
prominent function in GCs. Sphingolipids are enriched in raft-like microdomains, 
specialized membrane domains where transmembrane signaling occurs through 
receptors and associated signaling components 78. Genes upregulated in CA1 neurons, 
relative to GCs, were enriched in only a few specific functions with modest scores. No 
functional differences were found between dMSNs and vMSN. This is in agreement 
with the minimal methylation differences between these two closely related neuronal 
subtypes (Fig. 2.1E).  
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Figure 2.5. IPA analysis of neuronal subtype-specific DMRxDE genes between the 
hippocampus and striatum (CA1 vs. dMSN and GC vs. dMSN). Description of the 
figure is identical to that in Fig. 2.4B.  
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2.3 Discussion 
Our work describes, for the first time, a set of simple principles that govern in 
vivo DNA methylation and demethylation during neuronal development. By dividing 
neurodevelopment to 3 major stages and applying the principles to each of these 
stages, we created a matrix that comprehensively describes DNA methylation and 
demethylation events in two neuronal lineages and five different neuronal subtypes; a 
total of ten cell types spanning the entire neurodevelopment (Fig. 2.6).  
First, we found alternating large-scale gains and loss of methylation through 
neuronal development. Although ESCs highly express both Dnmt3a and Dnmt3b, 
Dnmt3a is the predominant de novo DNA methyltransferase involved in the transition 
of ESCs to neuronal progenitors 79. Loss of methylation during early differentiation 
(E10.5-E17.5) was associated with an increase in Tet3 (Fig. 2.1F) suggesting its role 
in active demethylation, with the potential involvement of passive methylation. 
Indeed, several lines of evidence indicate a fundamental role for Tet3, and associated 
active demethylation, during neuronal differentiation and maturation. Genetic deletion 
of Tet3 results in neonatal lethality in mice 80, depletion of Xenopus xlTet3 causes 
small head and eyeless phenotype 81, knockdown of TET2 and TET3 expression in 
E13.5 mouse embryonic cortex leads to abnormal cortical development at E17.5 82, 
and Tet3 knockout ESCs exhibit impaired neurogenesis and increased apoptosis 83. 
Methylation during neuronal maturation (from P5 in DG) was likely related to Dnmt3a 
activity because its conditional knockout prevented the gain in methylation that 
normally occurs when young GCs undergo maturation. Evidence supports the 
importance of Dnmt3a in neuronal maturation and/or mature neuron functioning. 
Conditional deletion of Dnmt3a in postmitotic excitatory neurons in the mouse 
forebrain, shortly after birth, caused no apparent behavioral or brain structural 
abnormalities in one report 84. However, others described that Dnmt3a deficient ESCs 
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have impaired neurogenic potential 79 and that Dnmt3a2, the shorter isoform encoded 
by the Dnmt3a gene, is linked to cognitive performance in mice 85. These data suggest 
that specific enzymes of the methylation/demethylation machinery may explain the 
large-scale changes in methylation dynamics through development. 
The second principle underlying developmental methylation is related to the 
dinucleotide context of the methylated and demethylated cytosines. Initially, gain and 
loss of methylation are limited to CpG sites, while during neuronal maturation changes 
also occur at a significant number at non-CpG sites in both the hippocampal and 
striatal lineages. This finding is consistent with previous observations of non-CpG 
methylation in mouse frontal cortex during fetal to young adult development 30 and 
with the high mCpH content of the adult brain 62,86. In summary, these data indicate 
that CpH methylation ensues after neurons became postmitotic while undergoing 
field-specific maturation. 
The third principle is that the developmental methylation program is 
remarkably similar in the hippocampus and striatum, with significant divergence only 
during neuronal maturation. This is in contrast to the transcriptional program that 
shows substantial lineage differences from the progenitor stage through 
neurodevelopment. Interestingly, the DNA methylation program of hematopoietic 
cells is the exact opposite, dominated by lineage specific, over developmental stage 
specific, methylation changes 87. 
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Figure 2.6. The five general principles governing DNA methylation during lineage 
and subtype specific development. These are: i) The program consists of 3-stages 
(1+2+3). An initial genome-wide methylation during progenitor proliferation is 
followed by a loss of methylation during the transition of regional progenitors to 
“young” hippocampal and striatal neurons, which is then reversed by a gain in 
methylation during maturation to subtype specific neurons. ii) At the first two stages, 
gain and loss of methylation are limited to CpG sites, while during the third 
maturation stage methylation also occurs at non-CpG sites in both lineages (1/2+3). 
Paralleling these events, iii) targets of methylation/demethylation are initially highly 
similar in the two lineages, while diversification in methylation during maturation 
creates subtype specific methylation differences (1/2+3). iv) At first, methylation 
targets all genomic locations, while later, during early and late differentiation the 
preferred targets are intronic and intergenic sequences with enhancer-like activity 
(1+2/3). v) Differentially methylated genes are enriched in neurodevelopmental 
functions (from progenitor proliferation, through migration and neuritogenesis, to 
synaptic transmission); upregulated genes representing current and consecutive stage 
specific functions, while downregulated genes representing preceding functions that 
are no longer required (1+2+3).
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The fourth principle is that methylation during progenitor proliferation targets 
most genomic features, except CGI promoters, while later, during young and mature 
neuron development, loss and gain of methylation occurs preferentially at introns. The 
initial, large-scale methylation during progenitor proliferation could promote genome 
integrity since hypomethylated DNA is structurally instable and mutable 88,89. The 
targeted methylation changes during differentiation could serve regulatory functions, 
as some of these sites exhibited enhancer-like activity.  
Finally, differentially methylated genes were enriched in neurodevelopmental 
functions; hypomethylated/upregulated genes representing current and consecutive 
stage-specific functions, while hypermethylated/downregulated genes representing 
preceding functions that are no longer required. This indicates that while there is no 
global correspondence between methylation and expression during neuronal 
development, methylation correlates with gene expression within specific functional 
categories. For example, during early differentiation (E10.5-E17.5), genes with 
functions in neuronal migration, neurite formation, and even synaptogenesis and 
synaptic transmission underwent intronic hypomethylation and associated activation, 
well before the manifestation of the associated functions. Adjustments in intronic 
methylation, again preferential hypomethylation, accompanied by gene activation, 
continued during maturation (from E17.5) in neuritogenesis and synaptic transmission 
genes. In contrast, proliferation and migration genes whose expression is no longer 
required during maturation underwent intronic methylation and downregulation. This 
suggests that DNA methylation is not secondary to prior, other epigenetic 
modifications. Rather, consistent with numerous reports 90-93, methylation could be 
directly involved in modulating the accessibility of transcription factors and co-factors 
to DNA during neurodevelopment.  
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The overarching theme emerging from our work is that neuronal 
methylation/demethylation is principally associated with differentiation, with minimal 
lineage specificity, but later, during neuronal maturation, methylation contributes to 
neuron subtype specification. Beyond increasing our understanding of the epigenetic 
regulation of normal development, this work will be useful in research focused on 
neurodevelopmental disorders. Neuronal development, like development in general, is 
highly vulnerable to environmental perturbations. Developmental perturbations can 
lead to persistent abnormalities, exemplified by autism and schizophrenia stemming 
from severe maternal gestational infection, or child and adolescent behavioral 
problems emerging following pre/postpartum maternal stress and maltreatment 42,94,95. 
These early life adverse conditions are associated with persistent alterations in the 
methylome in human and animal models 26,96,97. Interference with the normal 
developmental dynamics of DNA methylation or overriding the already established 
developmental pattern by adverse early life experiences can be fundamental in the 
etiology of the resulting psychopathology or psychiatric disease-like behaviors in 
animal models. Our developmental methylation matrix can be cross-referenced with 
disease associated methylation changes to specify the possible events, and underlying 
principles, compromised in disease. 
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2.4 Methods 
Mice 
Animal experiments were carried out in accordance with the Weill Cornell 
Medical College Institutional Animal Care and Use Committee guidelines. All mice 
were group-housed up to five per cage, with 12-h light/dark cycle and with lights on at 
6 a.m. Food and water were available ad libitum. Wild-type C57BL/6 males were 
purchased from The Jackson Laboratory (Bar Harbor, ME). Conditional Dnmt3a 
knockout males were generated by breeding C57BL/6 mice carrying floxed Dnmt3a 
alleles (Dnmt3af/f)98(provided by Riken BioResource Center, Koyadai, Tbukuba, 
Ibaraki, Japan) and mice heterozygous for the tamoxifen inducible nestin-cre-ERT2 
transgene 99(kindly provided by Luis Parada, University of Texas Southwestern 
Medical Center, Dallas, Texas). Dnmt3af/f;Cre- females were crossed with 
Dnmt3af/f;Cre+ males to obtain Dnmt3af/f;Cre-.and Dnmt3af/f;Cre+ littermates. To 
induce Cre mediated Dnmt3a excision, pregnant females were injected with 6.7ug/kg 
tamoxifen at E13.5, as described 99. Since gestational tamoxifen injection interferes 
with females’ maternal care behavior, newborn pups were crossfostered to WT 
mothers.  
Tissue Collection for DNA isolation 
ESCs were cultured as described previously 86. Briefly, E14 ESCs were 
cultured on feeder cells (mitomycin-inactivated mouse embryonic fibroblasts) for at 
least two passages after thawing. Cells were split every 2 days with plating densities 
between 1.5 x 106 and 4 x 106 cells, on 10-cm cell culture plates. ESC medium was 
based on DMEM containing 15% ESC quality fetal bovine serum, LIF (1,000 U/ml, 
Millipore, Billerica, MA, USA), 1X non-essential amino acids, 2mM L-glutamine and 
β-mercaptoethanol (Invitrogen, Carlsbad, CA, USA). 
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Hippocampal progenitors were microdissected from the epithelium of the 
ventricular germinal layer, while striatal neuronal progenitors were isolated from the 
lateral lateral ganglionic eminence of E10.5 embryos. Young CA neurons and MSNs 
were dissected from the early hippocampus and striatum respectively from E17.5 
embryos. CA1 and CA3 pyramidal neurons and GCs were microdissected and isolated 
from frozen dorsal and ventral hippocampal 200µm sections of 8-10 week old male 
mice. MSNs were isolated as described 100,101. Briefly, dorsal and ventral straitum 
were dissected and homogenized in lysis buffer (0.32M Sucrose, 5mMCaCl2, 3mM 
MgCl2, 10mM Tris-HCL-pH8, 0.1M EDTA, 0.1% Triton100 and 1mM DDT in 
ddH2O). The homogenate was then resuspended in blocking buffer (1% goat serum, 
5mM MgCl2 in PBS) followed by incubating with anti NeuN antibody (Millipore, 
MAB377X). Nuclei were purified by diluting the lysate in sucrose buffer S1 (0.25M 
Sucrose, 5mM MgCl2 in PBS) and overlaying it over sucrose buffer S2 (1.1M 
Sucrose, 2mM MgCl2, 50mM Tris-HCL(pH8), 1mM DTT in ddH2O). Nuclei were 
pelleted at 2800g for 15min. Nuclei were then resuspended in resuspension buffer 
(2mM MgCl2 in TBS), filtered through a 40µ strainer, and FACS sorted at the Weill 
Cornell Core Facility. 
Bisulfite sequencing 
DNA was isolated from collected tissue using the DNeasy Blood & Tissue Kit 
(Qiagen, Valencia, CA). Single end 50bp enhanced reduced representational bisulfite 
sequencing was performed as described 61, using Illumina HiSeq2000 according to 
manufacturer instructions. An in-house pipeline was used for methylation calling and 
alignment to the mm9 reference genome 102. Differential methylation and statistical 
analysis were performed using the MethylKit package in R 102 at default setting. 
Differentially methylated sites were defined as sites where the SLIM corrected p-
values were > 0.01 and the difference in methylation between two samples were > 
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20%. Differentially methylated regions (DMRs) were defined as regions containing at 
least four differentially methylated sites with distance no greater than 1kb. Genomic 
and CGI annotations were based on Ensmbl data downloaded from the UCSC genome 
browser. Promoters were defined as regions ±2kb from the TSS while exons and 
introns were defined by reference. The percentage of total differentially methylated 
sites in a defined genomic feature was divided by the percentage expected to overlap 
each genomic feature by chance, based on the percentage of genomic space occupied 
by that feature, to determine the fold change from expected values. Additional 
methylation datasets were downloaded from the UCSC genome browser DNA 
methylation track hub 29,103,104. All graphs and statistical analysis were performed 
using R (http://ww.r-project.org), Bioconductor (www.bioconductor.org), and ggplot2 
(www.ggplot2.org) for visualization, unless stated otherwise. 
RNA-Seq 
Adult mice were perfused with 30% RNAlater (Ambion, Grand Island, NY) in 
saline. Embryonic and adult hippocampal samples were isolated as for DNA. Dorsal 
striatum were microdissected from frozen 200µm adult brain sections. Total RNA was 
isolated using the RNeasy Mini Kit (Qiagen, Valencia, CA). Single end 50bp RNA 
sequencing was performed on Illumina HiSeq2000 for HP, SP, yCA and yMSN 
samples. RNA from dorsal striatum was sequenced using 75bp pair-end sequencing. 
Adult GC and CA1 pyramidal neuron RNA data were from our previous report 
(GSE52069ECS)8. ESC data were downloaded from GSE20851. All reads were 
aligned to the mm9 reference genome using TopHat software version 2.0.11 105. 
Default parameters were used with the addition of “--no-novel-juncs” to align 
exclusively to known genes and isoforms. Gene counts were performed using the HT-
seq program 106 with the parameter “intersection-strict”. Values for fold-change in 
gene expression were calculated using the EdgeR 107 package in R, using tagwise 
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dispersion and default parameters. Differentially expressed genes were defined as 
genes containing a Benjamini-Hochberg corrected p-value ≥ 0.05. 
Transfection and Luciferase Reporter Assay 
Plasmids were constructed from Basic and Promoter pCpGfree Luciferase 
Vectors (Invivogen, San Diego, CA) using the In-Fusion Cloning Kit (Clontech 
Laboratories, Mountain View, CA). Intronic DMRs as well as a control drosophila 
sequence (see table below) were cloned into basic (with no promoter or enhancer 
activity) and promoter (containing minimal EF1 promoter with no enhancer activities) 
pCpGfree backbone vectors (InvivogeGen, San Diego, CA). 
 
DMR  Sequence 
Drosophila 
208bp 
ACGCCTAAAGCAACTCCACTGGCTCATCGGTAAAAAGTCAAAGCTGCGAG 
AGAAACTAAAGATTCTCGTCTACAAGACTATTCTCAAGCCAATCTGGACG 
TACGGAATTCAGCTGTGGGGCACTGCTTGCACATCACATAGAAGGAAGAT 
CCAGCGATTTCAAAACAGATGTTTGAGAATAGTCTCCAACGCCCATCCCT 
ACCACGA 
Grid2 CACTGTCTCAATGCAAATCCCAACCCTTTGCATCATCCACCCATCAGTCT 
TTAATCTGACTCACTATGGTCTCACTTCTCCAAGTTGGACCAGAACCTCT 
GTGAAGGCAGCAACCACATAGCAGTCTAGGACCATACGTTTGTATTTGGT 
TTTAAGGGGGGATGGGGGCAATAACACATGACAAAGTGTTCTTAGCCCTG 
ACTGGGACTGGCCTGGAACTTGCAATGTAAAGCAGGCTGGTTCAAACTCA 
GAGATCTGCCTGTCTCTGACTCCACAATGCTAGGGTTAATGTTCTTTTAT 
TAAGTACCATCACCTTGGTGCTATTAGAGATTTACTGGCCAGTTTCATCT 
GATCCTGGGTTGTCCCAAGAAAT 
Htr1 CGGCCTAGCCTCAACTCACTGGCTCGTGTTGAGAGTACTGAGTCAGCTGT 
ACATTCCACCCTCCCCCTTTTTTTGGAACGAGGAACAAGCCACCTTTTGT 
GTACTTCTTTTTTTCCTGCTCCCATACTCCTTTCACAGCTCTCTGGGCAA 
CACTCCCATATGTCCCTGAATTGATGCTGGTCCAGCCACACATCACACGG 
CTGGCTCCGGTTTTCCAGTTCGTCTCTGAGCTCTCTCCAGCAGCACGCAG 
ATTGCTTGCCAGGTTCATTGCATTTGTCTCTTGTCCCAAGTACCG 
Gria1 TGGAGTCCTCCGGGCTGAGAGCGAACATTTAACTGACATGATGTTGGAGG 
AGAACCTTTGCTTTTGTGCTTGCTTCCATTTGAGGAACATTTTGCTCCAT 
TCCTTCCCGCCTGCCTCTGCTCACCTCTTAATTAACTGGAGGTTGCGGGC 
GAAAGCAGCTGCCGGCTCTTTTCT 
Park2 TCAAGTGGTGGAACTGGGTTTTCTCCGGCGAATCTCAGGATTAACACAGT 
GCTAGGGAGATGCGGGCCCCAGATACAGCTCCGGGTCCTATTCCGCAGCA 
ACCCGAGGACGTCTTGCCAGAGAACCTGTAGCCGGGATCCTTG 
Crhr1 CGGTCCTCGAATTCCTCATCTAATTAGAGCTGGGTTGAGTGTGTGCAGTA 
ATGAGCTGGCTTTCGCACACTCCGGACTACCCCAAGGCCTCCACTGGGAA 
CATCCCTAACACAAGCAGGGTATGGGGGCGTACTGAGGGCACACCAAAAG 
GGTATACTGAGTCATTTTGCTTTTAGAGTGCTAAGGAGGGGTTTTGGCTC 
TAAGGACAGCTGAGTCACCG 
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N2A cells were cultured in media containing 88% DMEM + 10mM HEPES, 
1% penicillin/streptomycin, 10% fetal bovine serum, and 1% L-Glutamine in a 5% 
CO2 37°C incubator. Plasmids were transfected into N2A cell cultures using 
Lipofectamine Transfection Reagent (Life Technologies, Grand Island, NY) in 
triplicates. Briefly, 200,000 cells were seeded per well in 12-well plates in 1mL 
culture media. 24 hours later, 1µg of plasmid DNA was diluted in 85µl Opti-MEM 
media (Life Technologies) in tubes. After 5 minute incubation, 6µl Lipofectamine 
Transfection Reagent was added, followed by 20 minute incubation. 85µl of this 
solution was added to each well of N2a cells. The following day, media was aspirated 
and replaced with 400µl of culture media. 48 hours after transfection, 20µl aliquots of 
media were sampled into 96-well plates. 100µl Quanti-Luc luciferase substrate 
(InvivoGen, San Diego, CA) was added to each well, and plates were read 
immediately for luciferase activity. Luciferase activity data are shown as mean ± 
s.e.m. Outlier data was excluded based on ± 2 s.d. from the mean. One-way or 
repeated measures ANOVAs or t tests were used to compare tests. LSD post hoc 
analysis was used to assess statistical significance. 
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Supplementary Fig. 2.1. Isolation of homogenous populations of neuronal 
progenitors and neurons. A. Photograph of E10.5 telencephalon illustrating the 
position of the ammonic/ dentate epithelium and LGE, which are the source of 
hippocampal and striatal progenitors. B. E17.5 telencephalon showing the developing 
hippocampus and striatum and which served as the source of yHNs and yMSNs. C. 
Adult mouse brain illustrating the distinct layers of CA1 and CA3 neurons and GCs, 
as well as the dorsal striatum and NAc, the source of d- and vMSNs. D. The vast 
majority of nuclei in the GC layer are NeuN positive (intense green nuclear staining) 
with only a few cells being positive for the glia marker GFAP (blue cytoplasmic 
staining). BrdU positive cells (red) were also visualized to assess the number of 
neurons in the S phase of the cell cycle. E. Isolation of MSNs from the striatum. DAPI 
(blue) and NeuN (green) positive nuclei before fluorescence activated cell sorting 
(FACS), showing that many but not all nuclei are neuronal. F. Representative FACS 
scatter plot from striatal nuclei labeled with a NeuN antibody, according to the 
protocol of Jiang et al. 101. Y axis represents FITC intensity at 488nm while the X axis 
represents size:morphology. NeuN positive cells (blue) can be separated from negative 
cells (red). G. The proportion of NeuN positive nuclei in total DAPI positive nuclei is 
increased following FACS. 
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A.       B. 
 
 
 
 
 
Supplementary Fig. 2.2. Additional methylation data related to the ESC-neuronal 
progenitor transition. A. High concordance (t=586.375, df=79829, p<2.2e-16; r= 
0.9008746) between methylation levels in ESCs, cultured in the lab, and E6.5 
epiblasts, as reported by Smith et al. 29. The bimodal distribution of methylation is 
visible in both cell types, although less prominently in epiblasts. However, a large 
number of sites with intermediate methylation is also visible indicating that 
methylation is incomplete. B. Heat map representation of methylation levels at all 
ESC-HP and ESC-SP differentially methylated sites (DMSs) demonstrating a high 
level of similarity in the two lineages.  	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Supplementary Fig. 2.3. Overlap between differentially methylated sites (DMSs) for 
the three periods of neuronal development indicates that most sites are modified only 
once during development. 
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Supplementary Fig. 2.4. Mapping differentially methylated sites (DMSs) associated 
with the ESC to progenitor transition to genomic features.	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C 
 
Supplementary Fig. 2.5. Functional analysis of developmental and neuron subtype 
specific differentially methylated genes. A, B. Analysis of intronic/intergenic 
differentially methylated genes during the progenitor to young neuron (A) and from 
the young to mature neuron (B) transition. C. Analysis of neuronal subtype-specific 
differentially methylated and differentially expressed (DMR x DE) genes between 
regions within the hippocampus (CA1 vs. GC). Description of the figure is identical to 
that of Fig. 4B. G3P, glyceraldehyde-3-phosphate, an intermediate in several central 
metabolic pathways; PIP2 and PIP3, phosphatidylinositol 4,5-bisphosphate and 
phosphatidylinositol 3,4,5-trisphosphate. 	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CHAPTER 3 
 
DIFFERENTIAL GENE BODY METHYLATION AND REDUCED 
EXPRESSION OF CELL ADHESION AND NEUROTRANSMITTER 
RECEPTOR GENES IN ADVERSE MATERNAL ENVIRONMENT 
 
* Oh J., Chambwe N., Klein S., Gal J., Andrews S., Gleason G., Shaknovich R., 
Melnick A., Campagne F., and Toth M. 2013. Differential gene body methylation and 
reduced expression of cell adhesion and neurotransmitter receptor genes in adverse 
maternal environment. Published in Translational Psychiatry. 
 
3.1 Introduction 
A significant factor in the development of psychiatric disorders, including 
anxiety, depression, autism and ADHD is the environment, both prenatally and during 
early postnatal life108,109. Early life adversity, such as maternal stress, maternal 
infection (e.g. immune activation during pregnancy)110 and maternal separation during 
early postnatal life111, and its behavioral consequences on the offspring can be 
reproduced in non-human primates and rodents. Although many genetic tools are 
available for the mouse, establishing early life adversity paradigms with robust and 
reproducible behavioral outcomes is challenging in this species112,113. We have 
recently developed a mouse model of maternal adversity, that is based on a deficit in 
the maternal 5-HT1A receptor (R) and which causes innate anxiety, increased stress 
reactivity and impaired vocal communication in the offspring12,114. This model has 
construct validity because reduced binding of 5-HT1AR has been found in depression, 
including peri/postpartum depression, a condition that can represent early life 
adversity for the offspring12,115. This model was developed on the outbred Swiss 
Webster (SW) background (a strain often used in behavioral experiments), to avoid the 
possible contribution of homozygous genetic variants in inbred strains to behavioral 
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phenotypes116. The unique feature of our maternal adversity model is that the initial 
trigger is well defined (e.g. maternal receptor deficit as opposed to more complex 
paradigms such as maternal stress and inflammation) and this gives a foothold from 
which to investigate the underlying molecular mechanism. A partial receptor deficit 
(heterozygosity, H) in the mothers is sufficient to elicit the behavioral abnormalities in 
the wild type (WT) offspring12 and the behaviors develop independently of the 
offspring’s own receptor genotype (e.g. similar effect in the WT and mutant 
offspring)12. Further studies showed that the anxiety of the offspring of 5-HT1AR-
deficient mothers is prenatally determined, is not related to maternal care114 (a major 
postnatal factor in anxiety in other models117), and is linked to the delayed maturation 
of dentate granule cells (DGCs) in the ventral but not in the dorsal HIP12.  
The ventral (v)-HIP is part of the distributed and interconnected network of 
brain regions involved in anxiety. The role for the v-HIP in innate anxiety is supported 
by the reduced fear and avoidant behavior of rodents following its lesion118,119. 
Sensory inputs, via the entorhinal cortex (EC), arrive to v-DGCs that are connected to 
v-CA3 and v-CA1 neurons, that together form the classical trisynaptic HIP circuit. 
This circuit sends direct projections to the medial prefrontal cortex (m-PFC) and 
activity in the v-HIP is synchronized with m-PFC to produce appropriate defensive 
and anxiety-related behaviors120. Other connections of v-HIP that are relevant to 
anxiety include those to the amygdala and the bed nuclei of stria terminalis121.  
Previous studies suggested that adverse maternal environment can produce 
permanent epigenetic changes in neurons122-125. Among the various epigenetic 
modifications, CpG methylation is probably the longest lasting, although it can still be 
dynamically regulated in certain circumstances126. Although DNA methylation assays 
have long been available, finding methylation changes that underlie environmental 
effects, including maternal effects, is complicated by the necessity to use homogenous 
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neuronal populations. Indeed, current knowledge on neuronal methylation is largely 
limited to whole brain127,128 and in vitro differentiated neurons/neuronal 
precursors47,129, although the methylation pattern of mouse DGCs has recently been 
reported126. Also, the effect of early environmental influences on neuronal DNA 
methylation has mostly been tested with candidate genes36,125, an approach that does 
not provide an unbiased survey of epigenetic changes induced by maternal adversity. 
Here we isolated v-DGCs and performed whole genome representational analyses by 
using two assays, HpaII tiny fragment enrichment by ligation-mediated PCR (HELP 
assay) and Enhanced Reduced Representation Bisulfite Sequencing (ERRBS), to 
determine the pattern and developmental dynamics of CpG methylation produced by 
maternal adversity. We found that the receptor deficient maternal effect induced large-
scale methylation changes in exons, introns and gene distal areas while changes were 
underrepresented in promoters. Methylation changes tended to be clustered and the 
affected genes encode proteins involved in synapse formation and function.  
 
3.2 Results 
Methylation changes in adverse maternal environment in dentate granule cells 
(DGCs) 
Since anxiety in the offspring of 5-HT1AR deficient mothers is associated with 
the delayed maturation of v-DGCs during early postnatal life, and because genetic 
interference with v-DGC maturation (by the inactivation of the cyclin dependent 
kinase inhibitor p16Ink4a) is accompanied by increased anxiety12, we tested v-DGCs 
for genomic methylation changes associated with the receptor deficient maternal 
environment. First we used the methylation enzyme based “HELP” assay, to 
interrogate CpG methylation at 14,392 known RefSeq gene promoters (out of the total 
of 29,716 based on the NCBI37/mm9 mouse assembly) and 9,114 CpG islands 
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(promoter and non-promoter, out of 16,026) by using custom arrays128. To identify H-
maternal specific methylation changes, WT offspring of WT mothers (WT(WT)) were 
compared to the WT offspring of H mothers (WT(H))(Fig. 1A). WT(WT) samples 
were also compared to KO(H) and KO(KO) samples because lack of the receptor in 
the offspring (in KO(H)) and/or the switch of the maternal receptor deficit from partial 
to complete (in KO(H)) had no additional effect on either the delayed DGC 
development or the anxiety of the offspring, elicited by the H maternal environment 
(Fig. 3.1A). 
By comparing the methylation level of WT offspring of H and WT mothers 
(WT(H) vs. WT(WT)), 35 differentially methylated regions (DMRs) were identified 
(Fig. 3.1B ) out of the 25,725 fragments assayed (Benjamini-Hochberg multiple 
testing, false discovery rate (FDR) <0.5%, methylation ratio >1.5, 3 litters per 
replicate, 3-4 biological replicates per group, r2>0.90 between replicates). The 
majority of the WT(H) specific DMRs represented hypomethylation (29 DMRs). 
When WT and KO littermates of H mothers were compared (WT(H) vs. KO(H), no 
DMRs were found indicating that the offspring’s own 5-HT1AR genotype elicited no 
methylation changes that were detectable by HELP (Fig. 3.1B). Importantly, most of 
the DMRs were also seen when KO offspring of H and KO mothers were compared to 
WT(WT) offspring ((KO(H) and KO(KO) specific DMRs), indicating that similar 
methylation changes can be elicited by the H and KO maternal genotype, 
independently of the offspring genotype, and that there is a good correspondence 
between methylation changes and anxiety. However, the KO as compared to the H 
maternal environment caused additional changes in methylation as shown by the heat 
map representation of all DMRs across the three comparisons (Fig. 3.1C). 
Approximately half of the DMRs overlapped CpG islands, a distribution similar to 
that of the assay. Taken together, the methylation changes, similarly to the delayed v-
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DGC developmental phenotype and anxiety12, were elicited by either the H or KO 
maternal environment and were independent of the offspring genotype. 
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Figure 3.1. The 5-HT1AR deficient maternal environment results in DNA hypo- 
and hypermethylation in offspring ventral DGCs. A, WT (and KO) offspring 
exposed to mutant (H or KO) maternal environment exhibit anxiety. B, Exposure to 
the H maternal environment is associated with differential methylation at 35 DNA 
fragments in the WT offspring and the majority of these DMRs are also present when 
the mother and/or the offspring are KO (KO(H) and KO(KO). C. Heat map 
representation of methylation levels at DMRs across biological replicates of the four 
groups of animals. 
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Since the receptor deficient maternal environment during the prenatal period is 
necessary and sufficient to elicit the anxiety-like phenotype12, we tested if prenatal 
exposure alone can produce hypomethylation at the Atbf1 and Smo DMRs. WT 
offspring implanted as embryos into the oviducts of KO mothers and then 
crossfostered at birth to WT mothers (referred to as WT(KO/WT) mice, Fig. 3.2C) 
showed hypomethylation within both DMRs (Fig. 3.2D). This indicates that exposure 
to the adverse maternal environment that is limited to the prenatal period is sufficient 
to elicit not only the anxiety phenotype but also the DNA methylation changes in the 
offspring. 
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Figure 3.2. Nucleotide level methylation across DMRs in two genes. A, Genomic 
structure around DMRs. Genomic structure around DMRs. Thick and thin gray bars 
with red frames indicate the minimal and maximal size of the differentially methylated 
HELP fragments between HpaII sites. Green boxes represent CpG islands. Blue boxes 
indicate regions that contained differentially methylated CpG sites, including CpGs at 
HpaII sites, within the HELP fragments. B, Methylation patterns at individual CpG 
sites in various groups of adult animals across DMRs. Similar patterns were 
reproduced with independent samples. Columns display mean methylation levels with 
SE; ANOVA with LSD posthoc: Atbf1, F1,3=48.00, P<0.00001, N=20; Smo, F1,3=9.31, 
P=0.0002, N=8; *p<0.05, **p<0.005, ***p<0.0005 indicate significant differences 
from the WT(WT) groups. Statistical analyses were performed by using CpG sites that 
showed a higher than 10% methylation level in WT(WT) samples because 
hypomethylation can be produced by the H maternal environment only at sites that 
have a measurable (above the baseline) methylation level when the mother is WT. 
While all CpG sites within the Atbf1 DMR, located at the last exon, fulfilled this 
criterion, the Smo DMR, located at the first exon (and close to the promoter), showed 
an overall lower methylation with measurable methylation only at interspersed CpG 
sites (indicated by arrows). C, Embryo transfer and crossfostering to isolate the effect 
of the pre- and postnatal receptor deficient maternal environment on DNA 
methylation. WT embryos were implanted to KO mothers (and to WT to serve as 
controls) and newborn pups were then crossfosstred to WT foster mothers. Other 
combinations of the pre- and postnatal maternal environment are listed in panel (D) 
but not shown here for simplicity. D, Offspring exposed to the prenatal KO 
environment or the combination of the KO pre/postnatal environment show 
hypomethylation at the Atbf1 and Smo DMRs. Kruskal-Wallis Rank Sum with Tukey 
posthoc. Atbf1: x2=33.4551, P<0.001, **p<0.005 vs. WT(WT/WT), N=20; Smo: 
x2=6.60372, P=0.0102, *p<0.05; N=6. 
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Genome-wide differential methylation in adverse maternal environment 
We used ERRBS to explore differential methylation at a larger fraction of 
CpGs and which is not limited to a predetermined set of CpG sites130. A total of 
376,016,818 aligned sequence reads of 51 bases were obtained from WT(WT), WT(H) 
and KO(H) v-DGC DNA, which, at >35X coverage, reported methylation rates (MR, 
fraction of methylated cytosines at a site) at 1,740,900 CpG sites (8.4% of all CpGs in 
the mouse129) across the three groups of offspring. We found 2.3% of the CpG sites to 
be differentially methylated in both WT(H) and KO(H) neurons compared to WT(WT) 
neurons (BH-FDR q<0.01; ΔMR>20%)(Fig. 3.3A). Island specific DMSs were 
underrepresented among all DMSs. This finding is in agreement with previous reports 
showing that islands are typically resistant to methylation; however, if methylated 
during development, islands usually are not subjected to tissue specific or 
environmentally induced methylation changes47,126,131.  
Close to half of the DMSs identified in adult DGCs (16,447) were spaced less 
than 1kb from each other (cl-DMSs; Fig. 3.3B and C) and more than 50% of these “<1 
kb” sites had an inter DMS distance between 2 and 100 bps indicating a significant 
clustering of methylation changes (Supplemental Fig. 3.2). Cl-DMSs specified a total 
of 6,357 DMRs. ERRBS also detected 4,187 differentially methylated clustered sites 
when WT(H) and KO(H) samples were compared indicating that the offspring 
genotype can elicit methylation changes as well. However, this smaller set of sites was 
not studied further because of lack of the association with the anxiety phenotype (Fig. 
3.1A). 
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Figure 3.3. Genomic features of differentially methylated sites in adverse 
maternal environment identified by ERRBS. A, CpG island and non-island specific 
DMSs (WT(WT) vs. WT(H)+KO(H)). B-C, Genomic features at clustered (<1kb) 
DMSs associated with CpG island and non-island sequences. 
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The maternally specified cl-DMSs were further analyzed for their genomic 
features132. CpG island-associated DMSs, whether hypo- or hypermethylated, were 
found more often in exons (~10 x enrichment, compared to all CpGs in islands) and 
less frequently in promoters (Fig. 3.3B). These findings are consistent with results of 
the HELP assay that identified DMRs within exons (RRBs also identified the Atbf1 
and Smo DMRs). The larger group of non-island DMSs (91%) showed a slight 
enrichment for intronic and exonic CpGs (34% vs. 29% and 13-14% vs. 10%, 
respectively), while promoter CpGs were underrepresented in cl-DMSs, at both 
hypo- and hypermethylated sites (16% vs. 8-9%)(Fig. 3.3C). Overall, these data 
indicate some preference of the maternal effect to modulate methylation at gene-
body CpGs, at both island and non-island sequences. 
CpG methylation in the developing dentate gyrus in normal and adverse 
maternal environment 
Majority of adult DGCs are generated during the perinatal and early postnatal 
period, followed by the gradual maturation of newly born cells133. In the maternal 
5HT1AR deficient model we observed normal proliferation but delayed neuronal 
maturation at the end of the first week of postnatal life, suggesting that young neurons 
may already have some epigenetic, either CpG methylation or chromatin, changes. To 
test this hypothesis, we profiled P7 neurons with ERRBS using the same statistical 
criteria and parameters that were employed for the analysis of adult DGCs. CpG 
methylation in both P7 and adult neurons showed the typical bimodal distribution 
where the majority of CpG sites are either highly methylated (>90%) or methylated 
at a low level (<10%). However the fraction of highly methylated CpG sites in P7 
was slightly lower indicating ongoing methylation in young neurons (Fig. 3.4A). 
Since many DMSs mapped to introns and exons, the distribution of gene-body CpGs 
was also assessed and showed a similar pattern (Fig. 3.4C). This analysis also 
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included E6.5 epiblasts (low coverage; from29) and ES cells (high coverage, this 
study) as references because epiblasts represent the last cell type with multipotency 
before the onset of gastrulation and cultured ES cells have an epiblast like 
methylome31. In agreement with previous reports, the distribution of methylated CpGs 
in epiblasts and ES cells indicated an incompletely methylated genome29,63.  
In contrast to the bimodal distribution of methylation at all CpGs, methylation 
at clustered DMSs (Fig. 3.3B and C) was mostly intermediate in both P7 and adult 
DGCs (in normal maternal environment) and overall methylation levels were even 
lower than in epiblasts and ES cells (Fig. 3.4B and D). These data indicate that 
methylation at environmentally sensitive sites, in contrast to most CpG sites, is 
typically maintained in the intermediate range up to P7 and beyond. However, a closer 
inspection revealed significant rearrangements in the methylation of DMSs during 
development in normal and adverse environment (from P7 to adult). One group of 
DMSs showed a gain or loss of methylation during normal postnatal development, 
changes that were inhibited by maternal adversity (Fig. 3.4E and Supplemental Fig. 
3.3). These “Type I DMSs” were divided into hypo and hypermethylated subgroups 
according to the direction of the change in adversity. Sixty percent of DMSs belonged 
to these categories (33% and 27% for hyper and hypo, respectively). Figs. 3.2B and 
3.4G illustrate clusters of type I hypo- and hypermethylated DMSs within the 
Atbf1/Smo and the Grik 4 genes, respectively. Methylation at “Type II DMSs” was not 
significantly changed during normal postnatal development but the H maternal 
environment resulted in hyper- or hypomethylation (Fig. 3.4F and Supplemental Fig. 
3.3). A total of 40% (20% hypo and 20% hyper) of DMSs were type II. Typical type II 
hypomethylated DMSs are shown in the Bsn gene (Fig. 3.4H). 
Although methylation at CpG sites is typically higher in P7 DGCs than in ES 
cells (and epiblasts) (Fig. 3.4A and C), methylation at DMSs in these cell types was 
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similar (Fig. 3.4EF and Supplemental Fig. 3.3), suggesting that no significant 
methylation changes occur at these sites in DGCs, either in normal or adverse 
environment, before their maturation (e.g. before P7). Thus, the maternal effect, 
although prenatal in its origin, does not have an impact on methylation at DMSs until 
neurons develop beyond the young neuronal stage. While Type I and II hypo- and 
hypermethylated DMSs are quite different in terms of their methylation behavior in 
adverse maternal environment, we found no obvious sequence context or genomic 
features that would be group specific or predict the direction of their methylation. 
Overall, both arrest in developmental methylation/demethylation and abnormal 
gain/loss of methylation seem to account for producing differential methylation at 
specific sites in adversity.  
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Figure 3.4. Methylation at DMSs during development in normal and adverse 
maternal environment. AB, Histograms with the distribution (% of total) of 
methylation levels at all CpG sites and DMSs in 10% bins in adult and P7 WT(WT) 
DGCs, E6.5 epiblasts (E6.5) and ES cells. BD. Same as in AB but with gene-body 
CpGs. EF, Methylation in P7 and adult DGCs in normal and adverse maternal 
environment at Type I and Type II hypo/hypermethylated DMSs. Hierarchical 
clustering within the four groups of DMSs shows similar methylation levels at P7 in 
normal and adverse environment and type I and II specific changes in adults. Center: 
Schematic representation of developmental changes at the four classes of DMSs from 
P7 to adult age; continuous and dashed lines represent changes in WT and H maternal 
environment, respectively. G, A representative DMR with Type I hyper DMSs in 
Girk4. H, A representative DMR with type II hypo DMSs in Bsn1. 
	  65	  
 
 
 
A B
Gene Body CpGs
F
G H Bsn
All CpGs
0
10
20
30
40
50
60 DMSs 
0
10
20
30
40
50
60
0
10
20
30
40
50
60
10 20 30 40 50 60 70 80 90 100
0
10
20
30
40
50
60
Oh et al. Fig.4
10 20 30 40 50 60 70 80 90 1000 010 20 30 40 50 60 70 80 90 100010 20 30 40 50 60 70 80 90 1000
F
re
q
u
e
n
c
y
F
re
q
u
e
n
c
y
F
re
q
u
e
n
c
y
F
re
q
u
e
n
c
y
Methylation (%) Methylation (%) Methylation (%) Methylation (%)
All genomic CpGs
Grik4
Adult
P7
ES
E6.5
Adult DMSs
P7 DMSs
0
20
40
60
80
100
Adult - WTWT
Adult - WTH
P7 - WTWT
P7 - WTH
ES
0
20
40
60
80
100
Chr9: 42735943-42736425
TSS
Chr9: 108082538-108086325
TSS
Adult DMSs
P7 DMSs
Adult
P7
ES
E6.5
C D
M
e
th
y
la
ti
o
n
 (
%
)
M
e
th
y
la
ti
o
n
 (
%
)
CpG sites CpG sites
W
T
(H
)
E
S
P
7
W
T
(H
)
P
7
 W
T
(W
T
)
W
T
(W
T
)
W
T
(H
)
E
S
P
7
W
T
(H
)
W
T
(W
T
)
P
7
 W
T
(W
T
)
E
W
T
(W
T
)
E
S
W
T
(H
)
P
7
W
T
(H
)
P
7
 W
T
(W
T
)
0 20 40 60 80 100
Value
Type I WT(WT)
WT(H)
M
e
th
y
la
ti
o
n
P7 Adult
Hypo
M
e
th
y
la
ti
o
n
P7 Adult
Hyper
M
e
th
y
la
ti
o
n
P7 Adult
Hyper
M
e
th
y
la
ti
o
n
P7 Adult
Hypo
Type II
All CpGs DMSs 
W
T
(W
T
)
E
S
W
T
(H
)
P
7
W
T
(H
)
P
7
 W
T
(W
T
)
	  66	  
 
Clusters of DMSs map to cell adhesion molecules and neurotransmitter receptor 
genes 
We used the Ingenuity Knowledge Database to identify genes with relevant 
biological functions in the list of 1,176 Ensembl genes harboring DMRs. A total of 
510 genes belonged to the category of “Nervous System Development and Function” 
and could be mapped to major steps in neuronal development (Fig. 3.5A). Genes with 
multiple functions were assigned to multiple developmental processes. This analysis 
identified neuritogenesis (103 genes with DMRs), migration (61 genes), and 
pre/postsynaptic differentiation (81 genes) as developmental processes highly enriched 
in differentially methylated genes. Neuritogenesis, the highest scoring process, is the 
growth and extension of neurites from the soma by precise cytoskeletal and adhesion 
dynamics, and guided by external attractive and repulsive cues. Migration and 
synaptic differentiation are tightly linked to neuritogenesis both in timing and shared 
molecules.  
An independent analysis of the differentially methylated genes by GeneGo 
MetaCore Process Network Analysis identified essentially the same genes grouped to 
the functional networks of “Synaptogenesis”, “Axonal Guidance” and three “Cell 
Adhesion” related clusters, “Cadherins”, “Attractive and Repulsive Receptors” and 
“Synaptic Contact” (FDR<0.05)(Fig. 3.5B). Indeed, the “Synaptogenesis” GeneGo 
category contained synaptic scaffolding proteins and neurotransmitter receptors that 
were also identified by the Ingenuity “Pre/postsynaptic differentiation” functional 
category. Similarly, cell adhesion molecules were identified by the Ingenuity analysis 
in migration, neuritogenesis, and pre/postsynaptic differentiation. Although the genes 
within these categories were 4.3 times larger than the average gene (138,278 vs. 
31,959 bp) and therefore could preferentially harbor DMSs, not all of these large 
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genes were differentially methylated. Indeed, 556 genes out of the total of 738 within 
the functional categories in Fig. 3.5B were not modified by methylation. The 
difference in size between modified and non-modified genes was only ~2-fold 
(224,942 and 109,909, respectively) which suggests that the differential methylation is 
not proportionate with gene size. Also, the larger size of genes within the functional 
categories is mostly due to introns, but more of the gene-associated DMRs (52% of 
total) were outside of introns in distal sequences (23%), exons (16%), promoters 
(11%), and downstream sequences (2%) than in introns (31%).  
Gene expression analysis of adult DGCs from offspring of WT and H mothers 
by RNA-Seq showed no overall correlation between expression and methylation at the 
3,069 DMR-containing genes, whether the DMRs mapped to promoters, exons, 
introns or distal sequences (data no shown). However, analysis of the 1,189 
differentially expressed genes (>1.3 fold; q<0.05, Fisher exact R, BH-FDR; of which 
193 contained DMR) with GeneGo Process Network identified “Synaptogenesis” as 
the top network (Fig. 3.5C). Essentially the same genes were also identified in the 
“Transmission of nerve impulse” network.  
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Figure 3.5. Differentially methylated genes encode synaptic proteins. AB, 
Ingenuity and GeneGo Process Network analysis of DMSs identifies synaptic 
functions. For the Ingenuity analysis, right-tailed Fisher’s exact test was used to 
calculate a p-value determining the probability that each biological function assigned 
to the dataset is due to chance alone. For the GeneGo analysis, statistical significance 
of a process was determined using the Hypergeometric distribution and adjusted for 
multiple testing by MetaCore. Ratio represents the differentially methylated vs. all 
genes in the functional categories. C, GeneGo Process Network analysis of 
differentially expressed genes. D, Differentially methylated genes encode adhesion 
molecules (blue) and their effectors (green), presynaptic proteins (pink), scaffolding 
proteins (grey) and neurotransmitter receptors (yellow). The figure positions the 
differentially methylated genes/proteins to the pre and postsynaptic compartments, 
also indicating those that interact with synaptic vesicles within the presynaptic 
compartment. The effect of cell adhesion molecules converge on the regulation of 
microtubule and actin organization that are essential in migration, neuritogenesis and 
synaptic differentiation, identified by functional analysis (panels AB). Cell adhesion 
molecules are also involved in the recruitment of synaptic receptors whose function 
controls neuronal excitability. Genes for both inhibitory and excitatory receptors were 
among those that were differentially methylated. Some of the differentially methylated 
genes were also downregulated in adult DGCs (red outline and arrow). Other synaptic 
genes were also downregulated but were not differentially methylated (white 
background with red outline and arrow). These data indicate a permanent 
hypofunction at many synaptic genes suggesting a persistent abnormality in synaptic 
plasticity and neuronal excitability. 
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Overall, these functional analyses identified two major groups of proteins; cell 
adhesion molecules and neurotransmitter receptors (Fig. 3.5D). Cell adhesion 
molecules have pre- and postsynaptic partners, and genes encoding both of these 
classes were differentially methylated. These included ephrins (EFNA1,A2,B2) and 
their receptors (EPHA4,A8,B1,B2), semaphorins (SEMA3F,4A,5B,6A,6B,6C,7A), 
and their plexin receptors (PLXNA1,B1), neurexin (NRXN1,2) and neuroligin 
(NLGN1), Wnts (WNT2,2b,3,7a,7b,10b,11) and frizzled (FZD7), cadherins (CDH9, 
11,13) and slit (SLIT3) and its receptors (ROBO1,3). Neurotransmission related 
differentially methylated genes included those that encode neurotrophin 3 (NT3), the 
TrkA receptor (TRK1), CRH receptor 1 (CRHR1), GABA-B receptor subunit 2 
(GABBR2), an NR1 subunit of the NMDA receptor (encoded by Grin1), the 
dopamine D3 receptor (DRD3), acetylcholine alpha 4 subunit (CHRNA4), adenosine 
A2 receptor (ADORA2A), a number of calcium channels (CACNA1A,1C,1G,B1) and 
K channels (KCNJ1,10,12,14), which all have been implicated in neuronal excitability 
as well as in anxiety134. A total of 18 genes within the functional clusters shown in 
Fig. 3.5A and B were also differentially expressed (Supplemental Table 3.1; see 11 
genes in Fig. 3.5D) and almost exclusively downregulated (17 of 18) suggesting 
hypofunction at these genes. Additional synaptic genes that showed no differential 
methylation were downregulated, including those that encode the NR2A and 2B 
NMDA subunits (Grin2a and Grin2b), HOMER and FZD1, 2 and 10 (Fig. 3.5D). 
Overall, the differential methylation/expression of a large number of pre- and post 
synaptic cell adhesion molecule and neurotransmitter receptor genes suggests a wide-
ranging and permanent effect of the adverse maternal environment on synaptic 
plasticity and neuronal excitability. 
 
 
	  71	  
2.3 Discussion 
Pre and early postnatal adversity is a major factor in the development of 
psychiatric conditions. Offspring development is dependent on the maternal 
environment during these periods and numerous human and animal studies 
demonstrate that abnormal maternal physiology and behavior, whether genetic or 
environmental in nature, result in disruptions in normal brain development, that in turn 
can result in adolescent and adult behavioral abnormalities117,135-137. 
The development of the hippocampus is particularly sensitive to environmental 
disruptions, presumably because hippocampal neurons show remarkable structural and 
functional plasticity138. The hippocampal circuit is involved in numerous behaviors 
including cognitive tasks, evaluation and termination of the stress responses, and 
emotional behavior118. Although the consequences of early life adversity on the 
hippocampus are relatively well documented at the behavioral and even morphological 
level112,117,138, little is known about the underlying molecular mechanisms. 
Development is programmed by both transcriptional and epigenetic mechanisms and 
here we studied the developmental dynamics of CpG methylation genome-wide in 
DGCs in normal and adverse maternal environment. We used a previously established 
maternal adversity paradigm that is based on a 5-HT1AR deficit in the mother and 
which produces a delay in the development of the v-DGCs as well as an anxiety-like 
behavior12. 
The main finding of our work is that, although the receptor deficient maternal 
environment had a genome-wide effect, DNA methylation changes occurred in 
specific genomic locations and contexts. Specifically, CpG sites that were targeted by 
the maternal effect tended to have an intermediate methylation level during neuronal 
development until P7 and even beyond compared to the majority of the genome that 
exhibited either high (>90%) or low (<10%) methylation levels early on. Indeed, 
	  72	  
methylation at DMSs in developing DGCs was similar or even less than in ES cell or 
epiblasts, cells that exhibit extensive epigenetic plasticity63 and we speculate that 
epigenetic metastability at DMSs explains their sensitivity to disruptions by maternal 
adversity. Although intermediate methylation can be due to allelic differences 
documented at dosage compensated and imprinted genes, partial methylation in 
hematopoietic cells was predominantly associated with stochastic variability in 
methylation139. Since the vast majority of DMSs were not at imprinted genes, and 
because partial methylation was also seen in males at the X chromosome, we believe 
that the intermediate methylation at most DMSs is stochastic in nature.  
The maternal effect either modified the developmental trajectory of 
methylation at DMSs by inhibiting programmed hypo/hypermethylation (type I 
DMSs) or induced abnormal hypo/hypermethylation at sites that normally stay 
unchanged during postnatal development (type II DMSs). These influences produced 
relative hypo- and hypermethylation in the H maternal as compared to the WT 
maternal environment in DGCs. This suggests different mechanisms for the hypo- and 
hypermethylation and further studies will be needed to determine the factors 
responsible for the direction of methylation change in adverse maternal environment. 
Since ERRBS typically profiles one strand, it was not possible to determine if gain in 
methylation during development, or by the maternal effect at DMSs, was due to de 
novo methylation or maintenance methylation at asymmetrically methylated sites. On 
the other hand, loss of methylation at DMSs is likely due to active rather than passive 
demethylation because in the postnatal gentate gyrus the majority of isolated DGCs 
are postmitotic and because the number of neuronal precursors, located in the 
subgranular layer, and glial cells is too low to significantly contribute to the overall 
signal. Several mechanisms have been shown to account for active demethylation 
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including oxidative demethylation of cytosines achieved by the ten-eleven-
translocation (TET) proteins and repair based mechanisms140.  
DMSs are relatively scarce at promoters and typically found in gene bodies 
and gene distal areas. This suggests that the maternal effect may not regulate 
transcription via proximal promoters, but may rather influences expression indirectly 
by modulating alternative splicing and promoter use, and/or miRNAs expression. 
Further analysis showed that clusters of DMSs, e.g. DMRs, were enriched in genes 
that encode proteins involved in adhesion molecules and neurotransmitter receptors. 
Up to 34% of the genes classified in these categories were differentially methylated 
suggesting a strong convergence of the maternal effect on these genes and functions. 
Gene expression studies identified some of the differentially methylated genes and 
overall differential methylation and expression showed a good correspondence.  
It is challenging to establish a causative relationship between the DNA 
methylation changes in DGCs and innate anxiety, the main phenotype of the offspring 
of receptor mutant mothers115, because it is expected that each individual differentially 
methylated gene contributes only a small fraction of the total phenotype. The 
association of the differentially methylated genes to the behavioral phenotype is likely 
similar to that of susceptibility genes to polygenic diseases/conditions. Network and 
functional analyses have been developed for these situations and we employed two 
computational models that use different algorithms to identify putative functionally 
relevant differentially methylated genes. The validity of our approach is strengthened 
by the fact that many of the differentially methylated/expressed genes and their protein 
products have individually been linked to anxiety in human or to anxiety-like behavior 
in animals by pharmacological and/or genetic evidence. The genes for the 
neurotransmitter receptors/subunits CRHR1, DRD3, ADORA2A, CHRNA4, 
GABRG3 and GABBR2 were differentially methylated and all of these receptors have 
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been linked to anxiety. Central administration of CRH in rodents produces behavioral 
effects via CRHR1/2 that correlate with a state of anxiety, such as a reduction in 
exploration in a novel environment or an enhanced fear response141. Also, genetic 
studies indicate that CRHR1 is important in regulating anxiety levels142,143. Dopamine 
D3 receptor (DRD3) knockout mice display reduced anxiety in the open field and 
elevated plus maze associated with increased locomotor activity144. Adenosine2a 
receptor (ADORA2A) null mice show increased anxiety in elevated maze and light 
dark box145. Mice null for the Ach receptor α4 subunit (CHRNA4), display an 
increased anxiety in the elevated plus maze test146. Inhibitory GABA-A receptors are 
central in the treatment of anxiety and receptor deficit in the hippocampus and 
parahippocampus has also been implicated in panic disorder and generalized anxiety 
disorder147-149. Similarly, GABRB2 KO mouse exhibit anxiety150. Increased 
excitability is another mechanism that can lead to anxiety. Differential methylation 
was detected in Grin 1, the gene for the NMDA NR1 subunit, in Grik3 and Grik4, the 
genes for KA receptor subunits, in genes for glutamate receptor interacting proteins 
such as Grip1, and Shank1,2,3 as well as in calcium (Cacna1c) and potassium channel 
(Kcnj) genes that can all influence neuronal excitability and modulate anxiety151-154. 
Cell adhesion molecules, comprising the other large group of genes with 
differential methylation, are utilized through many steps during CNS development, 
including neuronal migration, guidance, neurite outgrowth, and synapse formation. 
We detected differential methylation at genes encoding cadherins, ephrins, slit-robo, 
wnts, semaphorins-plexins and neurexin-neuroligins (see Fig. 5). Disruptions of these 
genes typically result in neurodevelopmental conditions with a wide variety of 
symptom including cognitive defects, anxiety, and abnormal social behavior. 
Mutations in some of these genes such as CDH9 and NRNX1 in human, that were 
differentially methylated in the presence of adverse maternal environment in mouse, 
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have been implicated in autism spectrum disorders and schizophrenia155-158. 
Specifically, loss of function mutations (deletion and CNVs) in NRXN1, a gene that 
was not only differentially methylated but also downregulated in our experiments, 
have been linked to a number but individually variable ASD symptoms within affected 
family members resulting in relatively selective behavioral abnormalities such as 
impaired social interactions, anxiety, or learning and memory deficits in 
individuals155,156,159. Another example of a relatively specific anxiety phenotype 
associated with an adhesion molecule is the increased avoidance of the open arm of 
mice with altered EPHB2, an ephrin receptor whose gene was also differentially 
methylated in the receptor deficient maternal environment160. Overall, our finding of 
differential methylation/expression at a large number of cell adhesion and 
neurotransmitter receptor genes suggests that some forms of anxiety following 
maternal adversity could be associated with epigenetic perturbations in multiple 
synaptic genes, each contributing only a small effect to the overall phenotype.  
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3.4 Materials and Methods 
Animals  
Adult, 10-13 week old Swiss Webster male mice were used in all experiments. 
Animals were generated as described previously12,114 and housed three-five per cage in 
a room with controlled temperature and a fixed lighting schedule (lights off from 
0600–1800 h). Food and water were available ad libitum. All experimental protocols 
were approved by Research Animal Resource Center (RARC) at the Weill Cornell 
Medical College. 
ES cell culture 
E14 ES cells were cultured on feeder cells (mitomycin-inactivated mouse 
embryonic fibroblasts (MEFs)) for at least two passages after thawing. Cells were split 
every 2 d with plating densities between 1.5 x 106 and 4 x 106 cells on 10-cm cell 
culture plates. ES medium was based on DMEM containing 15% FBS (ES cell 
qualified), LIF (1,000 U/ml, Millipore, Billerica, MA, USA), 1X non-essential amino 
acids, 2mM L-glutamine and β-mercaptoethanol (Invitrogen, Carlsbad, CA, USA). 
Sample dissection and DNA extraction 
Frozen brains were sectioned into 200 µm slices using a CM3050 cryostat 
(Leica, Germany) and the ventral dentate gyrus (vDG) area from the slices was 
microdissected using a micro-dissecting knife (FST, Foster City, CA, USA). vDG 
samples from 3-5 mice from at least 3 litters were pooled into one tube. DNA 
extraction was carried out with the QIAGEN Puregene Gentra cell kit (Qiagen, 
Valencia, CA, USA). DNA was dissolved in 10mM Tris 
(tris[hydroxymethyl]aminomethane)–HCl, pH 8.0, and DNA concentration was 
measured by using NanoDrop® ND-1000 (Thermo Scientific, Wilmington, DE, 
USA). 
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DNA methylation HELP arrays  
The HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay 
was carried out as previously described128,161,162 in the Epigenomics Core Facility of 
the Weill Cornell Medical College. Briefly, two samples of one microgram genomic 
DNA each were digested overnight with HpaII and MspI (New England Biolabs, 
Ipswich, MA, USA).  Adapters were ligated to the DNA ends and the fragments were 
amplified by ligation mediated PCR optimized for fragment size between 200 and 
2,000 bp.  The HpaII and MspI representations were then labeled with Cy5 and Cy3, 
respectively, followed by the co-hybridization of the labeled fragments to Roche 25K 
custom arrays representing mouse promoters and CpG islands.  The arrays were 
scanned using a GenePix 4000B scanner (Axon Instruments, Sunnyvale, CA, USA).   
HELP data normalization 
HELP data were preprocessed and normalized using the HELP data analysis 
package163 implemented in R. Normalized HELP methylation signal was compared 
across groups with the Limma R package. Limma implements moderated variance 
estimates especially useful with small number of biological replicates in each group. 
The Limma P-values were adjusted for multiple testing with the Benjamini Hochberg 
method. HELP fragments were considered differentially methylated if their fold-
change crossed zero (indicating a qualitative change in average methylation state for 
the fragment) and the Limma BH adjusted P-values was q<0.005 (stringent estimated 
false discovery rate of less than 0.5%). Differentially methylated regions (DMRs) 
were classified based on their CpG density and location.  CpG islands were defined as 
>200bp with GC content of 50% or greater.  Islands were divided to strong (CpGo/e 
>0.80) and weak (0.8 >CpGo/e >0.60) and island shores were defined as 2kb regions 
around islands.  Low CpG regions had a CpGo/e <0.60. 
DNA methylation sequencing by MassARRAY EpiTYPER 
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DNA methylation sequencing by MassARRAY EpiTYPER  
MALDI-TOF mass spectrometry based MassARRAY using EpiTYPER 
(Sequenom, San Diego, CA, USA) was performed on fragments identified by the 
HELP assay. First, the DNA was bisulfite converted as previously described164 
followed by sequencing. MassARRAY primers were designed to cover the HpaII 
amplifiable fragments (HAFs) and additional 2,000 bp upstream and downstream 
sequences in case the sites at HAFs were methylated and the DNA was cut at upstream 
and/or downstream HpaII sites in the HELP assay. The primers were designed using 
the Sequenom EpiDesigner beta software (http://www.epidesigner.com/). The primer 
sequences are displayed below.   
Atbf1 
1 TTAAGTTTATGTAGTATTTTAGGGGTTTAG TTCATCTTCAAAACTTACAATCTAAAAAT 
2 TTTTAAAAGGATATAATTTAATAGGGTTAG ACCTCAAATTCATACAACACCTCAA 
3 TTTTTTTAAAGGTATTATTGGTTTGG TTCTCCCCTAAAAATTAACTTCAAC 
4 TTGTAATAAGGTGGAGTGTTTTTTT AAATTATTTTCCCATATACCTATCTATACC 
5 GTGGTGAATTTGTAAGAGATGGTGT AAAACTAAACCCCTAAAATACTACATAAA 
6 TTTTTGAGGTGTTGTATGAATTTGA AAAAACCACCTAAAATCCCTCTACT 
7 GTTATTATGGTAATGGTTTTTTAGTTATTT TAAAAAAACCTCTCCTTTCTCCTTC 
8 GTTTTTAAGAAGGAGAAAGGAGAGG AAAAACAAACCTTCCATACCATACA 
Smo 
1 GGAATTTATTTTGTAGATTAGGTTGG AAACTCACAATTCTAAATCATAATCCA 
2 AGAAATTTTATGAGGTAGTTGGGTT AAAACAAACAAAAATTTTCACTCCA 
3 TTAAAGATTTAGTTAAGTGTTTTTGGGA CAACCCCCTAAACTCTCCCTAC 
4 TAGTTGGTTTTGTTTTTTGGAATGT CCAACTAAAAATTCAATCAAATACCTC 
5 GAGAGTAGGGTTAGTTAGAGTAATAAAGGA AAACTATCTTCAACCCTAAAAACC 
6 GAAGTTGTTTTTAATTTTGGGAATTT AAAACTAAAACTCCTCCTCTCCAAC 
7 GGAGGGTTTTTAGGGTTGAAGATAG CCAACAATACCAACAACAACAACTA 
8 AGTTGTTGTTGTTGGTATTGTTGG ACTAACTTCCCTAATCTCTTACCCC 
9 TGGTTAAATAGTTAATTTAGTAAAAGTTGA AAAAATTCCCAAAATTAAAAACAAC 
10 AATAGTTTGAGGTTTGAGTTTTTTTT TCAACTTTTACTAAATTAACTATTTAACCA 
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Enhanced Reduced Representation Bisulfite Sequencing (ERRBS) 
500 ng DNA from each group was processed by the standard RRBS protocol 
as described130DNA was digested with MspI restriction enzyme. This was followed by 
end repair and ligation of paired end Illumina sequencing adaptors fully methylated at 
all cytosines.  Size selection for library sizes of 150-400 bp was performed followed 
by a single round of bisulfite treatment using the EZ DNA Methylation Kit (Zymo 
Research). PCR amplification using Illumina PCR PE1.0 and 2.0 was followed by 
product isolation using AMPure XP beads per manufacturer’s recommended protocol 
(Agencort). Quality control was performed using quantitation on a Qubit 2.0 
fluorometer (Invitrogen) and library visualization using a Quant-iT dsDNA HS Assay 
Kit for (Agilent 2100 Bioanalyzer). The amplified libraries were sequenced using a 
50bp single end read run on a HiSeq2000 per manufacturer’s recommended protocol. 
Image capture, analysis and base calling were performed using Illumina’s CASAVA 
1.7. 
ERRBS read mapping 
The last bisulfite plugin parallelizes alignments with the last aligner, and 
otherwise follows the recommended protocol for aligning bisulfite reads with this 
aligner (i.e., see http://last.cbrc.jp/doc/bisulfite.txt).  
ERRBS methylation rate estimation 
Methylation rates were estimated with GobyWeb and the 
SEQ_VAR_GOBY_METHYLATION plugin. This plugin determine when 
methylation events occurs at a given genomic location. Events are defined as 
observing a C in the read when the reference has a C (methylation event on the 
forward strand) or observing a T in the read when the reference has a C (non-
methylation event on the forward strand). Similarly, G/G and G>A observations 
define methylation and non-methylation events for the reverse strand, respectively. 
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Methylation rates were estimated for sites were more than 35 events were observed. 
Methylation rates were estimated as the number of methylation events divided by the 
sum of non-methylation and methylation events. A methylation rate of 100% indicates 
that all events support methylation at this site. To identify differentially methylated 
sites, we calculate a Fisher Exact test comparing the number of methylation events and 
non-methylation events at a site between two groups of samples as reported earlier165. 
The Fisher p-values are adjusted for multiple testing across all sites observed with 
more than 35 events across the genome. This is done with the Goby fdr 
implementation of the Benjamini-Hochberg method (see 
http://goby.campagnelab.org). Sites are considered significantly differentially 
methylated when the adjusted q-value is less than 0.01 and the difference in 
methylation rate is larger than 20% between the groups. 
Sample preparation for RNA extraction and RNA-Seq 
Mice were perfused with ice-cold saline solution containing 30 % RNAlater 
(Ambion, Austin, TX, USA) to prevent RNA degradation during microdissection. 
Brains were rapidly removed, frozen and stored at −80 °C until sectioning. Isolation of 
vDG was as described above. Ventral DG samples from 3-5 mice from at least 3 litters 
were pooled.  
 
RNA extraction and RNA sequencing (RNA-Seq) 
Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA, 
USA). RNA concentration was measured using NanoDrop® ND-1000 (Thermo 
Scientific, Wilmington, DE, USA) and RNA quality control was performed by using 
Bioanalyzer 2100 (Agilent Technologies, Palo Alto, California, USA).  RNA was 
fragmented with divalent cations at high temperature and converted to cDNA libraries 
following the Illumina recommended sample preparation guide (Document 1004898 
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Rev. D) using Illumina kits (Illumina, San Diego, CA, USA)164. The libraries were 
sequenced on the Illumina GAIIx instrument (one sample per lane), with the single 
end protocol and 42 cycles of sequencing.   
RNA-Seq Data Analysis  
RNA-Seq data were received as FASTQ files from the core facility and 
uploaded to a local instance of GobyWeb (http://gobyweb.campagnelab.org).  
Alignments were performed with and the bwa aligner166 against the MM9 mouse 
reference genome. Alignments were filtered to keep only reads that matched with less 
than 5% sequence differences (accepting 2 mismatches at most over a 42 bp read) and 
to exclude those generated from reads that mapped in more than one location in the 
reference genome. Differential expression analysis was conducted with GobyWeb. 
Briefly, alignments were used to estimate the number of reads that match gene 
annotations with the Goby alignment-to-counts mode. Annotations were obtained the 
Ensembl release corresponding to NCBI37.55/MM9. Gene counts were estimated as 
the sum of the number of reads that partially overlap with any of the exons of a gene, 
but do not lie completely within the introns of the gene. Counts were compared 
between groups with a Fisher exact test (R implementation) adjusted for multiple 
testing with the method of Benjamini Hochberg (adjusted Fisher exact test P-
value<0.01 and fold-change>1.3 in either direction of change).  
Statistical analysis 
Data are shown as means +/- SE. One way ANOVA or Kruskal-Wallis Rank 
Sum Test was used in the analyses to compare multiple groups followed by LSD and 
Tukey posthoc analysis, respectively to assess statistical significance. Differences 
between groups were considered to be significant when P<0.05. 
Functional Enrichment Analysis 
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The list of differentially methylated genes was analyzed through the use of 
Ingenuity Pathways Analysis (http://www.ingenuity.com).   The Functional Analysis 
identified the biological functions that were most significant to the data set. Right-
tailed Fisher’s exact test was used to calculate a p-value determining the probability 
that each biological function assigned to the data set is due to chance alone. Analysis 
of functional enrichment was carried out using MetaCore from MetaCore from 
Thomson Reuters (http://www.genego.com/metacore.php, version 6.10) searching for 
enrichment in the manually curated GeneGO Process Networks, representing a pre-set 
network of protein interactions.  Statistical significance of a process was determined 
using the Hypergeometric distribution and adjusted for multiple testing by MetaCore. 
Data Access 
Raw data (HELP, RNA-Seq and RRBS) have been deposited into the GEO 
database and are included in the super series identified by accession number 
GSE35856. 
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Supplemental Table 3.1: List of differentially methylated (ERRBS) and 
expressed genes  encoding synaptic proteins 
	   	   	   	   	  Gene	   Expression	   Significance	   	  	   Ensembl	  gene	  ID	  	  	   wt(wt/wt(h)	   	  	   	  	   	  	  ADAM11	   0.748699135	   4.58E-­‐10	   	  	   ENSMUSG00000020926	  SLIT3	   0.734192828	   2.77E-­‐11	   	  	   ENSMUSG00000056427	  PRKCA	   0.578599904	   6.59E-­‐42	   	  	   ENSMUSG00000050965	  PRKCH	   0.702094347	   0.000497419	   	  	   ENSMUSG00000021108	  BMP7	   0.637856801	   9.53E-­‐05	   	  	   ENSMUSG00000008999	  EFNA1	   1.351590619	   0.00396434	   	  	   ENSMUSG00000027954	  SMO	   0.75645254	   0.000290135	   	  	   ENSMUSG00000001761	  DOCK1	   0.758581453	   0.0011486	   	  	   ENSMUSG00000058325	  APP	   0.762555476	   6.84E-­‐112	   	  	   ENSMUSG00000022892	  NRXN1	   0.766524349	   2.42E-­‐16	   	  	   ENSMUSG00000024109	  DNM1	   0.731609174	   4.17E-­‐169	   	  	   ENSMUSG00000026825	  GABBR2	   0.765843385	   4.34E-­‐24	   	  	   ENSMUSG00000039809	  SV2B	   0.715696659	   2.19E-­‐55	   	  	   ENSMUSG00000053025	  BSN	   0.709602339	   3.05E-­‐157	   	  	   ENSMUSG00000032589	  GRIK4	   0.755007588	   1.89E-­‐08	   	  	   ENSMUSG00000032017	  CAMK1D	   0.709018718	   2.37E-­‐32	   	  	   ENSMUSG00000039145	  PTPRF	   0.761945399	   5.44E-­‐13	   	  	   ENSMUSG00000033295	  FGFR1	   0.728395781	   5.54E-­‐18	   	  	   ENSMUSG00000031565	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CHAPTER 4 
TRAITS OF A PSYCHIATRIC DISEASE-LIKE PHENOTYPE PROPAGATE 
THROUGH THE MATERNAL LINE VIA SEGREGATED ITERATIVE-
SOMATIC AND GAMETIC EPIGENETIC MECHANISMS 
 
* Mitchell E., Klein S., Sharma A., Toth J.G., Argyropoulos K., Chen R., Barboza L., 
Bavley C., Bortolozzi A., Chen Q., Lodhi N., Ingenito J., Mark W., Dudakov J., Gross 
S., Paolo G.D., Artigas F., and Toth M. 2015. Manuscript submitted for review. 
 
4.1 Introduction 
The concept of “non-genetic” inheritance of parental behavioral traits is 
gaining acceptance because it may significantly contribute to the development of 
disease phenotypes, including psychiatric disorders4,167. For example, stress and 
resulting stress disorders in parents increase the risk for PTSD, depression, and 
anxiety disorders in their progeny39,43. Many aspects of this “intergenerational” 
transmission paradigm can be reproduced in rodents.  In particular, parental stress was 
shown in several studies to result in abnormal emotional behavior in the 
offspring17,40,41. Some human studies also suggest the transmission of parental 
behavioral/psychiatric conditions to the grandchildren. As a result, the mechanism of 
“multigenerational” transmission of parental traits has been extensively studied in 
rodent models, especially through the male line because of its relatively 
straightforward interpretation via germ cells and the ease of obtaining sperm for 
epigenetic studies17-19,40,41,168,169. 
However, epidemiological studies indicate that many inter/multigenerational 
non-genetic behavioral phenotypes are exclusively or prominently transmitted through 
the maternal line4,42,170. This is not surprising because, in contrast to paternal, maternal 
conditions can impact the offspring during gametogenesis and through fetal life, 
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increasing phenotypic complexity and the overall inter/multigenerational effect. One 
prominent example is the increased vulnerability of the adult children and 
grandchildren of Holocaust survivors to psychological distress171,172. Additional 
studies suggest that maternal stress4,39 and infection95,173 increase the incidence of 
anxiety, depression, schizophrenia, autism, and attention deficit hyperactivity disorder 
(ADHD) in the progeny. Non-genetic inheritance can also be initiated by altered 
“internal” maternal environment, represented by maternal mutations that perturb fetal 
development, but are not transmitted genetically to the offspring. A recent example 
relevant to psychiatric conditions is maternal (but not paternal) mutations in 
tryptophan hydroxylase I (an enzyme responsible for serotonin synthesis in the 
periphery) resulting in increased risk for ADHD in the offspring174. Non-genetic 
multigenerational transmission of behavior through the female line has also been 
demonstrated in rodents40,175. 
Although these examples demonstrate the non-genetic transmission of complex 
behavioral traits via the maternal line across at least two generations and underscore 
its potential clinical importance in psychiatry, the idea that multifaceted offspring 
phenotypes can be the aggregate of the consecutive actions of germline and various 
somatic maternal effects has not been previously studied as a collective basis for 
complex diseases. Maternal intergenerational effects during pre/postnatal life are 
believed to be primarily mediated by hormonal and/or cytokine signaling pathways, 
emanating from the mother and altering the development of the fetal brain8,176,177. 
However, these “somatic” mechanisms are limited to first generation phenotypes, 
unless the maternal phenotype is self-perpetuating, a possibility that has not been 
explored comprehensively, presumably because its substantiation requires relatively 
complex embryo transfer and crossfostering experiments. Therefore the question 
remains whether multigenerational transmission via the maternal line is gametic, as 
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was found in a recent animal model178, and/or somatic, mediated by an iterative 
process, similar in concept (but not in mechanism) to non-verbal cultural 
transmission/learning. 
To answer this question, we dissected a composite maternally-transmitted 
psychiatric disease-like phenotype, resembling in dimensions179 comorbid general 
anxiety and depression, to elementary behaviors/circuits and their corresponding 
transmission mechanisms. Depression and stress disorders are associated with reduced 
postsynaptic serotonin1A receptor (5-HT1AR) levels, and we reported that 5-HT1AR+/- 
dams not only exhibit anxiety-like (i.e. increased innate fear) and stress-reactivity 
traits, but also transmit them non-genetically to their F1 wild-type offspring12,26,115. 
Here we show that, the elementary traits of the composite phenotype are propagated 
beyond the F1 generation up to the F3 generation, and that, in contrast to Mendelian 
inheritance, the maternal traits are not inherited in unison, but rather transmitted by 
segregated somatic and gametic mechanisms, each with generation-dependent 
penetrance and sex specificity. We also demonstrate that somatic transmission can be 
iterative and results in a multigenerational phenotype without the involvement of the 
gametes. Whether iterative somatic or gametic, the transmission mechanisms converge 
on enhancer-like sequences within synaptic genes, implicating abnormal neuronal 
signaling in the manifestation of the offspring phenotype.  Our data introduce 
segregated non-genetic transmission of traits as a mechanism that may explain some 
aspects of the non-Mendelian propagation of behaviors and dimensions of psychiatric 
diseases across generations. 
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4.2 Results 
Traits of a psychiatric disease-like phenotype are propagated non-genetically 
across multiple generations in a mouse model 
We reported behavioral abnormalities in the genetically wild type (WT) male 
offspring of 5-HT1AR+/- heterozygote (H) and/or 5-HT1AR-/- knockout (KO) parents12. 
These behaviors included anxiety-like behavior in the elevated plus maze and 
increased escape directed behavior in the forced swim test.  Here we tested if these 
behaviors propagate to the next (F2) generation through the maternal line. F2 males, 
produced by mating F1 WT females with control WT males (Supplementary Fig. 4.1), 
exhibited reduced exploration of the fear-inducing open arm of the elevated plus maze 
(measured as reduced distance travelled in percent of total distance) (Fig. 4.1a). Total 
activity was unchanged, indicating that the reduced activity was specific for the open 
arm and consistent with innate anxiety-like behavior (Supplementary Fig. 4.2). 
Anxiety of F2 males were comparable to that of KO males (or H males, not shown but 
see12), demonstrating the robustness of the non-genetically transmitted behavior. To 
test if the anxiety-like behavior is propagated beyond the F2 generation, F3 males, 
with age-matched F1, as well as WT controls were generated.  The anxiety phenotype 
was not transmitted to the F3 generation, while the F1 males, as in our previous 
study12, exhibited the phenotype (Fig. 4.1b). Of note, to avoid genetic drift, the H line 
was backcrossed every 5-10 generations to WT mice obtained from large colonies 
kept at Taconic Biosciences (Germantown, NY), and then the H and WT lines were 
reestablished; non-genetic transmission of anxiety was reproduced following three 
such backcrosses.  Return of open arm behavior in F3 males to the WT level is also 
consistent with a non-genetic, rather than spurious genetic, transmission. Next, we 
generated age-matched WT, H, F1, F2, and F3 females (males were used for 
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epigenetic studies) to study if sex influences transmission. Although F1 females 
showed a trend for anxiety, F2 and F3 females were indistinguishable from that of WT 
(Fig. 4.1c), indicating sex differences in the transfer and/or manifestation of anxiety.  
We also reported that fetal exposure to the H maternal environment (by 
embryo transfer and consecutive crossfostering to WT mothers) is sufficient to 
produce anxiety-like behavior in the elevated plus maze in WT mice12.  We refer to 
these mice as F1-S, to indicate their “somatic” “exposure” to the H mothers. In 
contrast, anxiety did not result when exposure to H maternal environment was limited 
to the period of gametogenesis (G) and early embryogenesis; up to the 2-4 cell stage 
(Fig. 4.1d). These F2-G offspring were generated by transferring F2 early embryos 
from from F1 donors to WT recipients. Overall, these data are most consistent with a 
model in which anxiety is transmitted via an iterative non-gametic mechanism from H 
mothers to the F1 generation, and then from the F1 females to the F2 males. 
Gestational LPS resulted in the similar propagation of anxiety across two generations 
(Supplementary Fig. 4.3), indicating that the phenomenon of iterative somatic 
programming of behavior may apply more broadly to adverse early-life experiences.  
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Figure 4.1. Non-genetic transmission of emotional behavioral traits, associated 
with maternal 5-HT1AR deficit. a. Anxiety in the open arm of the EPM as % of total 
activity.  F2 males, similar to KO males, exhibit increased avoidance of the open arm 
(group effect in distance traveled; ANOVA: F2,35=13.28, P<10-4; LSD post hoc 
***p<0.005 compared to WT; N=11, 12, and 15 mice per group). All data are 
presented as mean ± s.e.m. b. F1, but not F3, males travel less distance in the open 
arm (group effect, ANOVA: F2,54=6.46, P=0.003; LSD post hoc **p<0.01 compared 
to WT, N=17, 15, and 26 mice per group). c. Anxiety of female mice in the elevated 
plus maze (group effect, ANOVA: F4,57=4.22, P=0.0046; N=12 WT, 13 H, 7 F1, 19 
F2, and 11 F3).  Significant anxiety in H (LSD post hoc *p<0.05) and a trend for 
anxiety in F1 females (+p <0.10). d. Males derived by embryo transfer from WT germ-
cells that were exposed to H (F2-G), as compared to and WT (WT-G) grand-maternal 
environment during gametogenesis exhibited no EPM anxiety (distance in open arm in 
% of total; t-test:, T=-0.202, p=0.841, N=16 and 20 animals per group).  e. Distance 
traveled in the open field. F2 males, similar to KO males, exhibit reduced activity 
(ANOVA: F2,47=13.47, P<10-4; LSD post hoc ***p<0.005, N=17, 17, and 16). f. Total 
activity of F1 and F3 males in open field is not different from that of WT males. g. 
Female H and F3 offspring are hypoactive while F1 offspring exhibit a trend for 
hypoactivity in the open field (ANOVA: F4,49=3.25, P=0.019; LSD post hoc 
**p<0.01, trend +p<0.10, N=13, 14, 7, 8, and 11). h. Hypoactivity is somatically 
programmed (WT-S vs. F1-S males: t-test: T=2.286, *p= 0.036, N=13 and 5 animals 
per group; WT-G vs. F2-G males: T=-1.279, p=0.208, N=30 and 15. i. Stress 
reactivity, measured as mobility in the forced swim test. F2 males have increased 
mobility (ANOVA: F2,45=10.12, P<0.001; LSD post hoc ***p<0.005, N=17, 14, and 
17). j. No stress phenotype in F1 and F3 males. k. Female F1 and F2 have reduced 
mobility (ANOVA: F4,49=7.92, P<10-4; LSD post hoc **p<0.01, ***p<0.005, N=14, 
14, 7, 9, and 10). l. Increased stress reactivity of F2 males is gametically programmed 
(ANOVA: F2,32=3.48, P=0.042; LSD post hoc *p<0.05, N=12, 8, and 15). 
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Although their overall activity was unchanged in the elevated plus maze, F2 
males, similar to KO males, exhibited reduced locomotor activity in the larger and less 
stressful open field, (Fig. 4.1e). Albeit hypoactivity can be interpreted as a sign of 
anxiety, in a relatively low stress environment it may rather reflect reduced 
motivation. In contrast to F2 males, neither F1 nor F3 male offspring showed 
hypoactivity (Fig. 4.1f).  F1 females showed only a trend for reduced activity, while 
F3, like H females, exhibited significant hypoactivity (Fig. 4.1g).  Overall, these data 
indicate a modest phenotype with variable penetrance and sex specificity across three 
generations. Interestingly, while F1 males showed no phenotype, hypoactivity was 
robust in F1-S male offspring, indicating that somatic exposure through fetal life to the 
H maternal environment is sufficient to elicit hypoactivity (Fig. 4.1h), and that 
continuous exposure to the H environment during the first three weeks of postnatal life 
in F1 males may moderate the fetal programming effect (Fig. 4.1f). This could also 
explain the significant hypoactivity of F2 males (Fig. 4.1e) because they, like F1-S 
males, are raised by genetically WT mothers. Similar non-genetic transmission to 
grandchildren that skips the F1 generation (but which is propagated through the 
paternal line) has previously been suggested in human180. Based on the phenotype of 
F1-S and F2 males, we concluded that the hypoactivity trait is also transmitted by 
iterative somatic programming. Consistent with somatic transmission, the hypoactivity 
phenotype was not transmitted to F2-G males (Fig. 4.1h). 
An additional variable receptor-associated non-genetic trait is reduced 
immobility/increased escape-directed behavior in the forced swim test12. Though 
traditionally interpreted as an “antidepressant”-like behavior, it more likely reflects 
increased reactivity to a stressful environment12. Although weak and below 
significance in F1 and KO males, the escape response was robust in F2 males (Fig. 
4.1i,j). F1 and F2 females also exhibited a phenotype, but in the opposite direction, 
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indicating a sex difference (Fig. 4.1k). We have previously reported that the increased 
stress reactivity phenotype was absent in F1-S males12 suggesting that the trait is not 
somatically transmitted.  Here we show that F2-G males have increased stress 
reactivity (Fig. 4.1l). Lack of increased stress-responsiveness phenotype in F1 males, 
while present in both F2 and F2-G, supports the possibility that the H maternal 
fetal/early postnatal environment moderates the gametically programmed phenotype. 
The increased stress reactivity phenotype, seen in F2-G males was not apparent in the 
next generation (Supplementary Fig. 4.4), indicating that gametic programming of this 
phenotype is not strictly transgenerational.   
Surprisingly, we also found that, while WT mice predictably responded to the 
5-HT1AR agonist 8-OH-DPAT with hypothermia, F2 and F3 males and females, 
similar to H or KO mice, had a partially/completely blunted drug response (Fig. 
4.2a,b). The hypothermic response of the drug is mediated by 5-HT1A presynaptic 
autoreceptors in the raphe nucleus181. Embryo transfer itself induced blunted 
hypothermic response (presumably because of the surgical/transplantation 
procedure(s) and the resultant effect on the mother and/or embryo), preventing us from 
determining the exact transmission mechanism of this particular trait (Supplementary 
Fig. 4.5). Nevertheless, this data suggests that an environmental perturbation can 
disturb thermoregulation, revealed by a receptor agonist.  To directly test if the blunted 
drug response in F2 males was due to reduced receptor availability in the raphe, we 
measured receptor binding by using [3H]-8-OH-DPAT. Indeed, F2 males had 
significantly reduced receptor binding in the dorsal raphe nucleus (Fig. 4.2c, 
Supplementary Fig. 4.6).  F1 males, consistent with their drug-induced hypothermia 
response, had normal receptor binding. In F2 males, binding was also reduced in the 
hippocampus, expressing 5-HT1A postsynaptic receptors, indicating that the non-
genetic effect is not restricted to the presynaptic pool. However, levels of postsynaptic 
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receptors in two cortical areas were unchanged in F2 animals. Since in situ 
hybridization and RNA-Seq showed no receptor mRNA changes in F2 dorsal raphe 
and hippocampus (Fig. 4.2d), the absence of drug-induced hypothermia/5-HT1AR-
binding is not based on a direct transcriptional mechanism, but presumably on 
impaired translation and/or receptor trafficking/coupling, that can be either a 5-HT1AR 
specific or a broader mechanism. 
Schematic representation of the transmission of the four traits in Fig. 4.2e 
underscores the variable and sex specific penetrance of the associated behaviors, 
resulting in a high degree of pleiotropy in the pedigree. The anxiety trait is 
characterized by fully penetrant but limited intergenerational transmission, as it was 
present in both male and female F1 offspring, but only in F2 males and not in F3 
animals. In contrast, the other traits seem to be partially penetrant but 
multigenerational because they were weak or not expressed in F1, expressed more 
robustly in F2 (especially in males), and were occasionally transmitted to the F3 
generation. Importantly, the traits were transmitted and/or expressed independently 
from each other across the generations, even the somatically programmed anxiety and 
hypoactivity traits, indicating their segregated transmission. 
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Figure 4.2. Non-genetic transmission of trait associated with the lack of drug-
induced hypothermia and summary of transmission of all traits. a. F2, F3, H, and 
KO males exhibit blunted response (repeated measures ANOVA: group, F5,86=23.9, 
P<10-6; dose, F3,258=67.9, P<10-6; and group x dose, F15,258=29.7, P<10-6; LSD post 
hoc ***p<0.005, relative to WT at the same dose; N=WT 19, F1 13, F2, 23, F3 12, H 
15, KO 16). b. F2 and F3 females also exhibit blunted hypothermia response to drug 
(repeated measures ANOVA: group, F2,24=13.7, P=0.0001; dose, F3,72=17.1, P<10-6; 
and group x dose, F6,72=7.6, P=0.000002; LSD post hoc *p<0.05, ***p<0.005, relative 
to WT at the same dose, N=WT 6, F1 8, F2, 10, F3 11). c. F2 males have reduced 
[3H]-8-OH-DPAT binding (ANOVA: DR, F2,15= 6.37, P=0.01; CA, F2,15=4.46, 
P=0.030; LSD post hoc *p<0.05, N=6 for all groups), but d. not receptor mRNA 
expression. DR, dorsal raphe; CA, CA subfields of the hippocampus; mPFC, medial 
prefrontal cortex; EntCtx, entorhinal cortex. e. Variable penetrance, gender specificity 
and different modes of transmission of traits generate a highly variable phenotype in 
the pedigree. Each quarter circle represents significant phenotype, while trend is 
represented by one eight of a circle. 
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Transmission of the somatic anxiety trait 
To gain insight into the mechanism of somatic programming, we focused on 
the anxiety phenotype because it was robustly transmitted to F1 and F2 males. We 
hypothesized that transmission of this particular trait is linked to a brain-immune-brain 
pathway because a deficit in 5-HT1ARs is associated with depression and stress 
disorders182, conditions that can lead to a proinflammatory status in both mother and 
offspring183, and because immune activation in the offspring can result in abnormal 
emotional behaviors184. Indeed, F1 and F2 neonates (3 days old), similarly to 5-HT1AR 
H or KO pups, had elevated peripheral neutrophil and monocyte counts, indicating a 
proinflammatory status (Fig. 4.3a). Flow analysis of neonatal spleens showed similar 
myeloid (neutrophil, monocyte, macrophage) changes, together with an elevated 
number of NK and T cells (Fig. 4.3b). Notably, a significant number of monocytes 
transmigrated to F1 and F2 brains suggesting their activated state (Fig. 4.3c). This 
finding may provide a plausible mechanism to explain the anxiety-like phenotype of 
F1 and F2 males because the presence of activated monocytes and their development 
to macrophages in brain parenchyma have been shown to cause anxiety-like behavior 
in mice185. 
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Figure 4.3. Neonatal immune alterations in the F1 and F2 offspring of 5-HT1AR 
deficient H mothers. a,b. Blood and spleen of F1 and F2 P3 neonates have increased 
number of neutrophils and monocytes (Blood, ANOVA: F4,72=9.99, P=0.000002; LSD 
post hoc ***p<0.01, trend +p<0.10, N=15, 22, 15, 8, and 14; Spleen, ANOVA: 
F2,12=6.53, P=0.012; LSD post hoc **p<0.01 and *p<0.05, N=6, 3, and 6).  c. Brains 
of F1 and F2 P3 neonates have transmigrated monocytes (ANOVA: F2,12= 10.07, 
P=0.0027; LSD post hoc ***p<0.005 and *p<0.05, N=6, 3, 6).  Lower panels show 
the gating strategy. 
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Neuronal transcriptome and metabolome changes in lipid signaling track the 
anxiety-like phenotype across generation 
Anxiety in the elevated plus maze has been linked to dentate gyrus granule 
cells, in particular in the ventral hippocampus, in lesion, pharmacological and 
optogenetic studies119,186. Consistent with this association, we reported delayed 
granule cell maturation, specifically in the ventral hippocampus, in F1 offspring12. 
Delayed hippocampal development in turn may result in persistent transcriptional 
abnormalities that could contribute to the F1 adult anxiety phenotype.  
The high density and clustering of granule cell bodies in the granule cell layer 
of the dentate gyrus and their separation from most other cell types (Fig. 4.4a) allowed 
us to microdissect them from cryosections and then assess gene expression, primarily 
in this cell type, as a function of prior maternal environment.  RNA-Seq identified 
~3,000 differentially expressed genes in both F1 and F2 adult males (FDR q<0.01), 
with a significant (2/3) overlap, consistent with the shared anxiety phenotype of these 
mice (Fig. 4.4a). Surprisingly, differentially expressed genes in both F1 and F2 (same 
direction of change) were primarily enriched in membrane lipid-related functions, 
including sphingolipid, glycerophospholipid (i.e. phosphatidylethanolamine) and 
diacylglycerol metabolism (Ingenuity Functional Analysis, p=0.000037, 0,00019, and 
0.0045, respectively; Supplementary Table 4.1). Although anxiety is typically viewed 
as a dysfunction in neurotransmission, membrane lipids and their metabolizing 
enzymes are known to regulate membrane receptor function and intracellular 
signaling78 and have been implicated in psychiatric diseases, including anxiety 187,188. 
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Figure 4.4. The impact of the receptor deficient maternal environment on the 
F1/F2 neuronal transcriptome and metabolome. a. A sagittal section of the ventral 
hippocampus highlighting the location of ventral granule cells, the source of mRNAs 
and metabolites. Granule cells can be isolated as a homogenous population because of 
their clustering in the granule cell layer (cells are highlighted by their green NeuN 
positive nuclei). Only a few cells positive for the glia marker GFAP present within the 
granule cell layer (blue cytoplasmic staining). Most of the differentially expressed F1 
and F2 genes overlap. b. Ingenuity functional analysis of differentially expressed 
overlapping F1-F2 genes identified enrichment in functions related to sphingolipid 
metabolism (right), receptor signaling (center) and glycerophospholipids (left), 
indicated by solid grey circles, as a result of the maternal effect. Gene/protein 
nomenclature, see Supplementary Table 2.  Lipid changes shown in panel c are also 
highlighted (blue box represents reduced and red increased levels in both F1/F2 
granule cells, while red/blue boxes with staggered outline represent changes in either 
F1 or F2. Cer, ceramide; DAG, diacylglycerol; ETA, ethanolamine; GalCer, 
galactosylceramide, GM3, monosialodihexosylganglioside; MAG, monoacylglycerol; 
PA, phosphatidic acid; PE, phosphatidylethanolamine, PEp, plasmalogen 
phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, 
phosphatidylserine; SM, sphingomyelin. c. Glycerophospholipid and sphingolipid 
composition of F1 and F2 ventral granule cells, relative to WT cells. BMP, 
bis(monoacylglycero)phosphate; LPI, lysophosphatidylinositol.  N=6 per group. 
Columns represent total levels of lipid subclasses. Results are presented as mean and 
bars as s.e.m, *p⩽ 0.05; and trend +p  0.1 by ANOVA with Bonferroni posthoc test 
(α: 0.0166). Blue and red boxes in insets represent significantly reduced and increased 
levels in specific lipid species within lipid subclasses; see also Supplementary Table 4 
for the extent of changes. 
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Differentially expressed genes encoded key enzymes in sphingolipid 
metabolism (Smpd1-4, Cerk, Nsmaf, Asah2, Degs2, Fasn, Scd and Cln3; see genes 
with expression changes in Fig. 4.4b, and the list of all genes in Supplementary Table 
4.2). Regulation was complex, with both up and downregulation, even within gene 
families (e.g. Smpd1-4), suggesting microdomain specific rather than global changes 
in corresponding lipids. Interestingly, we also found seven genes, all upregulated, that 
are involved in the metabolism of the glycosphingolipid GM3 (UGT8, HexB, Gm2A, 
Large, St6galnac4, St6galnac6, and St8sia1), suggesting a possible coregulation of 
these genes. Additional differentially expressed genes were associated with 
glycerophospholipid metabolism (Dgke, Chka, Chkb, Pisd, Dgat1, Dgka, Mgat3, Mgll, 
and Pla2g3). Moreover, Ingenuity analysis identified the canonical Superpathway of 
Inositol Phosphate Compounds (p=0.00014, see within the glycerophosholipid 
network in Fig. 4.4b), represented by a substantial number of genes (Plcb2, Plcb4, 
Plcg1, Plcg2, Pik3cb, Pip4k2b, Pip5kl1, Pikfyve, Ppip5k1 and 2).  Phosphoinositol 
signaling is triggered by receptor activation, and we also found a number of 
differentially expressed genes encoding membrane receptors, including GPCRs and 
their downstream signaling molecules, such as Gαq, Gα12/13, adenylate cyclase 6/9, 
AKT3, embedded into the lipid networks (Supplementary Table 5.1, Fig. 4.4b). In 
sum, the transcriptome data suggest a broad dysfunction in lipid signaling in F1 and 
F2 ventral granule cells.  
Next, we performed untargeted profiling of 3,156 metabolites in granule cells 
from individual WT and F1 mice that identified 21 differentially-expressed 
metabolites (p≤0.05), of which 11 were structurally-defined, and which confidently 
distinguished F1 from WT granule cells (Supplementary Fig. 4.6 and Supplementary 
Table 4.3). Remarkably, 9/11 of the structurally-defined molecules were recognized as 
membrane/bioactive lipids, comprised of 5 glycerophospholipids, phosphatidic acid 
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43:2, phosphatidylethanolamine 38:5, phosphatidylcholine 38:6, diacylglycerol 40:8 
and 40:7, 3 lactosylceramides (differing in carbon chain length and degree of 
unsaturation), and 1 lipid metabolite (3-phosphoglyceroinositol), all diminished in F1 
as compared to WT granule cells by 10-90%.  
A more comprehensive targeted lipidomic study assessed the levels of a large 
number of lipid species in both F1 and F2 granule cells. Phosphatidic acid levels 
(measured in the range of 30-42 in total fatty acid chain length) again were reduced, 
but reached statistical significance only in F2 neurons (Fig. 4.4c, Supplementary Table 
4.4), in line with the generally more robust behavioral phenotype of the F2 offspring 
(Fig. 4.2e). Phosphatidic acid is known to play major roles in regulating membrane 
trafficking and cellular signaling through interaction with effector proteins or by direct 
effects on lipid bilayers189. Levels of specific plasmalogen phosphatidylethanolamine 
(36:1 and 36:3) and phosphatidylglycerol (34:0, 34:1, 36:1) species were reduced in 
both F1 and F2 granule cells. Levels of some bis(monoacylglycerol)phosphate species 
were also generally reduced, but reached statistical significance only in F2. In contrast, 
different lysophosphatidylinositol species were increased in both F1 and F2 neurons. 
Although untargeted metabolomics suggested reductions in the levels of specific 
molecular species of phosphatidylcholine and diacylglycerol as well, these changes 
were not verified by targeted lipidomics (however, the diacylglycerol species 
identified in untargeted metabolomics were not analyzed in the targeted lipidomics 
experiment). In sum, levels of major glycerophospholipids were reduced in F1 and F2 
neurons, in some cases only in F2 neurons (Fig. 4.4c). Regarding sphingolipids, 
sphingomyelin levels were reduced, but only in F2 neurons, while galactoceramide 
levels were increased in F1 GCs. However, levels of another glycosphingolipid, GM3, 
were increased in both F1 and F2 neurons and represented the largest changes in the 
F1/F2 lipidome (Fig. 4.4c). GM3 and other sphingolipids are enriched in raft-like 
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microdomains, specialized membrane domains where transmembrane signaling occurs 
through receptors and associated signaling components78. Taken together, the deficit 
in major glycerophospholipids and the surplus in some glycosphingolipids in F1/F2 
granule cells suggest an imbalance between two major classes of membrane lipids. 
These data, in combination with the transcriptional findings, strongly implicate 
abnormal neuronal signaling through altered lipid metabolites and/or lipid-receptor 
interactions in F1 and F2 granule cells, possibly underlying the iterative anxiety 
phenotype. 
DNA methylation changes in lipid and transmembrane signaling genes 
cosegregate with the anxiety phenotype 
We have previously reported permanent DNA methylation changes in adult F1 
ventral granule cells26. Here we profiled F1, F2, and F3 ventral granule cells from 
adult males and followed the segregation of methylation signatures with the anxiety 
phenotype across generations. Methylation at ~1.5 million CpGs and 6-7 million non-
CpGs was measured genome-wide by bisulfite sequencing61. Differentially methylated 
sites (>15%, q<0.01) tended to be clustered (>4), forming differentially methylated 
regions (DMRs, average size 200-300bp). DMRs were present in all F1, F2 and F3 
neurons (Fig. 4.5a). The change in methylation occurred at CpGs (>95%), either 
hypomethylation or hypermethylation (55% and 45%), and was unidirectional in all 
differentially methylated sites at 87% of the DMRs. Thus the methylation landscape in 
F1-F3 ventral granule cells was characterized by mostly uniformly hypomethylated or 
hypermethylated DMRs distributed across the genome.  
Most DMRs (>80%) mapped to intragenic sequences and therefore could be 
assigned to specific genes. We hypothesized that DMRs and their genes are associated 
with anxiety if present in both F1 and F2 granule cells, while the set of DMR genes 
present in all F1, F2 and F3 neurons may lack key differentially methylated genes 
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required for the development of anxiety (F3 males do not exhibit anxiety). 
Approximately half of the 659 F2 DMRs was also present in F1 neurons, of which the 
majority was absent in F3 neurons, demonstrating the existence of a substantial pool 
of genes that meets the criteria for association (Fig. 4.5a). As Fig. 4.5b shows, 
functional analysis of DMRs present in both F1 and F2 neurons identified 
sphingolipid/ceramide-related processes (Supplementary Table 4.5) and included 
genes previously identified by the transcriptome analysis (Cerk, Smpd3, St8sia1, 
Dgke). In contrast, these functions were not identified by DMRs present across all the 
F1-F3 neurons. These data indicate the cosegregation of differentially methylated 
membrane lipid genes with anxiety and further strengthen the association between 
these genes and the phenotype, first suggested by the transcriptome and lipidomics 
studies.  
Besides membrane lipid related functions, F1-F2 shared DMR genes were also 
enriched in neurotransmission and synaptic functions (Supplementary Table 4.5). 
Furthermore, the F1-F2 DMR gene dataset also identified anxiety (p=0.00002), the 
very trait that was transmitted to the F1 and then to the F2 generation, as the top 
associated behavior (Supplementary Table 4.5). Of note, the transcriptome analysis 
did not recognize these networks, suggesting that although differentially methylated in 
a significant number, neurotransmission/synaptic function and anxiety related genes 
are not differentially expressed in high enough numbers to produce statistically 
significant enrichment. The broader functional categories identified by differential 
DNA methylation, relative to differential expression, could be due to persistent 
hypo/hypermethylation from early life at genes that regulate synaptic development but 
which are no longer required in mature neurons, or simply to subtle or isoform specific 
changes that were not detected in our transcriptome studies.  
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Figure 4.5. Impact of the receptor deficient maternal environment on the F1/F2 
neuronal methylome. a. Overlap of genes with differentially methylated regions 
(DMRs) in F1, F2 and F3 ventral granule cells. b. Overrepresentation of DMR genes 
in F1 and F2, but not in all F1, F2 and F3 granule cells, in the process of 
sphingolipid/ceramide-related processes (see list of genes in Supplementary Table 
5.5). The short and long columns indicate the lowest and highest significance levels 
for these processes. c. Similar changes in DNA methylation and gene expression in F1 
and F2 neurons.  F1 and F2 overlapping differentially methylated and expressed genes 
are distributed to four quadrants, according to their expression (up/downregulated) and 
average methylation at differentially methylated sites within DMRs 
(hyper/hypomethylated; +/-). Color of genes is rendered according to their differential 
expression/differential methylation values in F1 (blue, up/hypo quadrant; purple: 
down/hypo; green, down/hyper; and red, up/hyper), while their actual positions reflect 
values in F2. Most genes in a quadrant are of a similar color, indicating similar 
expression and methylation changes in F1 and F2 neurons.  d. F1/F2 overlapping 
DMRs are overrepresented at exonic regions. e. Selected DMRs from Cerk and Dgke 
(Fig. 5.4b)  have no promoter, but significant enhancer-like, effects on the EF1 
promoter, similar to that of the CMV enhancer, in transfected 293 cells (ANOVA: 
F4.49=163.16, P<10-4; LSD post hoc ***p<0.005 for both CERK and DGKE, in 
addition to the positive control CMV). An intergenic Drosophila sequence has neither 
promoter nor enhancer activity. 
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Next, we intersected the DNA methylation and gene expression data that again 
identified sphingolipid and glycerophospholipid related functions (Supplementary 
Table 4.6). There was no direct correlation between methylation and expression 
changes (Fig. 4.5c); not an unexpected finding, given the multitude of possible effects 
of intragenic methylation on gene expression. However, these data showed that the 
direction of expression changes was identical and the overall methylation changes 
largely the same in F1 and F2 neurons, indicating that programming of the 
transcriptome and methylome, similar to that of anxiety, is iterative. 
Anxiety associated DMRs map to exons and have enhancer-like activity 
Since most DMRs were intragenic, assignment of DMRs to specific gene 
features may shed light on their function.  As Fig. 4.5d shows, F1-F2 shared DMRs 
were enriched in exons, including those that map to alternative promoters, but 
excluded from proximal promoters, introns, and intergenic areas. DMRs from Cerk 
and Dgke, two representative DMRs (~200 bp), from differentially expressed and 
methylated genes associated with lipid signaling (Fig. 4.4b), were selected for further 
studies. They reside within H3K4me3/H3K27ac/H3K9ac and H3K27ac/H3K4me1 
peaks, respectively, in both neuronal (cerebellar neurons) and non-neuronal cells 
(ENCODE190). These chromatin signatures are typically associated with promoter and 
enhancer sequences. In a luciferase reporter assay, these DMRs exhibited no promoter 
activity, while enhancing the activity of the EF1 promoter in 293 cells (Fig. 4.5e). An 
arbitrary 208bp intergenic drosophila sequence had neither promoter nor enhancer 
activity. These data suggest that at least some of the DMRs represent regulatory 
elements associated with enhancers and that their enhancer-like activity is not limited 
to neurons and could contribute to gene regulation in multiple tissues. 
DNA Methylation at Gametically Programmed Genes 
	  112	  
Altered stress reactivity of the F2 offspring in the forced swim test is 
gametically transmitted through the maternal line (Fig. 4.1i,l). Since the genome of 
female primordial germ cells (PGCs), following an almost complete demethylation by 
E12.5-13.5, is gradually remethylated reaching partial methylation in oocytes, we 
tested if this process is altered in PGCs exposed to the H grandmaternal environment. 
We isolated E18.5 F2 and WT PGCs from pregnant H and WT mothers by FACS191 
and identified 220 gametically programmed DMRs (Fig. 4.6a). Methylation at 
differentially methylated sites within these DMRs was partial in WT PGCs, while 
mostly unmethylated in F2 PGCs, with some sites methylated completely (Fig. 4.6b), 
suggesting dysregulated remethylation/reprogramming in female PGCs at specific 
regions. DMR associated genes were enriched in few functions, most prominently in 
imprinting (p=0.00034) and fertility (p=0.00042), encompassing some of the same 
genes (Supplementary Table 4.7). These DMR genes regulate proliferation, growth 
and differentiation and imprinted genes are known to be essential in early embryonic 
growth and development192. Although CpG islands were underrepresented in PGC 
DMRs, 3 out of the 5 within imprinted loci (Airn/Igfr2, Dio, and Blcap/Nnat) were 
mapped to islands, which however were not the imprinted control regions and were 
not imprinted.   
Next we asked if PGC DMRs survive reprogramming in the early F2 embryo 
and propagate to somatic cells. Methylation at CpG sites that were differentially 
methylated in PGCs was similar (FDR >0.05, <15%) between F2 and WT and F2-G 
and WT-G granule cells. Moreover, methylation at these sites had the typical bimodal 
distribution in neurons, independent of whether the offspring were the granddaughter 
of WT or H mothers (Fig. 4.6b). These data indicate that the initial methylation 
differences at PGC DMRs were later corrected. 
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Since PGC DMRs, by altering embryonic development, may produce 
secondary neuronal DMRs193 or perhaps neuronal DMRs are tagged in the gametes by 
an epigenetic mark other than DNA methylation, we mapped gametically programmed 
DMRs in hippocampal granule cells. We reasoned that such DMRs (referred to as 
neuronal gametically programmed DMRs) should be present in the brain of two 
independent sets of animals with H grandmaternal ancestry, F2 and F2-G, both 
exhibiting increased stress reactivity (Fig. 4.1i,l). F2 mice, derived by normal 
breeding, carry both somatic and gametically programmed DMRs, while F2-G 
animals, obtained through embryo transfer, harbor gametically programmed DMRs 
and perhaps DMRs that are produced by the embryo transfer procedure194. By 
overlapping these two DMR sets, one can identify common DMRs that are directly or 
indirectly related to gametic programming, while eliminating obvious confounds. This 
approach identified 17 overlapping DMRs (FDR q<0.05, overlap Fisher exact test 
p=0.0065, odds ratio 4.11) representing 21 genes, none of which matched PGC 
DMRs, as expected (Fig. 4.6a).  These data also suggest that the much larger group of 
F2 DMRs represents mostly non-gametic (i.e. somatic) DMRs (see also the large F1-
F2 overlap for iterative DMRs, Fig. 4.5a). 
Differentially methylated CpGs within neuronal gametically programmed 
DMRs were mostly hypomethylated (80%)(Fig. 4.6c). Though the low number of 
gametic DMRs prevented us to analyze their association with genomic features, we 
found that three representatives of neuronal gametic DMRs, located at distal 
promoter/exon sequences, all enhanced the activity of the EF1 promoter in luciferase 
assays (Fig. 4.6d), indicating that, similar to somatic DMRs, they represent regulatory 
elements, presumably enhancers.  
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Figure 4.6. Characteristics of gametically-programmed DMRs. A. PGC DMRs are 
unrelated to neuronal gametically programmed DMRs, which are defined as 
overlapping DMRs in F2 and F2-G neurons.  b. Distribution of methylation levels at 
individual CpG sites, differentially methylated in F2 PGCs, in PGCs and hippocampal 
granule cells. c. Methylation changes at neuronal gametically programmed sites are 
predominantly hypomethylation. d. Neuronal gametically programmed DMRs have no 
promoter, but significant enhancer, activity (ANOVA: F5,57=170.82, P<10-4; LSD post 
hoc ***p<0.005 for KIF19, SRCIN1, and MGMT).  
	  115	  
 
 
  
	  116	  
Unlike somatic, neuronal gametically programmed DMR genes were not 
enriched in membrane lipid signaling and neurotransmission related functions. Rather, 
9/21 of these genes mapped directly to synaptic morphology-related functions and/or 
neuropsychiatric risk genes. Specifically, Disc1 and Srcin1 are involved in spine 
maintenance and morphogenesis, respectively (Ingenuity p=0.00085 and 0.0034); 
Itga6 in neurite morphogenesis (p=0.00085); Gng7 and Soc5 in transmembrane 
signaling (p=0.0084 and p=0.025), Kif19 in microtubule dynamics (p=0.00338); while, 
Disc1, Pias4, Rsrc1 and Frem have been implicated in autism, schizophrenia and 
neurological disorders. Intriguingly, Disc1 was also associated with adaptive behavior 
and immobility in the forced swim test195,196 (p=0.00069 and p=0.0014), the very trait 
identified as gametically programmed.  However, escape directed behavior in the 
forced swim test has been linked to multiple brain regions, including the prefrontal 
cortex, raphe and the hippocampus; thus it will be important to test if the hippocampal 
gametically programmed DMRs are also present in other relevant brain regions. 
 
4.3 Discussion 
Here we address a central problem in the epidemiology and diagnosis of 
psychiatric disorders; particularly, how their symptoms are propagated across 
generations, even in the absence of plausible genetic factors197,198, and why they may 
present differently in individuals, even those in the same family tree. For example, 
family members can have various combinations of anxiety, depression, bipolar 
disease, and schizophrenia symptoms, complicating diagnosis and treatment.  
While the behavioral manifestations associated with a genetic risk factor are 
transmitted together, here we show that the individual traits of a complex psychiatric 
disease-like phenotype are propagated across multiple generations by parallel non-
genetic mechanisms.  The “anxiety” and “hypoactivity” traits were transmitted by a 
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somatic, while the “increased stress-reactivity” trait was transmitted by a gametic, 
mechanism. In humans, these traits transcend diagnostic categories and are found in 
comorbid generalized anxiety and depression disorders and other psychiatric 
conditions.  Since the individual traits/pathways each have their own generation-
dependent penetrance and gender specificity, the resulting cumulative phenotype is 
pleiotropic.  Pleiotropy, which refers to the ability of a single gene or factor to produce 
multiple phenotypic outcomes199, is a commonly occurring phenomenon in psychiatric 
disorders200, complicating diagnosis and treatment. It is typically assumed that this 
phenomenon in the context of genetic disease arises from individual differences in 
vulnerability to the various effects of the causative gene. However, the work presented 
here reveals that pleiotropy can be produced by the variable distribution and 
segregated transmission of behavioral traits. 
Although some of the maternal traits propagated to the F2 and even to the F3 
generation (i.e. hypoactivity), contrary to our expectation, this was not based on a true 
transgenerational mechanism, but rather on the reiteration of single generational 
somatic transmission, referred here to as iterative somatic transmission. The iterative 
propagation of anxiety is most compatible with a model in which, the inflammatory 
state is acquired by F1 males from their H mothers and then by the F2 males from 
their F1 mothers. The increased number of monocytes and their transmigration to the 
brain parenchyma in F1 and F2 males could be central to the transmission mechanism 
and the resulting anxiety phenotype. Monocytes develop to macrophages in the brain 
and activate resident microglia, as reported in various animal models of psychiatric 
disorders185,201,202. Because microglia participate in programmed cell death, survival, 
axon remodeling, pruning, and synaptogenesis in various brain regions, including the 
hippocampus203, it is reasonable to hypothesize that the increased number of 
peripheral monocytes and their transmigration to the brain contributes, via microglia 
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activation, to the development of anxiety-like phenotype in the F1 and F2 male 
offspring. The hypoactivity trait also followed a somatic programming scheme, but its 
manifestation was highly variable across generations, which contributed to the 
pleiotropy.  
The somatically programmed behaviors, in particular the anxiety-like behavior 
that can be linked to the ventral hippocampus, were accompanied by DNA 
methylation changes that converged on the functional networks of lipid signaling and 
synaptic/neurotransmission in hippocampal granule cells. Corresponding 
transcriptional and lipidomics changes further argue for the role of the lipid signaling 
network in somatic programming.  However, complexity and high redundancy in the 
regulation of lipid metabolic pathways204 complicate linking the specific 
transcriptional changes directly to the lipid alterations.  Nevertheless, studies implicate 
membrane lipids and their metabolites in psychiatric diseases, including anxiety187,188.  
Embryo transfer experiments showed that the increased stress reactivity trait 
was propagated to the F2 generation by gametic transmission in our model. This 
indicates that gametically programmed information survives reprogramming in the 
early embryo and persists into adulthood.  However, it was erased in the F3 germline, 
therefore the transmission is not strictly transgenerational.  Although we identified 
gametically programmed DMRs in both F2 PGCs and adult hippocampal neurons, 
their dissimilarity makes it difficult to link them causally. However, it has recently 
been suggested that primary PGC epigenetic signatures may initiate a cascade of 
developmental changes in the early zygote and later development, leading to 
secondary epigenetic signatures in adult tissues205.  Indeed, PGC DMRs were 
associated with imprinted genes that are known to be essential in early growth and 
development192.  Alternatively, epigenetic changes other than alterations in DNA 
methylation could be formed in PGCs at neuronal DMR regions that later, during 
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neuronal development, acquire the adult neuronal DNA methylation signatures.  
Whether derived from PGC DMRs indirectly or from other “primed” regions, 
neuronal gametically programmed DMRs map to genes whose dysfunctions can be 
linked to the altered stress reactive phenotype. 
In summary, our data introduce segregated non-genetic transmission of traits as 
a mechanism that may explain the non-Mendelian propagation and pleiotropy of 
behavioral/psychiatric phenotypes across generations. A transmission-pathway based 
concept can complement the current gene-centered view of inheritance in psychiatric 
disease, as well as facilitate the development of animal models with better construct 
validity206 and novel therapeutic approaches. 
 
4.4 Methods 
Mice 
Animal experiments were carried out in accordance with the Weill Cornell 
Medical College Institutional Animal Care and Use Committee guidelines. All mice 
were group housed up to five per cage with 12-h light/dark cycle with lights on at 6 
a.m. Food and water were available ad libitum. 5-HT1AR KO mice were originally 
generated on the 129SvEv background207 and backcrossed to the Swiss–Webster (SW, 
Taconic Biosciences, Germantown, NY) background >10 times.  We used the outbred 
SW background (a strain often used in behavioral experiments), to avoid the possible 
contribution of homozygous genetic variants in inbred strains to behavioral 
phenotypes116. Of note, the H line was backcrossed every 5-10 generations to WT 
mice obtained from large colonies kept at Taconic Biosciences (Germantown, NY), 
and the H and WT lines were reestablished, to avoid genetic drift. The F1 generation 
consisted of littermate 5-HT1AR+/+ (F1-wild-type; F1), 5-HT1AR+/- (H, heterozygote) 
and 5-HT1AR-/- (knockout; KO) mice (generated as previously described12,207), all 
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exposed to the receptor deficient H maternal environment. F1 females were crossed 
with WT males to generate F2 offspring (all WT). F2 females were crossed with WT 
males to generate F3 offspring. A separate WT lineage provided control WT offspring 
exposed to normal, WT gestational environment. Typically, 1-2 animals were 
randomly selected from litters; thus at least 3 litters were used per group.  Since many 
groups consisted of more than 10 animals, the number of litters typically exceeded 6-
8.   
Behavioral Procedures 
All tests were conducted using offspring aged 8-12 weeks. During all 
behavioral tests the investigators who performed the tests were blind to the genotype 
and treatment of the animals.  Moreover, all behavioral tests are fully automatized 
with no human input on data collection. Behavioral tests were conducted during the 
light on phase, between 10am and 4pm. Mice were first tested in open field for overall 
activity, followed by elevated plus maze and forced swim test, followed by the drug-
induced hypothermia test. At least 24 hours rest was allotted between different tests. 
All tests were conducted between 9 a.m and 6 p.m (i.e. during the light cycle). 
Offspring were selected from >5 litters.  The elevated plus maze12 was performed 
using a cross maze with 12 x 2 inch arms at dim light (50 lux).  Animals were 
introduced to the middle portion of the maze facing an open arm and allowed to freely 
explore for 10 minutes. Time spent and distance traveled in the open and closed arms 
were measured by a video-tracking system (Noldus Information Technology, 
Wageningen, The Netherlands.).  The open-field test12 used a 15 x 21 inch black box, 
divided into 12 even-sized (4 x 3 inch) rectangles. The time spent in and distance 
traveled in the two rectangles at the center of the field at 150 lux were recorded by the 
video-tracking system to evaluate anxiety, and data was presented as a percentage of 
total distance traveled. In the forced swim test12, mice were placed into a clear, water-
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filled cylinder (diameter, 20.3 cm; depth, 10 cm), essentially as described by Porsolt at 
al.208. In this test, immobility of the mice is scored by an observer in two minute bins 
for a total of six minutes. On test days, animals were transported to the dimly 
illuminated behavioral laboratory and left undisturbed for at least 1 hr before testing.  
Hypothermic Response 
Hypothermic response209 was assessed at different dosages of 8-OH-DPAT 
over the course of four days because the response does not show habituation. Animals 
were individually housed 1-2 hours prior to the start of the experiment. On Day 1, 
animals were injected (i.p.) with 100uL saline. After 30 minutes, rectal temperature 
was measured. On Day 2-4, mice were administered 0.8mg/kg, 0.4mg/kg, and 
0.2mg/kg 8-OH-DPAT, respectively, prior to taking temperature measurements.  
Embryo Transfer 
Two types of embryo transfers were performed12. SW WT embryos (E0.5-
E2.5) were implanted into pseudopregnant 5-HT1AR+/- females (7-9 weeks old) to 
generate F1-S (somatically-exposed) offspring. To generate F2-G (gametically-
exposed) offspring, embryos (E0.5-E2.5), derived from female PCGs/oocytes exposed 
to the 5-HT1AR+/- grandmaternal environment (within the WT F1 female fetus) were 
implanted into pseudopregnant SW WT females (7-9 weeks old).  
5-HT1AR Receptor Binding/5-HT1AR Expression 
Tissue preparation, in situ hybridization, and receptor autoradiography 
procedures were performed as previously described209. Briefly, mice were killed by 
pentobarbital overdose and brains rapidly removed, frozen on dry ice and stored at -
80ºC. Coronal tissue sections (14µm) were cut using a microtome-cryostat (HM500-
OM, Microm, Walldorf, Germany), thaw-mounted onto 3-aminopropyltriethoxysilane 
(Sigma-Aldrich)-coated slides and kept at -20ºC until use. For 5-HT1AR mRNA, 
antisense oligoprobe was complementary to bases 1780-1827 (GenBank accession 
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NM_008308). Oligonucleotide was labeled (2 pmol) at the 3'-end with [33P]-dATP 
(>2500 Ci·mmol-1; DuPont-NEN, Boston, MA) using terminal 
deoxynucleotidyltransferase (TdT, Calbiochem, La Jolla, CA). The autoradiographic 
binding assays for 5-HT1AR was performed using [3H]-8-OH-DPAT (233 Ci·mmol-1), 
Autoradiograms were analyzed and relative optical densities (ROD) were obtained 
using a computer assisted image analyzer (MCID; Mering, Germany). The system was 
calibrated with 3H-microscales standards to obtain fmol/mg protein equivalents from 
ROD data. The slide background and non-specific densities were subtracted. ROD 
were evaluated in two or three adjacent sections by duplicate of each mouse and 
averaged to obtain individual values. 
Complete Blood Count (CBC) 
All neonatal CBCs were performed on pups between 3-4 days old. Blood was 
collected from the trunk via decapitation. Total red blood cells, white blood cells, 
neutrophils, lymphocytes, monocytes, eosinophils, and basophils were quantified by 
both automated (IDEXX ProCyte Dx Hematology Analyzer, Westbrook, ME) and 
manual counts.  
Flow Cytometry 
The presence of immune subsets in spleens and brains was assessed in 3-4 day 
old pups by flow cytometry. All pups were anesthetized and perfused with saline in 
order to flush out circulating blood cells from the organs. Spleen cells were collected 
by homogenization and filtering through a 40µm cell strainer into FACS buffer (PBS 
with 0.5% BSA). Brains were harvested in FACS buffer followed by three sequential 
digestion steps in RPMI + 25mM HEPES + Collagenase D (1mg/mL) + DNAase 1 
(0.2mg/mL) at 37oC for 5 minutes each. Spleen and brain single cell suspensions were 
counted using a Z2 Coulter Counter (Beckman Coulter, Jersey City, NJ) and 
subsequently stained with a 10-color panel with the following antibodies: Ly6G-FITC, 
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Gr1-PE, NK1.1-PerCP-Cy5.5, CD11c-PE-Cy7, CD11b-APC (all from BD 
Biosciences, Franklin Lakes, NJ) and CD45-APC-Cy7, CD3-BV570, B220-BV650, 
CD4-BV711 and CD8-BV780 (all from BioLegend, San Diego, CA). Samples were 
acquired within an hour after staining in an LSR-II flow cytometer (BD Biosciences) 
and analyzed on FlowJo 9.7.6 software. 
Isolation of PGCs 
PGCs were isolated from E18.5 F1 and WT fetal ovaries based on side and 
forward scatter differences between germ cells and somatic cells in cell suspension, 
essentially as described191. This method provides higher than 90% purity of isolated 
PGCs, which was verified in our experiments by stationing sorted cells for VASA, a 
gemline specific marker210.  Following sorting of PGCs from individual embryos, the 
genotype of the embryo was determined, and only F2 PGCs from WT F1 fetuses were 
used for DNA isolation.   Because of the relative low number of germ cells per 
embryo, 45 F1 and 31 WT female fetuses were used.  
Enhanced Reduced Representation Bisulfite Sequencing 
Brains from adult male WT, F1, F2, F3, WT-S, F1-S, and F2-G offspring (8-12 
weeks old) from at least three different litters were quick frozen on dry ice and 
sectioned (200µM) in cryostat. The ventral dentate gyrus was microdissected from the 
sections. DNA was isolated using the DNeasy Blood & Tissue Kit (Qiagen, Valencia, 
CA). Single end 50bp eRRBS sequencing was performed as described61, using 
Illumina HiSeq2000 and 2500 machines according to manufacturer instructions. An 
in-house pipeline (R MethylKit) was used for methylation calling and alignment to the 
mm9 reference genome102. Differential methylation and statistical analysis were 
performed using default setting. Differentially methylated sites were defined as sites 
where the corrected p-value is > 0.01 (0.05 in the gametically programmed data) and 
the difference in methylation between two samples is > 15%. Differentially 
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methylated regions (DMRs) were calculated as regions containing at least four 
differentially methylated sites, where the distance between two neighboring sites was 
no greater than 1kb. Genomic and CpG island annotations were based on Ensmbl data 
downloaded from the UCSC genome browser. Promoters were defined as regions 
±2kb from the TSS; exons and introns were defined by reference; upstream regions 
were defined as extending 50kb from promoter regions; and downstream regions were 
50kb from the TES. The percentage of total differentially methylated sites in a defined 
genomic feature was divided by the percentage expected to overlap each genomic 
feature by chance, based on the percentage of genomic space occupied by that feature, 
to determine the fold change from expected values. Additional methylation datasets 
were downloaded from the UCSC genome browser DNA methylation track 
hub29,103,104. Data have been deposited: GSE68713.   
RNA-Seq 
WT, F1, and F2, adult offspring (8-12 weeks old) from at least three different 
litters were perfused with 30% RNAlater (Ambion, Grand Island, NY) in saline. 
Brains were frozen on dry ice and sectioned (200µM). The ventral dentate gyrus was 
microdissected from the sections. Total RNA was isolated using the RNeasy Mini Kit 
(Qiagen, Valencia, CA). Single end 50bp RNA sequencing was performed on Illumina 
HiSeq2000 and 2500 machines and aligned to the mm9 reference genome using 
TopHat software version 2.0.11105. Default parameters were used with the addition of 
“--no-novel-juncs” to align exclusively to known genes and isoforms. Genes were 
counted using HT-seq program106 with the parameter “intersection-strict”. Values for 
gene expression were calculated using EdgeR107 package in R using tagwise 
dispersion and default parameters. Differentially expressed genes were determined 
using Benjamini-Hochberg corrected p=0.05 threshold. Data have been deposited: 
GSE68713.   
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Transfection and Luciferase Reporter Assay 
Plasmids were constructed using the In-Fusion Cloning Kit (Clontech 
Laboratories, Mountain View, CA). HEK293 cells (American Tissue Type Collection) 
were cultured in culture media containing 88% DMEM + 10mM HEPES, 1% 
penicillin/streptomycin, 10% FBS, and 1% L-Glutamine in a 5% CO2 37°C incubator. 
Plasmids were transfected into HEK293 cell cultures using Lipofectamine 
Transfection Reagent (Life Technologies, Grand Island, NY) in triplicates. Briefly, 
0.2E6 cells were seeded in 12-well plates in 1mL of culture media. 24 hours later, 1µg 
of plasmid DNA was diluted in 85µl Opti-MEM media (Life Technologies) in tubes. 
After 5 minute incubation, 6µl Lipofectamine Transfection Reagent was added, 
followed by 20 minute incubation. 85µl of this solution was added to each well of 
HEK293 cells. The following day, media was aspirated and replaced with 400µl of 
culture media. 48 hours after transfection, 20µl aliquots of media were sampled into 
96-well plates. 100µl of Quanti-Luc luciferase substrate (InvivoGen, San Diego, CA) 
was added to each well, and plates were read immediately for luciferase activity. 
Metabolomics 
Brain metabolite extraction 
Hippocampal ventral granule cell bodies/nuclei were isolated by 
microdissection from adult male WT and F1 brain sections and washed twice with ice-
cold PBS, followed by metabolite extraction using -70ºC 80% methanol in water (LC-
MS grade methanol, Fisher Scientific, Grand Island, NY). The tissue–methanol 
mixture was subjected to bead-beating for 45 sec using a Tissuelyser cell disrupter 
(Qiagen, Valencia, CA). Extracts were centrifuged for 5 min at 5,000 rpm to pellet 
insoluble material and supernatants were transferred to clean tubes. The extraction 
procedure was repeated two additional times and all three supernatants were pooled, 
dried in a Vacufuge (Eppendorf) and stored at -80ºC until analysis. The methanol-
	  126	  
insoluble protein pellet was solublized in 0.2M NaOH at 95ºC for 20 min and 
quantified using the BioRad DC assay. On the day of metabolite analysis, dried cell 
extracts were reconstituted in 70% acetonitrile with 0.2% ammonium hydroxide at a 
relative protein concentration of 3µg/ml and 3µl of the reconstituted extract was 
injected for LC/MS-based untargeted metabolite profiling.  
LC/MS metabolomics platform for untargeted metabolite profiling 
Brain extracts were analyzed by LC/MS as described previously 211,212 using a 
platform comprised of an Agilent Model 1200 liquid chromatography system coupled 
to an Agilent 6230 time-of-flight MS analyzer. Chromatography of metabolites was 
performed using aqueous normal phase (ANP) gradient separation, on a Diamond 
Hydride column (Microsolv, Eatontown, NJ). Mobile phases consisted of: (A) 50% 
isopropanol, containing 0.025% acetic acid, and (B) 90% acetonitrile containing 5 mM 
ammonium acetate. To eliminate the interference of metal ions on the 
chromatographic peak integrity and electrospray ionization, EDTA was added to the 
mobile phase at a final concentration of 6 µM. The following gradient was applied: 0-
1.0 min, 99%B; 1.0-15.0 min, to 20%B; 15.0 to 29.0, 0%B; 29.1 to 37min, 99%B.  
Raw data were analyzed using MassHunter Profinder 6.0 and MassProfiler 
Professional 13.0 software package (MPP; Agilent Technologies, Santa Clara, CA). 
Unpaired t-tests (p<0.05) were used to determine significant differences between 
groups.  
Differentially expressed metabolite identification 
To ascertain the identities of differentially expressed metabolites (P<0.05) 
between F1 cross vs. wildtype vGC samples, molecular features were searched against 
an in-house METLIN Personal Metabolite Database (Agilent Technologies, Santa 
Clara, CA), annotated with accurate monoisotopic neutral masses (<5 ppm) and 
chromatographic retention times.  A molecular formula generator (MFG) algorithm in 
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MPP was used to generate and score empirical molecular formulae based on a 
weighted consideration of monoisotopic mass accuracy, isotope abundance ratios, and 
spacing between isotope peaks. A tentative compound ID was assigned when METLIN 
and MFG scores concurred for a given candidate molecule. Tentatively assigned 
molecules were verified based on a match of LC retention times and/or MS/MS 
fragmentation spectra to that of pure molecule standards. 
Analysis of lipids by high-performance liquid chromatography–mass 
spectrometry 
Tissue lipid extracts from isolated ventral granule cells were prepared using a 
modified Bligh/Dyer procedure, spiked with appropriate internal standards, and 
analyzed using a 6490 Triple Quadrupole LC/MS system (Agilent Technologies, Santa 
Clara, CA, USA). Glycerophospholipids and sphingolipids were separated with 
normal-phase HPLC as before 213,214 with a few changes. An Agilent Zorbax Rx-Sil 
column (inner diameter 2.1 × 100 mm) was used under the following conditions: 
mobile phase A (chloroform:methanol:1 M ammonium hydroxide, 89.9:10:0.1, v/v) 
and mobile phase B (chloroform:methanol:water: ammonium hydroxide, 
55:39.9:5:0.1, v/v); 95% A for 2 min, linear gradient to 30% A over 18 min and held 
for 3 min, and linear gradient to 95% A over 2 min and held for 6 min. Sterols and 
glycerolipids were separated with reverse-phase HPLC using an isocratic mobile 
phase as before 213 except with an Agilent Zorbax Eclipse XDB-C18 column (4.6 × 
100 mm). Individual lipid species were measured by multiple reaction monitoring 
transitions and lipid concentration was calculated by referencing to appropriate 
internal standards: D5-cholesterol, CE 17:0, 4ME 16:0 diether DAG, D5-TAG 
16:0/18:0/16:0, PA 14:0/14:0, PC 14:0/14:0, PE 14:0/14:0, PG 15:0/15:0, PS 
14:0/14:0, LPC 17:0, LPE 14:0, LPI 13:0, BMP 14:0/14:0, SM d18:1/12:0, dhSM 
d18:0/12:0, Cer d18:1/17:0, GalCer d18:1/12:0, LacCer d18:1/12:0 and Sulf 
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d18:1/17:0 (Avanti Polar Lipids, Alabaster, AL, USA). PI 16:0/16:0 was purchased 
separately (Echelon Biosciences, Salt Lake City, UT, USA). Some lipid classes did 
not have commercially available internal standards and hence these lipids were 
referenced to standards that are closely eluted in the liquid chromatography–mass 
spectroscopy method: Ether-linked species were normalized to corresponding acyl-
linked standards: GM3 to PI 16:0/16:0. Lipid concentration was normalized by molar 
concentration across all species for each sample, and the final data are presented as 
mean mol%. 
Data Analysis. 
Data are shown as mean ± s.e.m. Outlier data was excluded based on ± 2 s.d. 
from the mean. One-way or repeated measures ANOVAs or t tests were used to 
compare tests. LSD or Bonferroni post hoc analyses were used to assess statistical 
significance. Sample size was based on prior data and by using power calculation All 
graphs and statistical analysis were performed using R (http://ww.r-project.org), 
Bioconductor (www.bioconductor.org), and ggplot2 (www.ggplot2.org) for 
visualization, unless stated otherwise.  
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Supplementary Figure. 1. Breeding strategy of F1-F3 WT animals. Shaded boxes indicate 
genetically WT individuals. 
	  130	  
  
3500
3000
2500
2000
1500
1000
500
0
WT F2
Supplementary Figure. 2. Total locomotor activity of F2 males are not different from that of WT males, t-
test, p=0.645.  
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Supplementary Figure. 3. Gestational LPS results anxiety in the elevated plus maze in both F1 (distance 
in the open arm in % of total; t-test, T=3.571, ***P<0.005, N=35 and 34 mice per group) and F2 (t-test, 
T=3.033, **P<0.01, N=13 mice per group) offspring. 
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Supplementary Figure. 4. The increased stress reactivity phenotype seen in F2-G males is not 
transmitted to the next generation.   
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Supplementary Figure. 5. Blunted hypothermic response to the 5-HT1AR agonist 8-OH-DPAT following 
embryo transfer in both F2-G mice and their WT-G controls (repeated measures ANOVA: group, 
F2,129=10.8, P=0.0002; dose, F3,129=24.4, P<10-6; and group x dose, F6,129=8.4, P<10-6; LSD post hoc 
***p<0.005 for both groups, relative to WT at the same dose. N=18, 12, and 10 animals per group). 
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Supplementary Figure. 6. Representative coronal brain sections showing reduced 5-HT1AR expression 
in hippocampus and dorsal raphe nuclei assed by [3H]-8-OH-DPAT binding. 
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Supplementary Figure. 7. Untargeted metabolite profiling identifies differentially-expressed metabolites 
in GCs from F1 vs. WT mice (n = 6 mice/group). a. A total of 3,156 distinct molecular features were 
aligned and quantified by untargeted molecular feature extraction in all samples from at least one group, 
as either positive ions (1,726) or negative ions (1,503). b. Principal component analysis (PCA) shows 
within group clustering and between group separation of GC extracts from WT and F1 brains, considering 
the relative abundances of 21 differentially-expressed features from among the 3,156 species in panel a 
(P < 0.05). Each point corresponds to an individual mouse brain extract.  c. Unsupervised hierarchical 
clustering analysis (HCA) according to Euclidean distance metric and Ward’s linkage rule with samples 
color-coded by phenotype, displays expression patterns and clustering of the differentially-expressed 
metabolites (p<0.1). Feature intensity depicted as a heat map, ranging from red to blue, where red 
represents an expression level greater than the mean value and blue represents expression levels below 
the mean value. d. Volcano analysis of all 3,156 detected brain features, where between group 
differences in metabolite expression are plotted at the -log of fold-change vs. log of the p-value. Notably, 
of the 21 molecules that fulfill the criteria of differential expression with a p-value  0.05 (indicated in red), 
9 were identified as lipids with diminished abundance in F1 vs. WT brain samples while 11 were not 
structurally confirmed (see Extended Data Table 4). 
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CHAPTER 5 
 
ENVIRONMENTALLY MALLEABLE EPIGENOMIC REGIONS IN THE 
MAMMALIAN BRAIN  
 
* Klein S.L., Sharma A., Mitchell E., Lodhi N., Bovinico C., Barboza L., Bavely C., 
O’Dell S., and Toth M. 2015. Environmentally malleable epigenomic regions in the 
mammalian brain. Manuscript in preparation. 	  
5.1 Introduction 
The perinatal and early postnatal periods are highly sensitive to environmental 
influences which can lead to life-long behavioral and cognitive abnormalities109. 
Children of overtly stressed and/or anxious parents frequently display increased 
behavioral abnormalities including anxiety, hyperactivity, attention deficits, and drug 
abuse4,215,216. Maternal stress and/or anxiety can be caused by a variety of factors 
including reduced expression of the 5HT1A serotonin receptor that results in elevated 
and anxiety and depressive behavior12,182,217,218. In previous work we have shown that 
MA in mice due to 5HT1A-R deficiency results in elevated anxiety in genetically 
wild-type offspring that mirrors the human condition219,220.   
Maternal gestational infections have been linked to increased incidents of 
schizophrenia and autism in the offspring that are associated with increased anxiety-
like behavior38. Several mouse models of maternal infection have been used including 
injection of the bacterial mimetic, lipopolysaccharide (LPS), to induce an 
immunological response221. LPS administration leads to activation of the innate 
immune system through cytokine induction, fever, complement cascade activation and 
HPA axis activation. Offspring of mothers injected with LPS have increased numbers 
of activated microglia and decreased hippocampal neurogenesis, dendritic length, 
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arborization, and spine density221-223. Behaviorally, they display increased anxiety, 
deficits in social interaction and learning impairments221.  
Maternal neglect can result in mild neurocognitive impairment, impulsivity, as 
well as anxiety, attention, and social deficits224,225. The effects of maternal neglect 
were described in several studies, including one that followed children raised in 
Romanian orphanages who experienced limited human physical contact and care225. 
The children exhibited mild neurocognitive impairment, impulsivity, as well as 
anxiety, attention, and social deficits, including indiscriminate friendliness224,225. 
Animal models of maternal neglect include maternal separation (MS), where offspring 
are separated from their mothers for several hours per day in the early weeks of life. 
MS in several animal species, including mice, rats and monkeys, result in anxiety and 
behavioral abnormalities in adult offspring11,226,227.  
The various forms of adverse early life experiences differ from each other in 
many respects, including their timing (gestational, perinatal, early postnatal), duration, 
and severity. However, the repertoire of behavioral abnormalities exhibited by the 
offspring often overlap. In particular, anxiety is a frequent endophenotype of early life 
adversity136,228-230, suggesting a molecular convergence that results in altered 
expression of gene networks, circuitry, and behavior.  
Conceivably, the long-lasting behavioral effects of maternal MA, LPS, and MS 
may be explained by stable epigenetic changes in offspring neurons. Early life 
adversity induced epigenetic changes at candidate genes have been documented in 
rodent models, as well as postmortem human studies36,125,231,232. Some of these gene-
specific epigenetic changes correlated with the offspring’s phenotype96,123,125,233-236. 
However, no fundamental epigenetic signatures have been associated with early life 
adversity conditions, and it is unclear if certain genomic domains are particularly 
responsive to adverse environments.  
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Of the different epigenetic modifications, DNA methylation is relatively stable 
and closely associated with gene transcription237. The genomic localization of DNA 
methylation is important in the regulation of gene expression74. Promoter DNA 
methylation is a key regulator of gene expression during development and is 
contingent on CpG density31,74. However non-promoter/gene body DNA methylation 
is an important regulator of at neural gene expression24. Intragenic DNA methylation 
at intronic and exonic sequences may regulate isoform specific expression through 
their activity as enhancers or splice site regulators74. 
In Chapter 3 we described maternal environment-induced DNA methylation 
changes in homogenous populations of hippocampal neurons in the MA model. Here 
we show that the concept of epigenetic maleability at DMRs can be extended to 
additonal models of early life adveristies; specifically to the MS and LPS models. 
Furthermore we show that there are common regions of early environemtnally 
sensitive DMRs (E-DMRs) that may underlie the common anxiety phenotype. 
 
5.2 Results 
Behavioral phenotypes overlap in three models of early life adversity  
We tested the behavioral phenotypes of offspring exposed to maternal MA, 
LPS and MS to determine all possible convergent behavioral phenotype. We chose a 
panel of behavioral tests that measure innate anxiety, stress responsiveness/coping, 
and social anxiety. To better represent a natural population and avoid the spurious 
effects of recessive alleles in our behavioral studies, we used the outbred Swiss 
Webster (SW) strain of mice238,239. 
We previously reported increased innate anxiety in MA and LPS offspring12,240 
(see Chapter 4, Fig 4.1b and Sup Fig. 4.3), measured as increased avoidance of the 
fear-inducing open and raised arms of the elevated plus maze (EPM). Here we show 
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that the MS offspring also exhibit increased EPM anxiety (Fig. 5.1A, Fig. S5.1A). 
Innate anxiety can also be assessed, under less stressful conditions, in the open field 
(OF) test.  Less exploration of the open center area, as compared to the more protected 
peripheral area, is interpreted as increased anxiety. LPS and MS offspring exhibited 
more center exploration; i.e. less anxiety (Fig. 5.1A, Fig. S5.1B), while the MA 
offspring were similar to controls12. The opposite behavioral changes in the OF and 
EPM tests indicate that anxiety per se is not an obligatory association of early life 
adversity. Rather, depending on the context, adversity could lead to less anxiety, 
interpreted in the clinical literature as the inability to correctly assess novel 
environment/situation or risk taking behavior. Early childhood adversity is a 
recognized risk factor for risk taking behavior, including drug addiction241,242. 
Consistent with this interpretation, MS in rodents has been reported to result in 
increased risk taking behavior243,244.  
We previously reported increased escape behavior in the forced swim test 
(FST) of MA offspring12 (Fig. 4.1j). Here we observed a similar phenotype in MS 
offspring, while LPS offspring exhibited no significant behavioral change (Fig. 5.1A, 
Fig. S5.1C). We interpret this behavior as increased stress reactivity and lack of 
habituation to an otherwise inescapable situation. These data are consistent with the 
increased stress reactivity seen in many psychiatric disorders.   
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Figure 5.1. Convergence of anxiety and differential DNA methylation in three 
models of early life adversity: A. Summary of behavioral tests and their outcomes. 
EPM, elevated plus maze; OF, open field; FST, forced swim test. See Chapter 5 and 
Supplementary Figure 1 for details and statistics. B. Differentially methylated (DM) 
regions (DMRs) are defined as regions with >4 clustered DM sites (DMSs) where two 
DMSs are no greater than 1kb apart. C. E-DMRs (152, corresponding to 249 genes) 
are defined as overlapping DMRs from at least two of the three early adversity 
models. D. DMS CpGs within E-DMRs display an overall trend toward 
hypomethylation versus hypermethylation in all three models, though a substantial 
portion is differentially methylated in opposing directions in at least one of the early 
life adversity models. E. Methylation distribution of hyper- and hypomethylated E-
DMR DMSs in individual models relative to control. Distribution of all CpGs, which 
follow a bimodal arrangement, is also shown. F. Methylation distribution of control 
(gray) and E-DMR DMSs (blue) on the autosomes (solid) and X-chromosome 
(dashed). G. Correlation plot of E-DMR DMSs in six individual animals and in a 
pooled sample indicate that intermediate methylation is not due to inter-animal 
differences.  Methylation at all CpGs from the pooled sample is also included to show 
the lack of correlation with methylation at E-DMR DMSs. Boxed numbers denote 
Pearson regression coefficient r2.   
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Another overlap between two adversity models, specifically between MA and 
LPS, occurred in the 3 chamber social interaction test245. Although mice typically 
prefer to interact with a conspecific stranger as opposed to an inanimate object, both 
MA and LPS offspring exhibited absence of preference, interpreted as social anxiety 
(Fig. 5.1A, Fig. S5.1D). Social anxiety is a well-documented consequence of early life 
adversity, exemplified by autism, which is often associated with gestational 
infection38,246,247. However, MS offspring, similar to neglected children216, exhibited 
no anxiety towards strangers, or as referred in clinical literature, showed lack of 
stranger anxiety or indiscriminate friendliness.  
Taken together, profiling a range of emotional behaviors in MA, LPS, and MS 
offspring revealed EPM anxiety as a common behavioral outcome across the three 
models. EPM anxiety has been linked to the ventral hippocampus by lesion, 
pharmacological, electrophysiological, and more recently optogenetic 
studies119,186,248,249. These data suggest that all three adversity conditions may target 
the ventral portion of the hippocampus. Ventral hippocampal granule cells (v-GCs) 
play a central role in processing and distributing incoming tactile, olfactory and visual 
information to downstream v-CA neurons186,250. 
Three early life adversity conditions alter DNA methylation at shared DNA 
domains 
GC neuronal bodies were microdissected from the ventral dentate gyrus (DG) 
of adult animals and assayed for differential methylation by enhanced reduced 
representation bisulfite sequencing (eRRBS)61,130. DMRs were defined as genomic 
regions with >4 clustered differentially methylated sites (DMSs), each with >15 % 
methylation difference between control and adversity exposed animals, and SLIM 
corrected p-value of < 0.01251, where the distance between two DMSs in no greater 
than 1kb (Fig. 5.1B). 
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All three early life adverse conditions produced DMRs in adult v-GCs.  The 
average size of the DMRs, depending on the model, was 286-304 bp and contained 
4.7-5.2 DMSs. Furthermore, a total of 1.7% of eRRBS-profiled CpGs were 
differentially methylated in at least one model. Similar to the behavioral overlap, some 
of the model-specific DMRs intersected, indicating that the shared behavioral 
phenotypes may correspond to common DMRs (Fig. 5.1A and C). Specifically, 152 
DMRs (9.3 DMSs/DMR) were shared by at least 2 models. Because of their inherent 
sensitivity across at least two early life adversity models, we refer to these overlapping 
DNA blocks as “environmentally-sensitive” or E-DMRs. 
Early life adversity caused both hypomethylation and, to a lesser extent, 
hypermethylation at DMSs within E-DMRs (Fig. 5.1D). Approximately 60% of the 
DMSs were unidirectionally modified across models, while the rest were methylated 
variably between models.  
Environmentally malleable domains have intermediate levels of DNA 
methylation 
Environmentally malleable CpG sites in all three models, independently of 
whether shared or model specific, displayed intermediate methylation, between 25 and 
75%, that shifted to higher and lower levels following adversity (Fig. 5.1E and Fig. 
S5.2A). This is in contrast to the canonical bimodal distribution of DNA methylation, 
at majority of CpG sites, that are either fully methylated (>75%) or unmethylated 
(<25%). This raised the possibility that the intermediate methylation may be a proxy, 
or perhaps even a prerequisite, for epigenetic malleability by the environment.  
DNA methylation at an individual site is binary, therfore we sought to explain 
the nature of the observed intermediate methylation. Since each cell contains two 
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alleles the intermediate methylation phenomenon could be due mono-allelic 
methylation, similar to imprinting, resulting in intermediate methylation around 50%. 
However, DMSs within E-DMRs were in a range of 25-75%, rather than peaking at 
50% (Fig. 5.1E) and did not map to known imprinting control regions (Xie et al., 
2012). Furthermore, E-DMRs were also intermediately methylated, and bidirectionally 
modified by adversity, when present in single copies on the X chromosome in males, 
suggesting that the intermediate methylation is allele independent (Fig. 5.1F). Another 
possibility for the observed intermediate methylation is inter-animal variability 
resulting from pooled samples. However, DMSs within E-DMRs were highly 
correlated between individual mice (Fig. 5.1G). The only remaining explanation is 
neuron-to-neuron methylation variability in the hippocampus.  
The association of DMSs with intermediately methylated regions suggest that 
the intermediate methylation may be a marker of, or perhaps even a prerequisite for, 
epigenetic malleability by early life adversity. E-DMRs may underly an epigenetic 
mosaicism in the GC layer of the hippocampus as evidenced by the inter-neuronal 
methylation variability. 
E-DMRs are enriched in exonic sequences 
 DMSs within E-DMRs were enriched at exons and distal promoters,  while 
excluded from proximal promoters, introns and integenic regions (Fig. 5.2A). A 
similar pattern was seen within DMRs in individual models (Fig. S5.2B). The exonic 
and distal promoter enrichment of E-DMRs suggests a role in transcriptional 
regulation, perhaps via alternative promoter use or enhancer activity. To test this 
notion, we cloned several exonic E-DMRs into luciferase constructs to determine their 
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effect on transcription in 293 T-cells240.  Exonic E-DMRs from the cadherin-related 23 
(Cdh23) and cytohesin-4 (Cyth4) genes exhibited no promoter activity, but resulted in 
significantly increased activity of a minimal EF1 promoter (Fig. 5.2B). In contrast, an 
arbitrary 208 bp intergenic drosophila sequence had no effect on luciferase activity. 
We previously reported similar activity of the Kif19 E-DMR240. Although the selected 
E-DMRs all enhanced luciferase activity, their effect on neuronal transcription is 
difficult to predict. For example, enhancers may promote the transcription of certain 
RNA isoforms at the expense of others, or promote transcription of nearby genes 
rather than their own. Therefore, further studies will be needed to understand how 
differential methylation at exonic E-DMRs regulate gene expression in the 
hippocampus. 
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Figure 5.2. Genomic features of E-DMRs. A. Enrichment and exclusion of E-DMR 
DMSs relative to control CpGs at genomic features. B. E-DMRs have no promoter but 
increased enhancer activity C. Merged canonical pathways obtained with E-DMR 
genes using IPA: Ephrin Receptor Signaling (p=5.6-E3), BMP Receptor Signaling 
(p=7.4-E3), RAR Activation (p=8.1-E3), Integrin Signaling (p=1.0-E2), Notch 
Signaling (p=2.3-E2), IGF Signaling (p=2.5-E2) and NGF Signaling (p=3.3-E2).   
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E-DMRs are associated with genes regulating cell-to-cell adhesion and signaling 
Ingenuity Pathway Analysis (IPA) revealed that E-DMRs were enriched in a 
subset of genes involved almost exclusively in cell-to-cell adhesion/signaling and 
regulation of synaptic plasticity (Fig. 5.2C). Specifically, E-DMR genes mapped to the 
canonical pathways of Ephrin Receptor Signaling (p=5.6-E3; Abl1, Ephb2, Gnas, 
Grin3B, Pxn), BMP (bone morphogenic protein) Receptor Signaling (p=7.4-E3; Myl2, 
Smad6), RAR (retinoic acid receptor) Activation (p=8.1-E3; Gnas, Ncor2, Rara, 
Smad6, Smarcd3), Integrin Signaling (p=1.0-E2; Abl1,Archgap26, Map3K11, Myl2, 
Pxn), Notch Signaling (p=2.3-E2; Jag2, Notch1), IGF Signaling (p=2.5-E2; Grb10, 
Pxn, Socs7) and NGF Signaling (p=3.3-E2; Map3K11, Rps6ka4, Traf4). Although 
individually moderate, the combination of E-DMR associated pathways offers a 
compelling argument for a regulatory role in cell-to-cell adhesion and signaling. 
Importantly, these molecular pathways regulate the RHO-family GTPases and other 
downstream cytoskeletal stabilizing proteins and serve to control spinoskeletal actin 
structure and long-term spine maintenance 252.Taken together, we identified common 
epigenetic gene targets of the different models that may directly correspond to the 
regulation of spine cytoskeletal structure and the convergent EPM anxiety phenotype.  
 
Intermediate methylation of E-DMRs are formed during neuronal maturation 
To determine whether methylation at E-DMRs are intermediate from early 
development, or become intermediate later during neuronal differentiation, we 
analyzed embryonic stem cells (ESCs), embryonic day 10.5 hippocampal precursors 
(HPs), postnatal day 7 “young” immature GCs (yGCs), and adult mature GCs (Fig. 
5.3A). Methylation at “all” profiled CpG sites followed previously described 
methylation distributions through development. However, environmentally malleable 
CpGs, within E-DMRs, gradually assumed intermediate methylation from their mostly 
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hypomethylated state in ESCs (Fig. 5.3A). Specifically, intermediate methylation was 
established during development largely through the partial methylation of 
unmethylated sites. The de-novo methyltransferase most active during neuronal 
differentiation is Dnmt3a84,253. Therefore, we conditionally deleted Dnmt3a by 
tamoxifen-induced nestin-Cre-ERT2 (Dnmt3af/f,T-cre+; 75-85% efficiency), to test if 
formation of intermediate methylation at E-DMRs is disrupted. We took advantage of 
the delayed development of GCs and administered tamoxifen at embryonic day 13.5, 
thus avoiding possible undesirable effects during brain (for example cortical) 
development, while still influencing DNA methylation through most of GC 
development57,254. Conditional deletion of Dnmt3a substantially reduced the 
developmental gain in methylation, resulting in an incomplete formation of 
intermediate methylation in Dnmt3af/f,T-cre+, relative to control Dnmt3af/f,T-cre- GCs 
(Fig. 4.3B). The reduced methylation at E-DMRs suggests a role of Dnmt3a in the 
establishment of the intermediate methylation state at environmentally malleable CpG 
sites.  
Intermediate methylation of E-DMRs are  tissue specific 
Although we used SW mice, E-DMR-associated malleable intermediate 
methylation sites were also present in v-GCs derived from inbred B6 mice (which are 
preferred in genomic studies). Hierarchical clustering, based on the methylation level 
of malleable CpGs in E-DMRs, showed high similarity between the two strains at both 
young and mature neuronal stages (Fig. 5.3C). However, methylation levels were 
different in SW blood leukocytes, indicating tissue specific differences.    
	  157	  
Figure 5.3. Development and tissue specificity of E-DMRs. A. Methylation 
distribution of E-DMR DMSs and control CpG sites through neuronal development in 
the hippocampus. B. Methylation distribution of E-DMR DMSs following the 
conditional inactivation of Dnmt3a in the DG. C. Dendrogram of intermediately 
methylated sites in C57B6 and Swiss Webster mice indicates a high degree of 
similarity of E-DMR DMSs at two different stages of GC development. D. PCA plot 
based on methylation levels at E-DMR DMSs in multiple tissues suggests a high 
degree of similarity between ventral and dorsal GCs, extending to hippocampal CA3 
pyramidal cells as well striatal MSNs. E-F. Methylation of E-DMR DMSs in blood 
leukocytes of control and MA offspring are not intermediate, but blood has 
intermediate CpGs that are malleable by MA. G. Conservation of E-DMRs compared 
to random control regions sampled by eRRBS. Student T-test p-value 1.22 x10-71. 
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To determine the location and tissue specificity of E-DMRs, DNA methylation 
levels were compared in multiple tissue types. Another group of GCs reside in the 
dorsal (d) part of the DG/hippocampus.  While v-GCs are associated with emotional 
behaviors, d-GCs regulate cognitive behaviors118. PCA analysis showed similar 
methylation levels at E-DMR DMSs in v- and d-GCs (Fig. 5.3D). This is consistent 
with their shared origin from HPs in the dorsal telencephalon early in development. 
CpG methylation levels at E-DMR DMSs were also similar in hippocampal CA3 
neurons (originate from HPs but born earlier than GCs57,254), and even in striatal 
medium spiny neurons (MSNs), originating from the ventral telencephalon49. 
However, the methylation level of malleable CpGs were different in liver, blood 
leukocytes and ESCs (see also Fig. 5.3C). Specifically, these sites were mostly 
unmethylated in ESCs (Fig. 5.3A) and mostly methylated in blood leukocytes, in both 
the control and MA offspring (Fig. 5.3E). Overall, these data indicate that the 
methylation status of DMSs within E-DMRs are similar across different neuronal 
subtypes, but the similarity does not extend to non-neuronal tissue. More specifically, 
the more similar the tissue the greater the similarity of DNA methylation at E-DMRs. 
However, methylation profiling of blood leukocytes in the MA model revealed that 
blood leukocytes do have malleable intermediately methylated regions, but at different 
genomic locations (Fig. 5.3F). Taken together, environmentally malleable 
intermediate methylated sites are not limited to neurons, but their genomic location is 
tissue specific. 
Finally, we assessed the evolutionary conservation of neuronal malleable 
intermediately methylated regions by calculating the average PhastCons scores, 
generated by comparing 30 mammalian species (UCSC genome browser), at E-DMRs 
and control eRRBS regions of similar size. Although control sequences had a 
relatively high conservation score, due to eRRBS bias towards regions with higher 
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than average CpG content (for example exons), E-DMRs had a significantly higher 
score suggesting greater evolutionary conservation across mammalian species (Fig. 
5.3G).  
5.3 Discussion 
These results support the original hypothesis that different environmental 
conditions converge at the epigenetic level. While they each differed in timing, 
severity, and behavior, and resulted in unique DMRs, the overlap between the three 
adversities suggests an epigenetic convergence that may in part underlie the anxiety-
like behavior. We identified E-DMRs that have specific characteristics that distinguish 
them from the rest of the genome. Depending of the neuronal subtype, timing and 
strength of input, different regions will exhibit features that render them malleable and 
responsive to the environmental input.  
However, clustered intermediately methylated sites alone may not be sufficient 
to produce an E-DMR. Indeed, while a total of 2-3% of CpGs are malleable (which is 
close to the ~10% total intermediately methylated clustered CpGs, given that only 
three environmental conditions were tested), only 0.2% of CpGs are in E-DMRs. 
Additional features that may be required for environmental sensitivity across multiple 
adverse conditions include, histone modifications, RNA associations, protein-binding, 
and unique chromatin conformations. In fact many studies have demonstrated the 
inter-relatedness between DNA methylation and other epigenomic signatures. 
However, further studies will be needed to determine other unique and specific 
epigenomic features E-DMRs.  
Since CpG methylation at E-DMRs are not allele specific, intermediate 
methylation at the tissue level reflects epigenetic mosaicism consisting of neurons 
with methylated and unmethylated CpGs. Because the methylation status of 
neighboring CpGs in an allele tends to be similar (as determined from single molecule 
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Illumina reads); the inter-neuron variability in methylation could be extended to E-
DMRs (i.e. all or most CpGs in a specific E-DMR are either methylated or 
unmethylated in a cell). Furthermore, preliminary evidence (not shown) suggests E-
DMRs exhibit methylation dependent enhancer activity. Therefore, the ratio of 
neurons with a methylated vs. unmethylated E-DMRs may determine the number of 
cells expressing the associated gene or gene isoform(s) at high or low levels, 
essentially creating transcriptional mosaicism on top of the epigenetic mosaicism. E-
DMRs were mapped to genes involved in cell-to-cell adhesion and signaling that are 
highly regulated in neuronal cells. Therefore, neurons expressing high and low levels 
of a gene and/or isoform can differ in neuronal functions. 
Furthermore, the methylated vs. unmethylated allele ratio at each E-DMR may 
shift following a sustained environmental influence. Since environmental challenges 
primarily hypomethylate CpGs within E-DMR, the number of neurons with an 
unmethylated E-DMR, at the expense of methylated, can increase. The change in the 
ratio of cells with methylated E-DMRs may alter the topology of the epigenetic and 
transcriptional mosaicism in the DG. This in turn can have a substantial effect on 
network function due to sparse coding in GCs, where neurons encode sensory 
information using a small number of active neurons255. The phenomenon of 
environmental malleability of intermediately methylated CpG sites may help to 
answer a long standing question in neuroscience regarding how prior experience is 
stored via epigenetic memory in neuronal networks. 
However, there is a delay between the early environmental adversity and 
differential methylation at E-DMRs after P7, in the adult animal. Furthermore, we 
were able to show that the overall developmental methylation patterns remain 
unperturbed until that time point. However, we show that three different stressors, at 
different time points in development, lead to similar epigenetic changes. This suggests 
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an intermediate step that connects the initial stressors to the delayed appearance of 
epigenetic changes in the hippocampus.   
Previous studies of the three models of early life adversity report HPA axis 
activation and elevated proinflammatory markers in both human and animal 
studies11,220,222. In fact exposure of animals to proinflammatory agents, such as IL-6 or 
IL-10, is sufficient to produce behavioral abnormalities223,256, while increased 
inflammatory cytokine expression has been shown to increase anxiety-like 
behavior257.Additionally, administration of anti-proinflammatory agents, such as anti-
IL-6 or IL-ra, can mitigate early environment induced behavioral abnormalities223. 
Therefore, it is conceivable that there is an immunological intermediary between the 
initial environmental insult and resulting neurological affect. One mode of 
transmission could be through the increased number of monocytes in the affected 
offspring and their transmigration to the brain. Monocytes may develop into 
macrophages in the brain and activate resident microglia203. Microglia participate in 
programmed cell death, survival, axon remodeling, pruning, and synaptogenesis in 
various brain regions, including the hippocampus10,185,203. Therefore, it is reasonable to 
hypothesize that an increased number of peripheral monocytes and their 
transmigration to the brain may contribute, via microglia activation, to the 
development of anxiety phenotype in affected offspring (Fig. 5.4). 
Intermediate methylation at E-DMRs were present not only in GCs, but also in 
hippocampal CA3 neurons and even in more distant striatal MSNs, indicating that it is 
a panneuronal feature. However, these genomic regions were not intermediately 
methylated or malleable in non-neuronal cells. Nonetheless, non-neuronal cells, 
specifically blood leukocytes, had their own environmentally sensitive intermediately 
methylated regions. This suggests that malleability at intermediately methylated 
regions is a general phenomenon. Furthermore, it is possible that tissue-specific 
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environmentally malleable DMRs may play important roles in tissue specific 
environmental response. For instance, differential methylation in blood leukocytes, in 
response to a stressful environment, may trigger an adaptive immunological response. 
 
Figure 5.4:  Summary of proposed mechanism of stress induced methylation 
changes in brain. Stress activates the HPA axis (green) resulting in the release of 
proinflammatory molecules such as glucocorticoids into the blood stream. 
Environmentally sensitive regions in the blood may respond to these proinflammatory 
molecules by undergoing differential methylation that may alter the transcriptional 
profile of the affected genes resulting in the increased release of monocytes into the 
bloodstream. The monocytes will then transmigrate to the brain where they will 
transverse the blood brain barrier and develop into macrophages and activate resident 
microglia. The activated microglia may release factors that will affect neurons in the 
hippocampus via the differential methylation at E-DMRs.  
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5.4 Methods 
Mice 
Animal experiments were carried out in accordance with the Weill Cornell 
Medical College Institutional Animal Care and Use Committee guidelines. All mice 
were group housed up to five per cage with 12-hour light/dark cycle with lights on at 6 
a.m. Food and water were available ad libitum. Male MA, LPS, and MS mice were 
generated on the Swiss-Webster (SW, Taconic Biosciences, Germantown, NY) 
background. The MA offspring were wild-type (WT) mice born to 5-HT1AR+/- 
parents generated as previously described220. The LPS offspring were generated 
following maternal injection of 50µg/mg of LPS once a day from E16 to E18 as 
previously described110,221. For the MS model, newborn pups were removed from the 
maternal cage for 3 hours per day and placed on a warming pad from P1 to P14111. A 
separate SW WT line provided control WT offspring exposed to normal, WT, early-
life environment. Adult mice exposed to chronic unpredictable stress and voluntary 
wheel running were 8 week old SW males, obtained from Jackson Laboratory. After a 
3 day acclimation period, mice were either kept at control conditions or exposed to 
running or a CUS protocol258 for 4 weeks. Stressors used for chronic unpredictable 
stress were: restraint, cold (9 ˚C for 1-2 h), cage shake, forced swim, bobcat odor, 
lights off, white noise (3-5 h), food deprivation, wet bedding, overnight light, 
overnight cage tilt, overnight light on, overnight strobe and overnight overcrowding. 
Two stressors were administered each day. Running animals were kept at similar 
conditions but in larger cages to accommodate the running wheels. 
Behavioral Procedures 
All tests for early life adversity models were conducted using offspring aged 8-
12 weeks. For adult models of environmental perturbation tests were carried out 12 
weeks after exposure to stress or running. Mice were first tested in open field for 
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overall activity, followed by elevated plus maze and forced swim test, followed by the 
3-chamber social interaction test. At least 24 hours rest was allotted between different 
tests. All tests were conducted between 9 a.m. and 6 p.m. (i.e. during the light cycle). 
Offspring were selected from ≥ 5 litters. The elevated plus maze was performed using 
a cross maze with 12 x 2 inch arms at dim light (50 lux)207. Animals were introduced 
to the middle portion of the maze facing an open arm and allowed to freely explore for 
10 minutes. Time spent and distance traveled in the open and closed arms were 
measured by a video-tracking system (Noldus Information Technology, Wageningen, 
The Netherlands.). The open-field test12 used a 15 x21 inch black box, divided into 12 
even-sized (4 x 3 inch) rectangles. The time spent in and distance traveled in the two 
rectangles at the center of the field at 150 lux were recorded by the video tracking 
system to evaluate anxiety, and data was presented as a percentage of total time spent 
in the field or total distance traveled. In the forced swim test12 mice were forced to 
swim in a clear, water-filled cylinder (diameter, 20.3 cm; depth 10cm), essentially as 
described by Porsolt et.208. In this test, immobility of the mice was scored by a 
blindsided observer for a total of six minutes. The three chamber test was conducted as 
described245. On test days, animals were transported to the dimly illuminated 
behavioral laboratory and left undisturbed for at least 1 hour before testing.  
eRRBS 
Brains from naïve male WT, MA, LPS, MS, Stress and Run mice (8-12 weeks 
old) from at least three different litters were flash frozen on dry ice and cryosectioned 
(200µM). The v-GC neuronal bodies were microdissected from the sections. DNA 
was isolated using the DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA). Single 
end 50bp eRRBS sequencing was performed as described61, using Illumina HiSeq2000 
and 2500 machines according to manufacturer instructions.  An in-house pipeline was 
used for methylation calling and alignment to the mm9 reference genome102. 
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Differential methylation and statistical analysis were performed using the MethylKit 
package in R102 at default settings. Differentially methylated (DM) sites were defined 
as sites where the corrected p-value was >0.01 and the difference in methylation 
between two samples was >15%. DMRs were calculated as regions containing at least 
four DMSs, where the distance between two neighboring DMSs was no greater than 
1kb. Genomic and CpG island annotations were based on Ensmbl data downloaded 
from the UCSC genome browser. Promoters were defined as regions ±2kb from the 
TSS while exons and introns were defined by reference. The percentage of total DM 
sites in a defined genomic feature was divided by the percentage expected to overlap 
each genomic feature by chance, based on the percentage of genomic space occupied 
by that feature, to determine the fold change from expected values. Additional 
methylation datasets were downloaded from the UCSC genome browser DNA 
methylation track hub29,103,104. 
RNA-Seq 
Naïve adult MA offspring (8-12 weeks old) from at least three different litters 
were perfused with 30% RNAlater (Ambion) in saline. Brains were frozen on dry ice 
and sectioned (200µM). The GC layer from V-DG was microdissected from the 
sections. Total RNA was isolated using the RNeasy Mini Kit (Qiagen). Single end 
50bp RNA sequencing was performed on Illumina HiSeq2000 and 2500 machines and 
aligned to the mm9 reference genome using TopHat software version 2.0.11105. 
Default parameters were used with the addition of “--no-novel-juncs” to align 
exclusively to known genes and isoforms. Genes were counted using HT-seq 
program106 with the parameter “intersection-strict”. Values for gene expression were 
calculated using EdgeR107 package in R using tagwise dispersion and default 
parameters. Differentially expressed genes were determined using Benjamini-
Hochberg corrected p=0.05 threshold. 
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Transfection and Luciferase Reporter Assay 
Plasmids were constructed using the In-Fusion Cloning Kit (Clontech 
Laboratories, Mountain View, CA). HEK293 cells were cultured in culture media 
containing 88% DMEM + 10mM HEPES, 1% penicillin/streptomycin, 10% FBS, and 
1% L-Glutamine in a 5% CO2 37°C incubator. Plasmids were transfected into 
HEK293 cell cultures using Lipofectamine Transfection Reagent (Life Technologies, 
Grand Island, NY) in triplicates. Briefly, 0.2-E6 cells were seeded in 12-well plates in 
1mL of culture media. 24 hours later, 1µg of plasmid DNA was diluted in 85µl Opti-
MEM media (Life Technologies) in tubes. After 5 minute incubation, 6µl 
Lipofectamine Transfection Reagent was added, followed by 20 minute incubation. 
85µl of this solution was added to each well of HEK293 cells. The following day, 
media was aspirated and replaced with 400µl of culture media. 48 hours after 
transfection, 20µl aliquots of media were sampled into 96-well plates. 100µl of 
Quanti-Luc luciferase substrate (InvivoGen, San Diego, CA) was added to each well, 
and plates were read immediately for luciferase activity. 
Data Analysis 
Data are shown as mean ± s.e.m. Outlier data was excluded based on ± 2 s.d. 
from the mean. One-way or repeated measures ANOVAs or t tests were used to 
compare tests. LSD or Bonferroni post hoc analyses were used to assess statistical 
significance. All graphs and statistical analysis were performed using R (http://ww.r-
project.org), Bioconductor (www.bioconductor.org), and ggplot2 (www.ggplot2.org) 
for visualization, unless stated otherwise.  	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Supplementary Figure 5.1: Behavioral analysis of adult offspring exposed to early 
life adversity. A. Distance traveled in the center field, a measure of exploratory 
activity (ANOVA: F=3.77, P=0.333, N=10, 15 and 14). LPS offspring exhibit reduced 
activity (LSD post hoc p=0.018), as well as MS offspring (LSD post hoc p=0.021). B. 
Stress reactivity, measured as mobility in FST (ANOVA: F= 2.86, P=0.0698, N= 13, 
15, and 14). LPS mice do no exhibit reduced activity (LSD post hoc p=0.47427). MS 
offspring exhibit reduced stress reactivity (LSD post hoc p=0.02577). C. Social 
interaction, measured as interaction with stranger mice in the three-chamber 
sociability and social novelty test (group effect of entry time and distance using 
Levenes’s Test of equality of error variances: F= 3.12, P =  0.013, F=2.98, P = 0.016, 
F = 2.638, P = 0.029, N = 26, 30 and 30).  LPS mice display decreased sociability  
(LSD post hoc p= 0.661, p = 0.069, p = 0.81) while MS mice display increased 
sociability (LSD post hoc p= 0.048 , p= 0.045,  p =  0.154). D. EPM - risk avoidance 
of the open arm in the EPM as % of total activity. MS mice exhibit increased risk 
avoidance (group effect of entry, time, and distance; ANOVA: F = 4.12, P= 0.024, F= 
2.42, P = 0.10, F= 3.04, P = 0.059; LSD post hoc p=0.009, p = 0.09, p = 0.02, 
compared to WT; N=13, 15, and 15 mice per group).  	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Supplementary Figure 5.2: Differentially methylated regions following individual 
early life adversities. A. Methylation distribution of clustered hyper- and hypo- 
methylated sites; from left to right: MA, LPS and MS.  B. Proportion of hyper and 
hypo methylated sites; from left to right: MA, LPS and MS. Both MA and LPS have a 
fairly even divide, MS mice have a strong bias toward hypomethylation. C. Genomic 
distribution of DMSs, from left to right: MA, LPS and MS. All three adversities result 
in exonic enrichment of DMRs.  	  	   	  
	  170	  
CHAPTER 6 
DISCUSSION  
6.1 Brief summary of novel findings 
First, Chapter 2 of this work identifies several principles of DNA methylation 
during development and lineage specification in the brain that have never been 
described before. This provides a foundation upon which we can understand how the 
process can be dysregulated in abnormal situations, such as neurodevelopmental 
disorders. Second, several studies have attempted to specify the epigenetic signature of 
regions that are sensitive and responds to environmental challenges, such as early life 
adversity, and which may also store prior environmental experience16,17,25,259. 
However, most of these studies used candidate gene approaches and were unable to 
define a single characteristic feature that would define regions of environmental 
sensitivity16,25,259. Chapters 3 and 4 identify several features that define 
environmentally (E) malleable regions. Their most prominent characteristic is an 
overall intermediate methylation profile due to inter-cellular mosaicism within 
affected tissue. While intermediately methylated regions have previously been 
documented in the brain and other tissues260, no functional role has been associated 
with them. Beyond their inherent sensitivity and responsiveness, E-DMRs may also 
explain how a stable, life-long, molecular “memory” of an early environmental insult 
is maintained in neurons and/or neuronal networks. Based on the data in Chapters 3 
and 4, a molecular and network model is proposed that attempts to explain how E-
DMRS sense and respond to environmental effects at the molecular level and how 
their epigenetic changes alter neuronal and network functions that eventually lead to 
the associated behavioral manifestations (see below). Finally, findings in Chapter 5 
support a non-genetic model of heritability by which DNA methylation signatures, and 
associated behavioral phenotypes, are passed from one generation to the next, 
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resembling genetic inheritance, but which is based on somatic and gametic parallel 
epigenetic pathways. 
 
6.2 Molecular Model 
Based on the results described in Chapters 3 and 4, there appear to be regions 
in the genome that display an inherent sensitivity and responsiveness to environmental 
conditions. Here, a molecular model is proposed that explains the a) sensitivity and b) 
responsiveness of E-DMRs and c) their capacity to store prior environmental 
information permanently. This model is proposed here, in the general discussion, 
because this project is still in progress and would be premature to include in the 
regular discussion.  However, this line of thinking represents the future direction of 
our work and therefore appropriate to describe here.  
Sensitivity: DNA methylation is a highly regulated process. Within a single 
tissue, majority of CpG sites normally display a fully methylated or unmethylated 
state74. The default state for CpG sites is methylation and mechanisms are in place to 
prevent methylation where necessary, such as at active gene promoters and CpG 
islands74. The presence of intermediately methylated sites at E-DMRs, represents 
inter-cellular variability and suggests a greater degree of regulation at these regions. 
This sensitivity can be due to the local chromatin and/or protein environment of the 
region. For instance, the local presence of DNA binding proteins such as MeCP2, 
HDACs as well as histones and their modifications can affect how easily DNA 
methyltransferases and demethylase enzymes can access and/or change the 
methylation status of a CpG site261. The malleability of these regions suggests a semi-
permissive state in which there is a stoichiometric probability that a site will be 
methylated.  The environmentally induced cellular changes could result in a change in 
the binding affinity of one more factors at E-DMRs, which in turn may change the 
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affinity of the region to DNA methyltransferases or demethylation components. 
Alternatively, the environmental stimulus may directly affect the concentration and/or 
binding affinity of DNA methyltransferases and/or demethylase components, thereby 
affecting their binding equilibrium. The change in binding and activity of the factors 
bound at these malleable regions can then have a direct effect on the methylation 
status of nearby CpG sites. 
Responsiveness: The environmental input may change the methylation pattern 
at one or more E-DMRs within a subpopulation of the cells. Since E-DMRs are 
located at gene regulatory sequences, and because methylation of E-DMRs modulates 
gene activity (unpublished data), environmentally induced methylation changes can 
have a profound effect on gene expression at a  fraction of cells within each 
subpopulation.   
Based on previous studies we know that changes in DNA methylation can 
result in altered gene expression262,263. Several studies have described activity 
mediated activation of synaptic receptors resulting in an intercellular signal cascade 
resulting in the altered DNA methylation and expression of neuronal genes24,264. For 
instance, neuronal activity of hippocampal granule cell resulted in increased Gadd45b 
expression24, which is believed to be a component of a demethylation pathway265,266. 
This in turn was associated with the demethylation of exon IX of the BDNF gene 
resulting in increased BDNF expression and activity24.  
Memory: The inherent malleability of E-DMRs may be characterized by the 
stochastic binding and unbinding of local chromatin bound proteins. The binding 
affinity of these proteins and modifications may be dependent on the presence of 
additional proteins, co-factors and modifications, as well as local transcriptional 
activity. Based on some preliminary experiments we know that the changes following 
acute stress are not the same as those following chronic stress. It is conceivable that 
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following acute stress there are some local changes at E-DMRs resulting in temporary 
transcriptional and epigenetic changes. However chronic stress may elicit 
transcriptional activity or silencing, concurrent with changes at the local chromatin 
level, that may lead to more stable chromatin modifications. For instance due the 
inherent sensitivity of these regions in the affected tissue, chronic transcriptional 
activity will shift the stoichiometric balance of the bound proteins and co-factors. 
Chromatin associated proteins, histone modifications, RNA binding and DNA 
methylation are co-regulated. Therefore, the persistent shift in the highly malleable 
local protein environment may shift the affinity of DNA methyltransferases and 
demethylases at these regions resulting in a stable shift in local DNA methylation. 
Unlike the initial stochastic nature of DNA methylation at a particular E-DMR, 
following chronic environmental stimuli, in the form of early life adversity, will result 
in a stable shift in a subpopulation of cells in the affected tissue. This will shift the 
stoichiometric balance of CpGs between the methylated versus unmethylated CpG 
state in one direction. 
 
6.3  Network Model 
The molecular model can be extended to a network model that eventually may 
explain the environmentally induced behavioral manifestations.  Based on theories of 
processing and sparse coding of information in a neuronal network, sustained 
environmental input is expected to target a particular subset of cells based on their 
intrinsic properties, such as the cell type, location as well as proteins and receptors 
present255. Because of the mosaicism in E-DMR methylation, cells  that have  E-
DMRs in a malleable epigenetic state will be affected through the gain and/or loss 
methylation at particular E-DMRs or clusters of CpG sites within E-DMRs. 
Interestingly, little to no overlap between E-DMRs and regions that change during 
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normal neural development and differentiation were observed. This suggests that the 
methylation pattern develops undisturbed until postnatal development, when, in a 
delayed fashion, the earlier environmental insult, “overwrites” the developmental 
pattern. We speculate that the delay is due to an immunological mechanism that links 
the environmental insult to the brain. 
Since E-DMRs are found at highly regulated synaptic genes, this model would 
explain how the brain can respond to the environment that could be, at least initially, 
adaptive. However, early life adaptation may result in alternative developmental 
trajectories that appear to cause disease, and thus maladaptive later in life. For instance 
in a stressful situation, such as in a war, a mother will display increased anxiety and 
stress pathology that will be transmitted to the offspring267,268. The child will then 
display similar increased anxiety and stress responsivity as the mother, so as to be 
better adapted to a volatile and potentially dangerous situation. Similarly, in the case 
of maternal neglect or abuse the child may seem to adapt by displaying a lack of 
stranger anxiety or indiscriminate friendliness and sociability to strangers216,225. This is 
perhaps a way to increase the probability of interacting with another individual(s) who 
may partially compensate for their lack of parental care. It is only when the early life 
environmental adversity does not match the adult environmental conditions that the 
initial adaptation becomes a maladaptation. For instance, in the maternal stress 
situation the increased anxiety and stress-responsivity is ill-suited to a peaceful 
environment. Similarly, children exposed to maternal neglect early in life, who are 
subsequently exposed to a stable and nurturing environment, are no longer benefited 
by increased anxiety and indiscriminate friendliness, which may do them more harm 
than good. This theory is supported only empirically in humans, but a number of well-
controlled ecological studies seem to support it269-271. For instance a study of squirrel 
populations found that mothers in high-density populations released more 
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glucocorticoids that resulted in increased growth rates in their offspring271. This 
provides their children with an adaptive advantage to the environmental conditions 
with the tradeoff of shorter lifespan.  
In summary, the experience dependent variations in DNA methylation may 
prime the genome for differential transcriptional response to later events. This 
metaplasticity may be especially important in brain regions responsible for processing 
environmental input to elicit a behavioral response. 
 
6.4 Implications 
 The presence of environmentally sensitive DMRs in blood at hematopoietic 
genes suggests that each tissue type may have its own environmentally sensitive 
regions (Fig. 4.3F). Similar to our findings in the brain and blood (Fig. 4.3E and 4.3F), 
these regions may be responsible for tissue-specific responses to the environment. We, 
and others260, have identified similar regions of intermediate methylation in other 
neuronal tissues as well as others such as the heart, liver. These tissue specific regions 
of intermediate methylation were enriched at exonic regions of tissue specific genes in 
multiple species, including humans260. If this mode of environmental regulation is 
similar to that described in this work, it is conceivable that they can be similarly 
dysregulated by adverse environmental conditions, specific to the affected tissue. 
Therefore, blood mononuclear cell DMRs could be used as a proxy to determine if 
neuronal DMRs were affected by the environmental insult. 
 In a heterogeneous population of individuals not all of those exposed to early 
environmental adversity will exhibit behavioral pathology. For instance, not all 
children exposed to a traumatic early life environment such as war or abuse will 
display adult behavioral pathologies267. However, it would be useful to identify which 
children, who experienced early trauma, have been affected at the molecular level that 
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may predispose them for subsequent adult psychiatric abnormalities. Obtaining neural 
tissue, even neurons from olfactory epithelia, is not feasible (or ethical) in these 
circumstances. Therefore, identification of blood-specific environmentally sensitive 
regions (Chapter 4) may provide a useful diagnostic tool. By identifying and 
classifying adversity-specific blood DMRs in affected populations versus non-
affected, we can create a reference for which to compare the blood of children exposed 
to adversity but do not yet exhibit any symptoms. In this way a simple blood test can 
be designed to determine the methylation at adversity-specific blood DMRs.  
Another area of translating our E-DMR data to the clinic is the development of 
therapeutics that target the epigenetically modified genes, mostly involved in synaptic 
functions. These include neuronal adhesion molecules, receptors and intracellular 
signaling. Another possible application is methyl donor therapy234.  Although it is 
nonspecific, our work suggests that in the adult CNS, regions with intermediate 
methylation preferentially respond to the level of methyl donors, while fully 
methylated and non-methylated areas remain stable.  As discussed earlier, only 1-2% 
of the genome is in intermediate level of methylation.  Therefore, a treatment that is 
considered non-specific, may actually be relatively selective to malleable regions with 
relatively moderate side effects.  Indeed, a number of papers reported behavioral 
normalization in animal models following environmental insults following a methyl 
treatment234,272,273.  For example, in one study of maternal separation in rats, the 
increased anxiety was mitigated by feeding them a methyl supplementation diet234. 
Another study of rats that displayed anxiety following early life exposure to low 
licking and grooming mothers found that the anxiety phenotype, and associated 
differential methylation, could be reversed through a methyl supplementation diet later 
in life234. 
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 In summary, the advances presented in this work may provide to foundation 
and knowledge necessary to make significant advances in the identification and 
treatment of individuals affected by adverse early life experiences.   
	  178	  
BIBLIOGRAPHY 
 1	   Kessler,	  R.	  C.	  et	  al.	  Lifetime	  and	  12-­‐month	  prevalence	  of	  DSM-­‐III-­‐R	  psychiatric	  disorders	  in	  the	  United	  States.	  Results	  from	  the	  National	  Comorbidity	  Survey.	  Arch	  Gen	  Psychiatry	  51,	  8-­‐19	  (1994).	  2	   Baker-­‐Andresen,	  D.,	  Ratnu,	  V.	  S.	  &	  Bredy,	  T.	  W.	  Dynamic	  DNA	  methylation:	  a	  prime	  candidate	  for	  genomic	  metaplasticity	  and	  behavioral	  adaptation.	  
Trends	  in	  neurosciences	  36,	  3-­‐13	  (2013).	  3	   Tsuang,	  M.	  T.,	  Bar,	  J.	  L.,	  Stone,	  W.	  S.	  &	  Faraone,	  S.	  V.	  Gene-­‐environment	  interactions	  in	  mental	  disorders.	  World	  psychiatry	  :	  official	  journal	  of	  the	  
World	  Psychiatric	  Association	  3,	  73-­‐83	  (2004).	  4	   Toth,	  M.	  Mechanisms	  of	  non-­‐genetic	  inheritance	  and	  psychiatric	  disorders.	  
Neuropsychopharmacology	  :	  official	  publication	  of	  the	  American	  College	  of	  
Neuropsychopharmacology	  40,	  129-­‐140	  (2015).	  5	   Lv,	  J.,	  Xin,	  Y.,	  Zhou,	  W.	  &	  Qiu,	  Z.	  The	  epigenetic	  switches	  for	  neural	  development	  and	  psychiatric	  disorders.	  Journal	  of	  genetics	  and	  genomics	  =	  
Yi	  chuan	  xue	  bao	  40,	  339-­‐346	  (2013).	  6	   Fuccillo,	  M.,	  Joyner,	  A.	  L.	  &	  Fishell,	  G.	  Morphogen	  to	  mitogen:	  the	  multiple	  roles	  of	  hedgehog	  signalling	  in	  vertebrate	  neural	  development.	  Nature	  
reviews.	  Neuroscience	  7,	  772-­‐783,	  doi:10.1038/nrn1990	  (2006).	  7	   Charron,	  F.	  &	  Tessier-­‐Lavigne,	  M.	  Novel	  brain	  wiring	  functions	  for	  classical	  morphogens:	  a	  role	  as	  graded	  positional	  cues	  in	  axon	  guidance.	  
Development	  132,	  2251-­‐2262,	  doi:10.1242/dev.01830	  (2005).	  8	   Liu,	  B.	  et	  al.	  Maternal	  hematopoietic	  TNF,	  via	  milk	  chemokines,	  programs	  hippocampal	  development	  and	  memory.	  Nature	  neuroscience	  17,	  97-­‐105	  (2014).	  9	   Bale,	  T.	  L.	  Epigenetic	  and	  transgenerational	  reprogramming	  of	  brain	  development.	  Nature	  reviews.	  Neuroscience	  16,	  332-­‐344,	  doi:10.1038/nrn3818	  (2015).	  10	   Knuesel,	  I.	  et	  al.	  Maternal	  immune	  activation	  and	  abnormal	  brain	  development	  across	  CNS	  disorders.	  Nature	  reviews.	  Neurology	  10,	  643-­‐660,	  doi:10.1038/nrneurol.2014.187	  (2014).	  11	   Kalinichev,	  M.,	  Easterling,	  K.	  W.,	  Plotsky,	  P.	  M.	  &	  Holtzman,	  S.	  G.	  Long-­‐lasting	  changes	  in	  stress-­‐induced	  corticosterone	  response	  and	  anxiety-­‐like	  behaviors	  as	  a	  consequence	  of	  neonatal	  maternal	  separation	  in	  Long-­‐Evans	  rats.	  Pharmacology,	  biochemistry,	  and	  behavior	  73,	  131-­‐140	  (2002).	  12	   Gleason,	  G.	  et	  al.	  The	  serotonin1A	  receptor	  gene	  as	  a	  genetic	  and	  prenatal	  maternal	  environmental	  factor	  in	  anxiety.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  107,	  7592-­‐7597	  (2010).	  13	   Abdolmaleky,	  H.	  M.,	  Thiagalingam,	  S.	  &	  Wilcox,	  M.	  Genetics	  and	  epigenetics	  in	  major	  psychiatric	  disorders:	  dilemmas,	  achievements,	  applications,	  and	  future	  scope.	  Am	  J	  Pharmacogenomics	  5,	  149-­‐160,	  doi:532	  [pii]	  (2005).	  
	  179	  
14	   Craddock,	  N.	  &	  Owen,	  M.	  J.	  The	  Kraepelinian	  dichotomy	  -­‐	  going,	  going...	  but	  still	  not	  gone.	  The	  British	  journal	  of	  psychiatry	  :	  the	  journal	  of	  mental	  
science	  196,	  92-­‐95	  (2010).	  15	   Kapur,	  S.,	  Phillips,	  A.	  G.	  &	  Insel,	  T.	  R.	  Why	  has	  it	  taken	  so	  long	  for	  biological	  psychiatry	  to	  develop	  clinical	  tests	  and	  what	  to	  do	  about	  it?	  Molecular	  
psychiatry	  17,	  1174-­‐1179	  (2012).	  16	   Dias,	  B.	  G.	  &	  Ressler,	  K.	  J.	  Parental	  olfactory	  experience	  influences	  behavior	  and	  neural	  structure	  in	  subsequent	  generations.	  Nature	  neuroscience	  17,	  89-­‐96,	  doi:10.1038/nn.3594	  (2014).	  17	   Franklin,	  T.	  B.	  et	  al.	  Epigenetic	  transmission	  of	  the	  impact	  of	  early	  stress	  across	  generations.	  Biological	  psychiatry	  68,	  408-­‐415,	  doi:10.1016/j.biopsych.2010.05.036	  (2010).	  18	   Gapp,	  K.	  et	  al.	  Implication	  of	  sperm	  RNAs	  in	  transgenerational	  inheritance	  of	  the	  effects	  of	  early	  trauma	  in	  mice.	  Nature	  neuroscience	  17,	  667-­‐669,	  doi:10.1038/nn.3695	  (2014).	  19	   Guerrero-­‐Bosagna,	  C.,	  Settles,	  M.,	  Lucker,	  B.	  &	  Skinner,	  M.	  K.	  Epigenetic	  transgenerational	  actions	  of	  vinclozolin	  on	  promoter	  regions	  of	  the	  sperm	  epigenome.	  PLoS	  One	  5,	  doi:10.1371/journal.pone.0013100	  (2010).	  20	   Walker,	  A.	  K.,	  Hawkins,	  G.,	  Sominsky,	  L.	  &	  Hodgson,	  D.	  M.	  Transgenerational	  transmission	  of	  anxiety	  induced	  by	  neonatal	  exposure	  to	  lipopolysaccharide:	  implications	  for	  male	  and	  female	  germ	  lines.	  
Psychoneuroendocrinology	  37,	  1320-­‐1335	  (2012).	  21	   Smrt,	  R.	  D.	  et	  al.	  Mecp2	  deficiency	  leads	  to	  delayed	  maturation	  and	  altered	  gene	  expression	  in	  hippocampal	  neurons.	  Neurobiology	  of	  disease	  27,	  77-­‐89	  (2007).	  22	   Blackman,	  M.	  P.,	  Djukic,	  B.,	  Nelson,	  S.	  B.	  &	  Turrigiano,	  G.	  G.	  A	  critical	  and	  cell-­‐autonomous	  role	  for	  MeCP2	  in	  synaptic	  scaling	  up.	  J	  Neurosci	  32,	  13529-­‐13536	  (2012).	  23	   Bienvenu,	  T.	  &	  Chelly,	  J.	  Molecular	  genetics	  of	  Rett	  syndrome:	  when	  DNA	  methylation	  goes	  unrecognized.	  Nat	  Rev	  Genet	  7,	  415-­‐426	  (2006).	  24	   Ma,	  D.	  K.	  et	  al.	  Neuronal	  activity-­‐induced	  Gadd45b	  promotes	  epigenetic	  DNA	  demethylation	  and	  adult	  neurogenesis.	  Science	  323,	  1074-­‐1077	  (2009).	  25	   Novikova,	  S.	  I.	  et	  al.	  Maternal	  cocaine	  administration	  in	  mice	  alters	  DNA	  methylation	  and	  gene	  expression	  in	  hippocampal	  neurons	  of	  neonatal	  and	  prepubertal	  offspring.	  PLoS	  One	  3,	  e1919	  (2008).	  26	   Oh,	  J.	  E.	  et	  al.	  Differential	  gene	  body	  methylation	  and	  reduced	  expression	  of	  cell	  adhesion	  and	  neurotransmitter	  receptor	  genes	  in	  adverse	  maternal	  environment.	  Translational	  psychiatry	  3,	  e218	  (2013).	  27	   Goldberg,	  A.	  D.,	  Allis,	  C.	  D.	  &	  Bernstein,	  E.	  Epigenetics:	  a	  landscape	  takes	  shape.	  Cell	  128,	  635-­‐638	  (2007).	  28	   Seisenberger,	  S.	  et	  al.	  Reprogramming	  DNA	  methylation	  in	  the	  mammalian	  life	  cycle:	  building	  and	  breaking	  epigenetic	  barriers.	  Philosophical	  
transactions	  of	  the	  Royal	  Society	  of	  London.	  Series	  B,	  Biological	  sciences	  
368,	  20110330	  (2013).	  
	  180	  
29	   Smith,	  Z.	  D.	  et	  al.	  A	  unique	  regulatory	  phase	  of	  DNA	  methylation	  in	  the	  early	  mammalian	  embryo.	  Nature	  484,	  339-­‐344,	  doi:10.1038/nature10960	  (2012).	  30	   Lister,	  R.	  et	  al.	  Global	  epigenomic	  reconfiguration	  during	  mammalian	  brain	  development.	  Science	  341,	  1237905,	  doi:10.1126/science.1237905	  (2013).	  31	   Borgel,	  J.	  et	  al.	  Targets	  and	  dynamics	  of	  promoter	  DNA	  methylation	  during	  early	  mouse	  development.	  Nat	  Genet	  42,	  1093-­‐1100	  (2010).	  32	   Paulsen,	  M.	  &	  Ferguson-­‐Smith,	  A.	  C.	  DNA	  methylation	  in	  genomic	  imprinting,	  development,	  and	  disease.	  J	  Pathol	  195,	  97-­‐110	  (2001).	  33	   Casey,	  B.	  J.,	  Tottenham,	  N.,	  Liston,	  C.	  &	  Durston,	  S.	  Imaging	  the	  developing	  brain:	  what	  have	  we	  learned	  about	  cognitive	  development?	  Trends	  Cogn	  
Sci	  9,	  104-­‐110	  (2005).	  34	   Forster,	  E.,	  Zhao,	  S.	  &	  Frotscher,	  M.	  Laminating	  the	  hippocampus.	  Nature	  
reviews.	  Neuroscience	  7,	  259-­‐267	  (2006).	  35	   Ji-­‐eun	  Oh,	  N.	  C.,	  Judit	  Gal,	  Stuart	  Andrews,	  Georgia	  Gleason,	  Rita	  &	  Shaknovich,	  A.	  M.,	  Fabien	  Campagne,	  Miklos	  Toth.	  Maternal	  Serotonin1A	  Receptor	  Programs	  the	  Level	  of	  Anxiety	  via	  Exonic	  CpG-­‐Island	  Methylation	  in	  the	  Offspring	  Hippocampus.	  	  (2011).	  36	   Murgatroyd,	  C.	  et	  al.	  Dynamic	  DNA	  methylation	  programs	  persistent	  adverse	  effects	  of	  early-­‐life	  stress.	  Nature	  neuroscience	  12,	  1559-­‐1566	  (2009).	  37	   Halmoy,	  A.	  et	  al.	  Attention-­‐deficit/hyperactivity	  disorder	  symptoms	  in	  offspring	  of	  mothers	  with	  impaired	  serotonin	  production.	  Arch	  Gen	  
Psychiatry	  67,	  1033-­‐1043	  (2010).	  38	   Atladottir,	  H.	  O.	  et	  al.	  Maternal	  infection	  requiring	  hospitalization	  during	  pregnancy	  and	  autism	  spectrum	  disorders.	  Journal	  of	  autism	  and	  
developmental	  disorders	  40,	  1423-­‐1430	  (2010).	  39	   Bowers,	  M.	  E.	  &	  Yehuda,	  R.	  Intergenerational	  Transmission	  of	  Stress	  in	  Humans.	  Neuropsychopharmacology	  :	  official	  publication	  of	  the	  American	  
College	  of	  Neuropsychopharmacology,	  doi:10.1038/npp.2015.247	  (2015).	  40	   Wehmer,	  F.,	  Porter,	  R.	  H.	  &	  Scales,	  B.	  Pre-­‐mating	  and	  pregnancy	  stress	  in	  rats	  affects	  behaviour	  of	  grandpups.	  Nature	  227,	  622	  (1970).	  41	   Morgan,	  C.	  P.	  &	  Bale,	  T.	  L.	  Early	  prenatal	  stress	  epigenetically	  programs	  dysmasculinization	  in	  second-­‐generation	  offspring	  via	  the	  paternal	  lineage.	  J	  Neurosci	  31,	  11748-­‐11755,	  doi:10.1523/JNEUROSCI.1887-­‐11.2011	  (2011).	  42	   Yehuda,	  R.,	  Bell,	  A.,	  Bierer,	  L.	  M.	  &	  Schmeidler,	  J.	  Maternal,	  not	  paternal,	  PTSD	  is	  related	  to	  increased	  risk	  for	  PTSD	  in	  offspring	  of	  Holocaust	  survivors.	  Journal	  of	  psychiatric	  research	  42,	  1104-­‐1111,	  doi:10.1016/j.jpsychires.2008.01.002	  (2008).	  43	   Yehuda,	  R.,	  Schmeidler,	  J.,	  Wainberg,	  M.,	  Binder-­‐Brynes,	  K.	  &	  Duvdevani,	  T.	  Vulnerability	  to	  posttraumatic	  stress	  disorder	  in	  adult	  offspring	  of	  Holocaust	  survivors.	  The	  American	  journal	  of	  psychiatry	  155,	  1163-­‐1171	  (1998).	  
	  181	  
44	   Moore,	  L.	  D.,	  Le,	  T.	  &	  Fan,	  G.	  DNA	  methylation	  and	  its	  basic	  function.	  
Neuropsychopharmacology	  38,	  23-­‐38,	  doi:10.1038/npp.2012.112	  (2013).	  45	   Stadler,	  M.	  B.	  et	  al.	  DNA-­‐binding	  factors	  shape	  the	  mouse	  methylome	  at	  distal	  regulatory	  regions.	  Nature	  480,	  490-­‐495	  (2011).	  46	   Thurman,	  R.	  E.	  et	  al.	  The	  accessible	  chromatin	  landscape	  of	  the	  human	  genome.	  Nature	  489,	  75-­‐82,	  doi:10.1038/nature11232	  (2012).	  47	   Mohn,	  F.	  et	  al.	  Lineage-­‐specific	  polycomb	  targets	  and	  de	  novo	  DNA	  methylation	  define	  restriction	  and	  potential	  of	  neuronal	  progenitors.	  
Molecular	  cell	  30,	  755-­‐766	  (2008).	  48	   Hirabayashi,	  Y.	  &	  Gotoh,	  Y.	  Epigenetic	  control	  of	  neural	  precursor	  cell	  fate	  during	  development.	  Nature	  reviews	  11,	  377-­‐388	  (2010).	  49	   Wilson,	  S.	  W.	  &	  Rubenstein,	  J.	  L.	  Induction	  and	  dorsoventral	  patterning	  of	  the	  telencephalon.	  Neuron	  28,	  641-­‐651	  (2000).	  50	   Bayer,	  S.	  A.	  Development	  of	  the	  hippocampal	  region	  in	  the	  rat.	  II.	  Morphogenesis	  during	  embryonic	  and	  early	  postnatal	  life.	  J	  Comp	  Neurol	  
190,	  115-­‐134	  (1980).	  51	   Deacon,	  T.	  W.,	  Pakzaban,	  P.	  &	  Isacson,	  O.	  The	  lateral	  ganglionic	  eminence	  is	  the	  origin	  of	  cells	  committed	  to	  striatal	  phenotypes:	  neural	  transplantation	  and	  developmental	  evidence.	  Brain	  Res	  668,	  211-­‐219	  (1994).	  52	   Campbell,	  K.	  Dorsal-­‐ventral	  patterning	  in	  the	  mammalian	  telencephalon.	  
Current	  opinion	  in	  neurobiology	  13,	  50-­‐56	  (2003).	  53	   Galceran,	  J.,	  Miyashita-­‐Lin,	  E.	  M.,	  Devaney,	  E.,	  Rubenstein,	  J.	  L.	  &	  Grosschedl,	  R.	  Hippocampus	  development	  and	  generation	  of	  dentate	  gyrus	  granule	  cells	  is	  regulated	  by	  LEF1.	  Development	  (Cambridge,	  England)	  
127,	  469-­‐482	  (2000).	  54	   Ericson,	  J.	  et	  al.	  Sonic	  hedgehog	  induces	  the	  differentiation	  of	  ventral	  forebrain	  neurons:	  a	  common	  signal	  for	  ventral	  patterning	  within	  the	  neural	  tube.	  Cell	  81,	  747-­‐756	  (1995).	  55	   Yun,	  K.,	  Potter,	  S.	  &	  Rubenstein,	  J.	  L.	  Gsh2	  and	  Pax6	  play	  complementary	  roles	  in	  dorsoventral	  patterning	  of	  the	  mammalian	  telencephalon.	  
Development	  128,	  193-­‐205	  (2001).	  56	   Horton,	  S.,	  Meredith,	  A.,	  Richardson,	  J.	  A.	  &	  Johnson,	  J.	  E.	  Correct	  coordination	  of	  neuronal	  differentiation	  events	  in	  ventral	  forebrain	  requires	  the	  bHLH	  factor	  MASH1.	  Mol	  Cell	  Neurosci	  14,	  355-­‐369,	  doi:10.1006/mcne.1999.0791	  (1999).	  57	   Altman,	  J.	  &	  Bayer,	  S.	  A.	  Prolonged	  sojourn	  of	  developing	  pyramidal	  cells	  in	  the	  intermediate	  zone	  of	  the	  hippocampus	  and	  their	  settling	  in	  the	  stratum	  pyramidale.	  J	  Comp	  Neurol	  301,	  343-­‐364	  (1990).	  58	   Wichterle,	  H.,	  Turnbull,	  D.	  H.,	  Nery,	  S.,	  Fishell,	  G.	  &	  Alvarez-­‐Buylla,	  A.	  In	  utero	  fate	  mapping	  reveals	  distinct	  migratory	  pathways	  and	  fates	  of	  neurons	  born	  in	  the	  mammalian	  basal	  forebrain.	  Development	  128,	  3759-­‐3771	  (2001).	  59	   Kamiya,	  D.	  et	  al.	  Intrinsic	  transition	  of	  embryonic	  stem-­‐cell	  differentiation	  into	  neural	  progenitors.	  Nature	  470,	  503-­‐509	  (2011).	  
	  182	  
60	   Papaioannou,	  V.	  E.,	  McBurney,	  M.	  W.,	  Gardner,	  R.	  L.	  &	  Evans,	  M.	  J.	  Fate	  of	  teratocarcinoma	  cells	  injected	  into	  early	  mouse	  embryos.	  Nature	  258,	  70-­‐73	  (1975).	  61	   Akalin,	  A.	  et	  al.	  Base-­‐pair	  resolution	  DNA	  methylation	  sequencing	  reveals	  profoundly	  divergent	  epigenetic	  landscapes	  in	  acute	  myeloid	  leukemia.	  
PLoS	  Genet	  8,	  e1002781	  (2012).	  62	   Xie,	  W.	  et	  al.	  Base-­‐resolution	  analyses	  of	  sequence	  and	  parent-­‐of-­‐origin	  dependent	  DNA	  methylation	  in	  the	  mouse	  genome.	  Cell	  148,	  816-­‐831,	  doi:10.1016/j.cell.2011.12.035	  (2012).	  63	   Lister,	  R.	  et	  al.	  Human	  DNA	  methylomes	  at	  base	  resolution	  show	  widespread	  epigenomic	  differences.	  Nature	  462,	  315-­‐322	  (2009).	  64	   Harris,	  R.	  A.	  et	  al.	  Comparison	  of	  sequencing-­‐based	  methods	  to	  profile	  DNA	  methylation	  and	  identification	  of	  monoallelic	  epigenetic	  modifications.	  Nat	  Biotechnol.	  65	   Ramsahoye,	  B.	  H.	  et	  al.	  Non-­‐CpG	  methylation	  is	  prevalent	  in	  embryonic	  stem	  cells	  and	  may	  be	  mediated	  by	  DNA	  methyltransferase	  3a.	  Proc	  Natl	  
Acad	  Sci	  U	  S	  A	  97,	  5237-­‐5242	  (2000).	  66	   Ziller,	  M.	  J.	  et	  al.	  Genomic	  Distribution	  and	  Inter-­‐Sample	  Variation	  of	  Non-­‐CpG	  Methylation	  across	  Human	  Cell	  Types.	  PLoS	  Genet	  7,	  e1002389	  (2011).	  67	   Fritz,	  E.	  L.	  &	  Papavasiliou,	  F.	  N.	  Cytidine	  deaminases:	  AIDing	  DNA	  demethylation?	  Genes	  Dev	  24,	  2107-­‐2114	  (2010).	  68	   Nabel,	  C.	  S.	  et	  al.	  AID/APOBEC	  deaminases	  disfavor	  modified	  cytosines	  implicated	  in	  DNA	  demethylation.	  Nat	  Chem	  Biol	  8,	  751-­‐758,	  doi:10.1038/nchembio.1042	  (2012).	  69	   Kohli,	  R.	  M.	  &	  Zhang,	  Y.	  TET	  enzymes,	  TDG	  and	  the	  dynamics	  of	  DNA	  demethylation.	  Nature	  502,	  472-­‐479,	  doi:10.1038/nature12750	  (2013).	  70	   Arand,	  J.	  et	  al.	  In	  vivo	  control	  of	  CpG	  and	  non-­‐CpG	  DNA	  methylation	  by	  DNA	  methyltransferases.	  PLoS	  Genet	  8,	  e1002750	  (2012).	  71	   Grove,	  E.	  A.	  &	  Tole,	  S.	  Patterning	  events	  and	  specification	  signals	  in	  the	  developing	  hippocampus.	  Cereb	  Cortex	  9,	  551-­‐561	  (1999).	  72	   Gutierrez-­‐Arcelus,	  M.	  et	  al.	  Passive	  and	  active	  DNA	  methylation	  and	  the	  interplay	  with	  genetic	  variation	  in	  gene	  regulation.	  eLife	  2,	  e00523.	  73	   Gutierrez-­‐Arcelus,	  M.	  et	  al.	  Passive	  and	  active	  DNA	  methylation	  and	  the	  interplay	  with	  genetic	  variation	  in	  gene	  regulation.	  Elife	  2,	  e00523,	  doi:10.7554/eLife.00523	  (2013).	  74	   Jones,	  P.	  A.	  Functions	  of	  DNA	  methylation:	  islands,	  start	  sites,	  gene	  bodies	  and	  beyond.	  Nat	  Rev	  Genet	  13,	  484-­‐492	  (2012).	  75	   Gerdeman,	  G.	  L.,	  Ronesi,	  J.	  &	  Lovinger,	  D.	  M.	  Postsynaptic	  endocannabinoid	  release	  is	  critical	  to	  long-­‐term	  depression	  in	  the	  striatum.	  Nat	  Neurosci	  5,	  446-­‐451,	  doi:10.1038/nn832	  (2002).	  76	   Malenka,	  R.	  C.	  &	  Bear,	  M.	  F.	  LTP	  and	  LTD:	  an	  embarrassment	  of	  riches.	  
Neuron	  44,	  5-­‐21,	  doi:10.1016/j.neuron.2004.09.012	  (2004).	  77	   Do	  Rego,	  J.	  L.	  et	  al.	  Neurosteroid	  biosynthesis:	  enzymatic	  pathways	  and	  neuroendocrine	  regulation	  by	  neurotransmitters	  and	  neuropeptides.	  
	  183	  
Front	  Neuroendocrinol	  30,	  259-­‐301,	  doi:10.1016/j.yfrne.2009.05.006	  (2009).	  78	   Sonnino,	  S.,	  Mauri,	  L.,	  Chigorno,	  V.	  &	  Prinetti,	  A.	  Gangliosides	  as	  components	  of	  lipid	  membrane	  domains.	  Glycobiology	  17,	  1R-­‐13R,	  doi:10.1093/glycob/cwl052	  (2007).	  79	   Wu,	  H.	  et	  al.	  Dnmt3a-­‐dependent	  nonpromoter	  DNA	  methylation	  facilitates	  transcription	  of	  neurogenic	  genes.	  Science	  329,	  444-­‐448	  (2010).	  80	   Gu,	  T.	  P.	  et	  al.	  The	  role	  of	  Tet3	  DNA	  dioxygenase	  in	  epigenetic	  reprogramming	  by	  oocytes.	  Nature	  477,	  606-­‐610,	  doi:10.1038/nature10443	  (2011).	  81	   Xu,	  Y.	  et	  al.	  Tet3	  CXXC	  domain	  and	  dioxygenase	  activity	  cooperatively	  regulate	  key	  genes	  for	  Xenopus	  eye	  and	  neural	  development.	  Cell	  151,	  1200-­‐1213,	  doi:10.1016/j.cell.2012.11.014	  (2012).	  82	   Hahn,	  M.	  A.	  et	  al.	  Dynamics	  of	  5-­‐hydroxymethylcytosine	  and	  chromatin	  marks	  in	  Mammalian	  neurogenesis.	  Cell	  Rep	  3,	  291-­‐300,	  doi:10.1016/j.celrep.2013.01.011	  (2013).	  83	   Li,	  T.	  et	  al.	  Critical	  role	  of	  Tet3	  in	  neural	  progenitor	  cell	  maintenance	  and	  terminal	  differentiation.	  Mol	  Neurobiol	  51,	  142-­‐154,	  doi:10.1007/s12035-­‐014-­‐8734-­‐5	  (2015).	  84	   Feng,	  J.	  et	  al.	  Dnmt1	  and	  Dnmt3a	  maintain	  DNA	  methylation	  and	  regulate	  synaptic	  function	  in	  adult	  forebrain	  neurons.	  Nature	  neuroscience	  13,	  423-­‐430	  (2010).	  85	   Oliveira,	  A.	  M.,	  Hemstedt,	  T.	  J.	  &	  Bading,	  H.	  Rescue	  of	  aging-­‐associated	  decline	  in	  Dnmt3a2	  expression	  restores	  cognitive	  abilities.	  Nat	  Neurosci	  
15,	  1111-­‐1113,	  doi:10.1038/nn.3151	  (2012).	  86	   Varley,	  K.	  E.	  et	  al.	  Dynamic	  DNA	  methylation	  across	  diverse	  human	  cell	  lines	  and	  tissues.	  Genome	  Res	  23,	  555-­‐567,	  doi:10.1101/gr.147942.112	  (2013).	  87	   Bock,	  C.	  et	  al.	  DNA	  methylation	  dynamics	  during	  in	  vivo	  differentiation	  of	  blood	  and	  skin	  stem	  cells.	  Mol	  Cell	  47,	  633-­‐647,	  doi:10.1016/j.molcel.2012.06.019	  (2012).	  88	   Eden,	  A.,	  Gaudet,	  F.,	  Waghmare,	  A.	  &	  Jaenisch,	  R.	  Chromosomal	  instability	  and	  tumors	  promoted	  by	  DNA	  hypomethylation.	  Science	  (New	  York,	  N.Y	  
300,	  455	  (2003).	  89	   Li,	  J.	  et	  al.	  Genomic	  hypomethylation	  in	  the	  human	  germline	  associates	  with	  selective	  structural	  mutability	  in	  the	  human	  genome.	  PLoS	  genetics	  8,	  e1002692	  (2012).	  90	   Ramirez-­‐Carrozzi,	  V.	  R.	  et	  al.	  A	  unifying	  model	  for	  the	  selective	  regulation	  of	  inducible	  transcription	  by	  CpG	  islands	  and	  nucleosome	  remodeling.	  Cell	  
138,	  114-­‐128,	  doi:10.1016/j.cell.2009.04.020	  (2009).	  91	   Baubec,	  T.,	  Ivánek,	  R.,	  Lienert,	  F.	  &	  Schübeler,	  D.	  Methylation-­‐dependent	  and	  -­‐independent	  genomic	  targeting	  principles	  of	  the	  MBD	  protein	  family.	  
Cell	  153,	  480-­‐492,	  doi:10.1016/j.cell.2013.03.011	  (2013).	  
	  184	  
92	   Lewis,	  J.	  D.	  et	  al.	  Purification,	  sequence,	  and	  cellular	  localization	  of	  a	  novel	  chromosomal	  protein	  that	  binds	  to	  methylated	  DNA.	  Cell	  69,	  905-­‐914	  (1992).	  93	   Hu,	  S.	  et	  al.	  DNA	  methylation	  presents	  distinct	  binding	  sites	  for	  human	  transcription	  factors.	  Elife	  2,	  e00726,	  doi:10.7554/eLife.00726	  (2013).	  94	   Cicchetti,	  D.	  &	  Toth,	  S.	  L.	  Child	  maltreatment.	  Annu	  Rev	  Clin	  Psychol	  1,	  409-­‐438,	  doi:10.1146/annurev.clinpsy.1.102803.144029	  (2005).	  95	   Atladóttir,	  H.	  O.	  et	  al.	  Maternal	  infection	  requiring	  hospitalization	  during	  pregnancy	  and	  autism	  spectrum	  disorders.	  J	  Autism	  Dev	  Disord	  40,	  1423-­‐1430,	  doi:10.1007/s10803-­‐010-­‐1006-­‐y	  (2010).	  96	   Roth,	  T.	  L.,	  Lubin,	  F.	  D.,	  Funk,	  A.	  J.	  &	  Sweatt,	  J.	  D.	  Lasting	  epigenetic	  influence	  of	  early-­‐life	  adversity	  on	  the	  BDNF	  gene.	  Biol	  Psychiatry	  65,	  760-­‐769	  (2009).	  97	   McGowan,	  P.	  O.	  et	  al.	  Promoter-­‐wide	  hypermethylation	  of	  the	  ribosomal	  RNA	  gene	  promoter	  in	  the	  suicide	  brain.	  PLoS	  One	  3,	  e2085,	  doi:10.1371/journal.pone.0002085	  (2008).	  98	   Kaneda,	  M.	  et	  al.	  Essential	  role	  for	  de	  novo	  DNA	  methyltransferase	  Dnmt3a	  in	  paternal	  and	  maternal	  imprinting.	  Nature	  429,	  900-­‐903	  (2004).	  99	   Chen,	  J.,	  Kwon,	  C.	  H.,	  Lin,	  L.,	  Li,	  Y.	  &	  Parada,	  L.	  F.	  Inducible	  site-­‐specific	  recombination	  in	  neural	  stem/progenitor	  cells.	  Genesis	  47,	  122-­‐131	  (2009).	  100	   Matevossian,	  A.	  &	  Akbarian,	  S.	  Neuronal	  nuclei	  isolation	  from	  human	  postmortem	  brain	  tissue.	  J	  Vis	  Exp,	  doi:10.3791/914	  (2008).	  101	   Jiang,	  Y.,	  Matevossian,	  A.,	  Huang,	  H.	  S.,	  Straubhaar,	  J.	  &	  Akbarian,	  S.	  Isolation	  of	  neuronal	  chromatin	  from	  brain	  tissue.	  BMC	  Neurosci	  9,	  42	  (2008).	  102	   Akalin,	  A.	  et	  al.	  methylKit:	  a	  comprehensive	  R	  package	  for	  the	  analysis	  of	  genome-­‐wide	  DNA	  methylation	  profiles.	  Genome	  biology	  13,	  R87,	  doi:10.1186/gb-­‐2012-­‐13-­‐10-­‐r87	  (2012).	  103	   Seisenberger,	  S.	  et	  al.	  The	  dynamics	  of	  genome-­‐wide	  DNA	  methylation	  reprogramming	  in	  mouse	  primordial	  germ	  cells.	  Mol	  Cell	  48,	  849-­‐862,	  doi:10.1016/j.molcel.2012.11.001	  (2012).	  104	   Song,	  Q.	  et	  al.	  A	  reference	  methylome	  database	  and	  analysis	  pipeline	  to	  facilitate	  integrative	  and	  comparative	  epigenomics.	  PLoS	  One	  8,	  e81148,	  doi:10.1371/journal.pone.0081148	  (2013).	  105	   Kim,	  D.	  et	  al.	  TopHat2:	  accurate	  alignment	  of	  transcriptomes	  in	  the	  presence	  of	  insertions,	  deletions	  and	  gene	  fusions.	  Genome	  Biol	  14,	  R36,	  doi:10.1186/gb-­‐2013-­‐14-­‐4-­‐r36	  (2013).	  106	   Anders,	  S.,	  Pyl,	  P.	  T.	  &	  Huber,	  W.	  HTSeq-­‐-­‐a	  Python	  framework	  to	  work	  with	  high-­‐throughput	  sequencing	  data.	  Bioinformatics	  31,	  166-­‐169,	  doi:10.1093/bioinformatics/btu638	  (2015).	  107	   Robinson,	  M.	  D.,	  McCarthy,	  D.	  J.	  &	  Smyth,	  G.	  K.	  edgeR:	  a	  Bioconductor	  package	  for	  differential	  expression	  analysis	  of	  digital	  gene	  expression	  
	  185	  
data.	  Bioinformatics	  26,	  139-­‐140,	  doi:10.1093/bioinformatics/btp616	  (2010).	  108	   Gilbert,	  R.	  et	  al.	  Burden	  and	  consequences	  of	  child	  maltreatment	  in	  high-­‐income	  countries.	  Lancet	  373,	  68-­‐81	  (2009).	  109	   Green,	  J.	  G.	  et	  al.	  Childhood	  adversities	  and	  adult	  psychiatric	  disorders	  in	  the	  national	  comorbidity	  survey	  replication	  I:	  associations	  with	  first	  onset	  of	  DSM-­‐IV	  disorders.	  Arch	  Gen	  Psychiatry	  67,	  113-­‐123	  (2010).	  110	   Chen,	  G.	  H.	  et	  al.	  Acceleration	  of	  age-­‐related	  learning	  and	  memory	  decline	  in	  middle-­‐aged	  CD-­‐1	  mice	  due	  to	  maternal	  exposure	  to	  lipopolysaccharide	  during	  late	  pregnancy.	  Behavioural	  brain	  research	  218,	  267-­‐279,	  doi:10.1016/j.bbr.2010.11.001	  (2011).	  111	   Veenema,	  A.	  H.,	  Reber,	  S.	  O.,	  Selch,	  S.,	  Obermeier,	  F.	  &	  Neumann,	  I.	  D.	  Early	  life	  stress	  enhances	  the	  vulnerability	  to	  chronic	  psychosocial	  stress	  and	  experimental	  colitis	  in	  adult	  mice.	  Endocrinology	  149,	  2727-­‐2736,	  doi:10.1210/en.2007-­‐1469	  (2008).	  112	   Millstein,	  R.	  A.	  &	  Holmes,	  A.	  Effects	  of	  repeated	  maternal	  separation	  on	  anxiety-­‐	  and	  depression-­‐related	  phenotypes	  in	  different	  mouse	  strains.	  
Neurosci	  Biobehav	  Rev	  31,	  3-­‐17	  (2007).	  113	   Priebe,	  K.	  et	  al.	  Maternal	  influences	  on	  adult	  stress	  and	  anxiety-­‐like	  behavior	  in	  C57BL/6J	  and	  BALB/cJ	  mice:	  a	  cross-­‐fostering	  study.	  Dev	  
Psychobiol	  47,	  398-­‐407	  (2005).	  114	   van	  Velzen,	  A.	  &	  Toth,	  M.	  Role	  of	  maternal	  5-­‐HT(1A)	  receptor	  in	  programming	  offspring	  emotional	  and	  physical	  development.	  Genes	  Brain	  
Behav	  9,	  877-­‐885	  (2010).	  115	   Gleason,	  G.,	  Zupan,	  B.	  &	  Toth,	  M.	  Maternal	  genetic	  mutations	  as	  gestational	  and	  early	  life	  influences	  in	  producing	  psychiatric	  disease-­‐like	  phenotypes	  in	  mice.	  Frontiers	  in	  psychiatry	  /	  Frontiers	  Research	  Foundation	  2,	  25	  (2011).	  116	   Zoghbi,	  H.	  Y.	  &	  Warren,	  S.	  T.	  Neurogenetics:	  advancing	  the	  "next-­‐generation"	  of	  brain	  research.	  Neuron	  68,	  165-­‐173	  (2010).	  117	   Meaney,	  M.	  J.	  Maternal	  care,	  gene	  expression,	  and	  the	  transmission	  of	  individual	  differences	  in	  stress	  reactivity	  across	  generations.	  Annu	  Rev	  
Neurosci	  24,	  1161-­‐1192	  (2001).	  118	   Bannerman,	  D.	  M.	  et	  al.	  Regional	  dissociations	  within	  the	  hippocampus-­‐-­‐memory	  and	  anxiety.	  Neurosci	  Biobehav	  Rev	  28,	  273-­‐283	  (2004).	  119	   Kjelstrup,	  K.	  G.	  et	  al.	  Reduced	  fear	  expression	  after	  lesions	  of	  the	  ventral	  hippocampus.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  99,	  10825-­‐10830	  (2002).	  120	   Adhikari,	  A.,	  Topiwala,	  M.	  A.	  &	  Gordon,	  J.	  A.	  Synchronized	  activity	  between	  the	  ventral	  hippocampus	  and	  the	  medial	  prefrontal	  cortex	  during	  anxiety.	  
Neuron	  65,	  257-­‐269	  (2010).	  121	   Ishikawa,	  A.	  &	  Nakamura,	  S.	  Ventral	  hippocampal	  neurons	  project	  axons	  simultaneously	  to	  the	  medial	  prefrontal	  cortex	  and	  amygdala	  in	  the	  rat.	  J	  
Neurophysiol	  96,	  2134-­‐2138	  (2006).	  
	  186	  
122	   Elliott,	  E.,	  Ezra-­‐Nevo,	  G.,	  Regev,	  L.,	  Neufeld-­‐Cohen,	  A.	  &	  Chen,	  A.	  Resilience	  to	  social	  stress	  coincides	  with	  functional	  DNA	  methylation	  of	  the	  Crf	  gene	  in	  adult	  mice.	  Nat	  Neurosci	  13,	  1351-­‐1353	  (2010).	  123	   Oberlander,	  T.	  F.	  et	  al.	  Prenatal	  exposure	  to	  maternal	  depression,	  neonatal	  methylation	  of	  human	  glucocorticoid	  receptor	  gene	  (NR3C1)	  and	  infant	  cortisol	  stress	  responses.	  Epigenetics	  3,	  97-­‐106	  (2008).	  124	   Zhang,	  T.	  Y.	  et	  al.	  Maternal	  care	  and	  DNA	  methylation	  of	  a	  glutamic	  acid	  decarboxylase	  1	  promoter	  in	  rat	  hippocampus.	  J	  Neurosci	  30,	  13130-­‐13137	  (2010).	  125	   McGowan,	  P.	  O.	  et	  al.	  Epigenetic	  regulation	  of	  the	  glucocorticoid	  receptor	  in	  human	  brain	  associates	  with	  childhood	  abuse.	  Nat	  Neurosci	  12,	  342-­‐348	  (2009).	  126	   Guo,	  J.	  U.	  et	  al.	  Neuronal	  activity	  modifies	  the	  DNA	  methylation	  landscape	  in	  the	  adult	  brain.	  Nat	  Neurosci	  14,	  1345-­‐1351	  (2011).	  127	   Rollins,	  R.	  A.	  et	  al.	  Large-­‐scale	  structure	  of	  genomic	  methylation	  patterns.	  
Genome	  research	  16,	  157-­‐163	  (2006).	  128	   Khulan,	  B.	  et	  al.	  Comparative	  isoschizomer	  profiling	  of	  cytosine	  methylation:	  the	  HELP	  assay.	  Genome	  Res	  16,	  1046-­‐1055	  (2006).	  129	   Meissner,	  A.	  et	  al.	  Genome-­‐scale	  DNA	  methylation	  maps	  of	  pluripotent	  and	  differentiated	  cells.	  Nature	  454,	  766-­‐770	  (2008).	  130	   Gu,	  H.	  et	  al.	  Preparation	  of	  reduced	  representation	  bisulfite	  sequencing	  libraries	  for	  genome-­‐scale	  DNA	  methylation	  profiling.	  Nature	  protocols	  6,	  468-­‐481	  (2011).	  131	   Irizarry,	  R.	  A.	  et	  al.	  The	  human	  colon	  cancer	  methylome	  shows	  similar	  hypo-­‐	  and	  hypermethylation	  at	  conserved	  tissue-­‐specific	  CpG	  island	  shores.	  Nature	  genetics	  41,	  178-­‐186	  (2009).	  132	   Giannopoulou,	  E.	  G.	  &	  Elemento,	  O.	  An	  integrated	  ChIP-­‐seq	  analysis	  platform	  with	  customizable	  workflows.	  BMC	  bioinformatics	  12,	  277	  (2011).	  133	   Muramatsu,	  R.,	  Ikegaya,	  Y.,	  Matsuki,	  N.	  &	  Koyama,	  R.	  Neonatally	  born	  granule	  cells	  numerically	  dominate	  adult	  mice	  dentate	  gyrus.	  Neuroscience	  
148,	  593-­‐598	  (2007).	  134	   Wood,	  S.	  J.	  &	  Toth,	  M.	  Molecular	  pathways	  of	  anxiety	  revealed	  by	  knockout	  mice.	  Molecular	  neurobiology	  23,	  101-­‐119	  (2001).	  135	   Charil,	  A.,	  Laplante,	  D.	  P.,	  Vaillancourt,	  C.	  &	  King,	  S.	  Prenatal	  stress	  and	  brain	  development.	  Brain	  research	  reviews	  65,	  56-­‐79	  (2010).	  136	   Phillips,	  N.	  K.,	  Hammen,	  C.	  L.,	  Brennan,	  P.	  A.,	  Najman,	  J.	  M.	  &	  Bor,	  W.	  Early	  adversity	  and	  the	  prospective	  prediction	  of	  depressive	  and	  anxiety	  disorders	  in	  adolescents.	  J	  Abnorm	  Child	  Psychol	  33,	  13-­‐24	  (2005).	  137	   Nemeroff,	  C.	  B.	  Early-­‐Life	  Adversity,	  CRF	  Dysregulation,	  and	  Vulnerability	  to	  Mood	  and	  Anxiety	  Disorders.	  Psychopharmacol	  Bull	  38	  Suppl	  1,	  14-­‐20	  (2004).	  138	   McEwen,	  B.	  S.	  Stress	  and	  hippocampal	  plasticity.	  Annu	  Rev	  Neurosci	  22,	  105-­‐122	  (1999).	  
	  187	  
139	   Hodges,	  E.	  et	  al.	  Directional	  DNA	  methylation	  changes	  and	  complex	  intermediate	  states	  accompany	  lineage	  specificity	  in	  the	  adult	  hematopoietic	  compartment.	  Molecular	  cell	  44,	  17-­‐28	  (2011).	  140	   Niehrs,	  C.	  &	  Schafer,	  A.	  Active	  DNA	  demethylation	  by	  Gadd45	  and	  DNA	  repair.	  Trends	  in	  cell	  biology	  22,	  220-­‐227	  (2012).	  141	   Sutton,	  R.	  E.,	  Koob,	  G.	  F.,	  Le	  Moal,	  M.,	  Rivier,	  J.	  &	  Vale,	  W.	  Corticotropin	  releasing	  factor	  produces	  behavioural	  activation	  in	  rats.	  Nature	  297,	  331-­‐333	  (1982).	  142	   Smith,	  G.	  W.	  et	  al.	  Corticotropin	  releasing	  factor	  receptor	  1-­‐deficient	  mice	  display	  decreased	  anxiety,	  impaired	  stress	  response,	  and	  aberrant	  neuroendocrine	  development.	  Neuron	  20,	  1093-­‐1102	  (1998).	  143	   Timpl,	  P.	  et	  al.	  Impaired	  stress	  response	  and	  reduced	  anxiety	  in	  mice	  lacking	  a	  functional	  corticotropin-­‐releasing	  hormone	  receptor	  1.	  Nature	  
genetics	  19,	  162-­‐166	  (1998).	  144	   Accili,	  D.	  et	  al.	  A	  targeted	  mutation	  of	  the	  D3	  dopamine	  receptor	  gene	  is	  associated	  with	  hyperactivity	  in	  mice.	  Proceedings	  of	  the	  National	  Academy	  
of	  Sciences	  of	  the	  United	  States	  of	  America	  93,	  1945-­‐1949	  (1996).	  145	   Ledent,	  C.	  et	  al.	  Aggressiveness,	  hypoalgesia	  and	  high	  blood	  pressure	  in	  mice	  lacking	  the	  adenosine	  A2a	  receptor.	  Nature	  388,	  674-­‐678	  (1997).	  146	   Ross,	  S.	  A.	  et	  al.	  Phenotypic	  characterization	  of	  an	  alpha	  4	  neuronal	  nicotinic	  acetylcholine	  receptor	  subunit	  knock-­‐out	  mouse.	  J	  Neurosci	  20,	  6431-­‐6441	  (2000).	  147	   Schlegel,	  S.	  et	  al.	  Decreased	  benzodiazepine	  receptor	  binding	  in	  panic	  disorder	  measured	  by	  IOMAZENIL-­‐SPECT.	  A	  preliminary	  report.	  European	  
archives	  of	  psychiatry	  and	  clinical	  neuroscience	  244,	  49-­‐51	  (1994).	  148	   Kaschka,	  W.,	  Feistel,	  H.	  &	  Ebert,	  D.	  Reduced	  benzodiazepine	  receptor	  binding	  in	  panic	  disorders	  measured	  by	  iomazenil	  SPECT.	  Journal	  of	  
psychiatric	  research	  29,	  427-­‐434	  (1995).	  149	   Tiihonen,	  J.	  et	  al.	  Cerebral	  benzodiazepine	  receptor	  binding	  and	  distribution	  in	  generalized	  anxiety	  disorder:	  a	  fractal	  analysis.	  Molecular	  
psychiatry	  2,	  463-­‐471	  (1997).	  150	   Mombereau,	  C.	  et	  al.	  Altered	  anxiety	  and	  depression-­‐related	  behaviour	  in	  mice	  lacking	  GABAB(2)	  receptor	  subunits.	  Neuroreport	  16,	  307-­‐310	  (2005).	  151	   Barkus,	  C.	  et	  al.	  Hippocampal	  NMDA	  receptors	  and	  anxiety:	  at	  the	  interface	  between	  cognition	  and	  emotion.	  Eur	  J	  Pharmacol	  626,	  49-­‐56	  (2010).	  152	   Lee,	  A.	  S.	  et	  al.	  Forebrain	  elimination	  of	  cacna1c	  mediates	  anxiety-­‐like	  behavior	  in	  mice.	  Mol	  Psychiatry	  (2012).	  153	   Dong,	  Y.	  et	  al.	  CREB	  modulates	  excitability	  of	  nucleus	  accumbens	  neurons.	  
Nature	  neuroscience	  9,	  475-­‐477	  (2006).	  154	   Catches,	  J.	  S.,	  Xu,	  J.	  &	  Contractor,	  A.	  Genetic	  ablation	  of	  the	  GluK4	  kainate	  receptor	  subunit	  causes	  anxiolytic	  and	  antidepressant-­‐like	  behavior	  in	  mice.	  Behavioural	  brain	  research	  228,	  406-­‐414	  (2012).	  155	   Szatmari,	  P.	  et	  al.	  Mapping	  autism	  risk	  loci	  using	  genetic	  linkage	  and	  chromosomal	  rearrangements.	  Nature	  genetics	  39,	  319-­‐328	  (2007).	  
	  188	  
156	   Kim,	  H.	  G.	  et	  al.	  Disruption	  of	  neurexin	  1	  associated	  with	  autism	  spectrum	  disorder.	  American	  journal	  of	  human	  genetics	  82,	  199-­‐207	  (2008).	  157	   Morrow,	  E.	  M.	  et	  al.	  Identifying	  autism	  loci	  and	  genes	  by	  tracing	  recent	  shared	  ancestry.	  Science	  (New	  York,	  N.Y	  321,	  218-­‐223	  (2008).	  158	   Wang,	  K.	  et	  al.	  Common	  genetic	  variants	  on	  5p14.1	  associate	  with	  autism	  spectrum	  disorders.	  Nature	  459,	  528-­‐533	  (2009).	  159	   Wisniowiecka-­‐Kowalnik,	  B.	  et	  al.	  Intragenic	  rearrangements	  in	  NRXN1	  in	  three	  families	  with	  autism	  spectrum	  disorder,	  developmental	  delay,	  and	  speech	  delay.	  Am	  J	  Med	  Genet	  B	  Neuropsychiatr	  Genet	  153B,	  983-­‐993	  (2010).	  160	   Attwood,	  B.	  K.	  et	  al.	  Neuropsin	  cleaves	  EphB2	  in	  the	  amygdala	  to	  control	  anxiety.	  Nature	  473,	  372-­‐375	  (2011).	  161	   Figueroa,	  M.	  E.,	  Melnick,	  A.	  &	  Greally,	  J.	  M.	  Genome-­‐wide	  determination	  of	  DNA	  methylation	  by	  Hpa	  II	  tiny	  fragment	  enrichment	  by	  ligation-­‐mediated	  PCR	  (HELP)	  for	  the	  study	  of	  acute	  leukemias.	  Methods	  Mol	  Biol	  538,	  395-­‐407	  (2009).	  162	   Figueroa,	  M.	  E.	  et	  al.	  An	  integrative	  genomic	  and	  epigenomic	  approach	  for	  the	  study	  of	  transcriptional	  regulation.	  PLoS	  ONE	  3,	  e1882	  (2008).	  163	   Thompson,	  R.	  F.	  et	  al.	  An	  analytical	  pipeline	  for	  genomic	  representations	  used	  for	  cytosine	  methylation	  studies.	  Bioinformatics	  (Oxford,	  England)	  
24,	  1161-­‐1167	  (2008).	  164	   Ehrich,	  M.	  et	  al.	  Quantitative	  high-­‐throughput	  analysis	  of	  DNA	  methylation	  patterns	  by	  base-­‐specific	  cleavage	  and	  mass	  spectrometry.	  Proceedings	  of	  
the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  102,	  15785-­‐15790	  (2005).	  165	   Gu,	  H.	  et	  al.	  Genome-­‐scale	  DNA	  methylation	  mapping	  of	  clinical	  samples	  at	  single-­‐nucleotide	  resolution.	  Nature	  methods	  7,	  133-­‐136	  (2010).	  166	   Li,	  H.	  &	  Durbin,	  R.	  Fast	  and	  accurate	  short	  read	  alignment	  with	  Burrows-­‐Wheeler	  transform.	  Bioinformatics	  25,	  1754-­‐1760	  (2009).	  167	   Bohacek,	  J.,	  Gapp,	  K.,	  Saab,	  B.	  J.	  &	  Mansuy,	  I.	  M.	  Transgenerational	  epigenetic	  effects	  on	  brain	  functions.	  Biol	  Psychiatry	  73,	  313-­‐320,	  doi:10.1016/j.biopsych.2012.08.019	  (2013).	  168	   Dias,	  B.	  G.	  &	  Ressler,	  K.	  J.	  Parental	  olfactory	  experience	  influences	  behavior	  and	  neural	  structure	  in	  subsequent	  generations.	  Nat	  Neurosci,	  doi:10.1038/nn.3594	  (2013).	  169	   Petropoulos,	  S.,	  Matthews,	  S.	  G.	  &	  Szyf,	  M.	  Adult	  glucocorticoid	  exposure	  leads	  to	  transcriptional	  and	  DNA	  methylation	  changes	  in	  nuclear	  steroid	  receptors	  in	  the	  hippocampus	  and	  kidney	  of	  mouse	  male	  offspring.	  Biol	  
Reprod	  90,	  43,	  doi:10.1095/biolreprod.113.115899	  (2014).	  170	   Yehuda,	  R.	  et	  al.	  Influences	  of	  maternal	  and	  paternal	  PTSD	  on	  epigenetic	  regulation	  of	  the	  glucocorticoid	  receptor	  gene	  in	  Holocaust	  survivor	  offspring.	  Am	  J	  Psychiatry	  171,	  872-­‐880,	  doi:10.1176/appi.ajp.2014.13121571	  (2014).	  
	  189	  
171	   Scharf,	  M.	  Long-­‐term	  effects	  of	  trauma:	  psychosocial	  functioning	  of	  the	  second	  and	  third	  generation	  of	  Holocaust	  survivors.	  Development	  and	  
psychopathology	  19,	  603-­‐622	  (2007).	  172	   Sigal,	  J.	  J.,	  DiNicola,	  V.	  F.	  &	  Buonvino,	  M.	  Grandchildren	  of	  survivors:	  can	  negative	  effects	  of	  prolonged	  exposure	  to	  excessive	  stress	  be	  observed	  two	  generations	  later?	  Canadian	  journal	  of	  psychiatry	  33,	  207-­‐212	  (1988).	  173	   Brown,	  A.	  S.	  et	  al.	  Elevated	  maternal	  interleukin-­‐8	  levels	  and	  risk	  of	  schizophrenia	  in	  adult	  offspring.	  Am	  J	  Psychiatry	  161,	  889-­‐895	  (2004).	  174	   Halmoy,	  A.	  et	  al.	  Attention-­‐deficit/hyperactivity	  disorder	  symptoms	  in	  offspring	  of	  mothers	  with	  impaired	  serotonin	  production.	  Arch	  Gen	  
Psychiatry	  67,	  1033-­‐1043	  (2011).	  175	   Liu,	  D.	  et	  al.	  Maternal	  care,	  hippocampal	  glucocorticoid	  receptors,	  and	  hypothalamic-­‐pituitary-­‐adrenal	  responses	  to	  stress.	  Science	  277,	  1659-­‐1662	  (1997).	  176	   Owen,	  D.,	  Andrews,	  M.	  H.	  &	  Matthews,	  S.	  G.	  Maternal	  adversity,	  glucocorticoids	  and	  programming	  of	  neuroendocrine	  function	  and	  behaviour.	  Neuroscience	  and	  biobehavioral	  reviews	  29,	  209-­‐226,	  doi:10.1016/j.neubiorev.2004.10.004	  (2005).	  177	   Smith,	  S.	  E.,	  Li,	  J.,	  Garbett,	  K.,	  Mirnics,	  K.	  &	  Patterson,	  P.	  H.	  Maternal	  immune	  activation	  alters	  fetal	  brain	  development	  through	  interleukin-­‐6.	  J	  
Neurosci	  27,	  10695-­‐10702,	  doi:10.1523/JNEUROSCI.2178-­‐07.2007	  (2007).	  178	   Padmanabhan,	  N.	  et	  al.	  Mutation	  in	  folate	  metabolism	  causes	  epigenetic	  instability	  and	  transgenerational	  effects	  on	  development.	  Cell	  155,	  81-­‐93,	  doi:10.1016/j.cell.2013.09.002	  (2013).	  179	   Casey,	  B.	  J.	  et	  al.	  DSM-­‐5	  and	  RDoC:	  progress	  in	  psychiatry	  research?	  Nat	  
Rev	  Neurosci	  14,	  810-­‐814,	  doi:10.1038/nrn3621	  (2013).	  180	   Kaati,	  G.,	  Bygren,	  L.	  O.	  &	  Edvinsson,	  S.	  Cardiovascular	  and	  diabetes	  mortality	  determined	  by	  nutrition	  during	  parents'	  and	  grandparents'	  slow	  growth	  period.	  Eur	  J	  Hum	  Genet	  10,	  682-­‐688	  (2002).	  181	   Martin,	  K.	  F.,	  Phillips,	  I.,	  Hearson,	  M.,	  Prow,	  M.	  R.	  &	  Heal,	  D.	  J.	  Characterization	  of	  8-­‐OH-­‐DPAT-­‐induced	  hypothermia	  in	  mice	  as	  a	  5-­‐HT1A	  autoreceptor	  response	  and	  its	  evaluation	  as	  a	  model	  to	  selectively	  identify	  antidepressants.	  Br	  J	  Pharmacol	  107,	  15-­‐21	  (1992).	  182	   Drevets,	  W.	  C.	  et	  al.	  Serotonin-­‐1A	  receptor	  imaging	  in	  recurrent	  depression:	  replication	  and	  literature	  review.	  Nucl	  Med	  Biol	  34,	  865-­‐877	  (2007).	  183	   Merlot,	  E.,	  Couret,	  D.	  &	  Otten,	  W.	  Prenatal	  stress,	  fetal	  imprinting	  and	  immunity.	  Brain	  Behav	  Immun	  22,	  42-­‐51,	  doi:10.1016/j.bbi.2007.05.007	  (2008).	  184	   Malkova,	  N.	  V.,	  Yu,	  C.	  Z.,	  Hsiao,	  E.	  Y.,	  Moore,	  M.	  J.	  &	  Patterson,	  P.	  H.	  Maternal	  immune	  activation	  yields	  offspring	  displaying	  mouse	  versions	  of	  the	  three	  core	  symptoms	  of	  autism.	  Brain	  Behav	  Immun	  26,	  607-­‐616	  (2012).	  185	   Wohleb,	  E.	  S.,	  Powell,	  N.	  D.,	  Godbout,	  J.	  P.	  &	  Sheridan,	  J.	  F.	  Stress-­‐induced	  recruitment	  of	  bone	  marrow-­‐derived	  monocytes	  to	  the	  brain	  promotes	  
	  190	  
anxiety-­‐like	  behavior.	  J	  Neurosci	  33,	  13820-­‐13833,	  doi:10.1523/JNEUROSCI.1671-­‐13.2013	  (2013).	  186	   Kheirbek,	  M.	  A.	  et	  al.	  Differential	  control	  of	  learning	  and	  anxiety	  along	  the	  dorsoventral	  axis	  of	  the	  dentate	  gyrus.	  Neuron	  77,	  955-­‐968	  (2013).	  187	   Mühle,	  C.,	  Reichel,	  M.,	  Gulbins,	  E.	  &	  Kornhuber,	  J.	  Sphingolipids	  in	  psychiatric	  disorders	  and	  pain	  syndromes.	  Handb	  Exp	  Pharmacol,	  431-­‐456,	  doi:10.1007/978-­‐3-­‐7091-­‐1511-­‐4_22	  (2013).	  188	   Bennett,	  C.	  N.	  &	  Horrobin,	  D.	  F.	  Gene	  targets	  related	  to	  phospholipid	  and	  fatty	  acid	  metabolism	  in	  schizophrenia	  and	  other	  psychiatric	  disorders:	  an	  update.	  Prostaglandins	  Leukot	  Essent	  Fatty	  Acids	  63,	  47-­‐59,	  doi:10.1054/plef.2000.0191	  (2000).	  189	   Ammar,	  M.	  R.,	  Kassas,	  N.,	  Bader,	  M.	  F.	  &	  Vitale,	  N.	  Phosphatidic	  acid	  in	  neuronal	  development:	  a	  node	  for	  membrane	  and	  cytoskeleton	  rearrangements.	  Biochimie	  107	  Pt	  A,	  51-­‐57,	  doi:10.1016/j.biochi.2014.07.026	  (2014).	  190	   Consortium,	  E.	  P.	  An	  integrated	  encyclopedia	  of	  DNA	  elements	  in	  the	  human	  genome.	  Nature	  489,	  57-­‐74,	  doi:10.1038/nature11247	  (2012).	  191	   Wojtasz,	  L.,	  Daniel,	  K.	  &	  Toth,	  A.	  Fluorescence	  activated	  cell	  sorting	  of	  live	  female	  germ	  cells	  and	  somatic	  cells	  of	  the	  mouse	  fetal	  gonad	  based	  on	  forward	  and	  side	  scattering.	  Cytometry	  A	  75,	  547-­‐553,	  doi:10.1002/cyto.a.20729	  (2009).	  192	   Ferguson-­‐Smith,	  A.	  C.	  Genomic	  imprinting:	  the	  emergence	  of	  an	  epigenetic	  paradigm.	  Nat	  Rev	  Genet	  12,	  565-­‐575	  (2011).	  193	   Rodgers,	  A.	  B.	  &	  Bale,	  T.	  L.	  Germ	  Cell	  Origins	  of	  Posttraumatic	  Stress	  Disorder	  Risk:	  The	  Transgenerational	  Impact	  of	  Parental	  Stress	  Experience.	  Biol	  Psychiatry	  78,	  307-­‐314,	  doi:10.1016/j.biopsych.2015.03.018	  (2015).	  194	   Rivera,	  R.	  M.	  et	  al.	  Manipulations	  of	  mouse	  embryos	  prior	  to	  implantation	  result	  in	  aberrant	  expression	  of	  imprinted	  genes	  on	  day	  9.5	  of	  development.	  Hum	  Mol	  Genet	  17,	  1-­‐14,	  doi:10.1093/hmg/ddm280	  (2008).	  195	   Clapcote,	  S.	  J.	  et	  al.	  Behavioral	  phenotypes	  of	  Disc1	  missense	  mutations	  in	  mice.	  Neuron	  54,	  387-­‐402,	  doi:10.1016/j.neuron.2007.04.015	  (2007).	  196	   Clapcote,	  S.	  J.	  &	  Roder,	  J.	  C.	  Survey	  of	  embryonic	  stem	  cell	  line	  source	  strains	  in	  the	  water	  maze	  reveals	  superior	  reversal	  learning	  of	  129S6/SvEvTac	  mice.	  Behav	  Brain	  Res	  152,	  35-­‐48	  (2004).	  197	   Danchin,	  E.	  et	  al.	  Beyond	  DNA:	  integrating	  inclusive	  inheritance	  into	  an	  extended	  theory	  of	  evolution.	  Nat	  Rev	  Genet	  12,	  475-­‐486	  (2011).	  198	   Manolio,	  T.	  A.	  et	  al.	  Finding	  the	  missing	  heritability	  of	  complex	  diseases.	  
Nature	  461,	  747-­‐753	  (2009).	  199	   Stearns,	  F.	  W.	  One	  hundred	  years	  of	  pleiotropy:	  a	  retrospective.	  Genetics	  
186,	  767-­‐773,	  doi:10.1534/genetics.110.122549	  (2010).	  200	   Consortium,	  C.-­‐D.	  G.	  o.	  t.	  P.	  G.	  Identification	  of	  risk	  loci	  with	  shared	  effects	  on	  five	  major	  psychiatric	  disorders:	  a	  genome-­‐wide	  analysis.	  Lancet	  381,	  1371-­‐1379,	  doi:10.1016/S0140-­‐6736(12)62129-­‐1	  (2013).	  
	  191	  
201	   Hsiao,	  E.	  Y.,	  McBride,	  S.	  W.,	  Chow,	  J.,	  Mazmanian,	  S.	  K.	  &	  Patterson,	  P.	  H.	  Modeling	  an	  autism	  risk	  factor	  in	  mice	  leads	  to	  permanent	  immune	  dysregulation.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  109,	  12776-­‐12781,	  doi:10.1073/pnas.1202556109	  (2012).	  202	   Meyer,	  U.	  et	  al.	  Relative	  prenatal	  and	  postnatal	  maternal	  contributions	  to	  schizophrenia-­‐related	  neurochemical	  dysfunction	  after	  in	  utero	  immune	  challenge.	  Neuropsychopharmacology	  33,	  441-­‐456,	  doi:10.1038/sj.npp.1301413	  (2008).	  203	   Beumer,	  W.	  et	  al.	  The	  immune	  theory	  of	  psychiatric	  diseases:	  a	  key	  role	  for	  activated	  microglia	  and	  circulating	  monocytes.	  J	  Leukoc	  Biol	  92,	  959-­‐975,	  doi:10.1189/jlb.0212100	  (2012).	  204	   Köberlin,	  M.	  S.	  et	  al.	  A	  Conserved	  Circular	  Network	  of	  Coregulated	  Lipids	  Modulates	  Innate	  Immune	  Responses.	  Cell	  162,	  170-­‐183,	  doi:10.1016/j.cell.2015.05.051	  (2015).	  205	   Rodgers,	  A.	  B.,	  Morgan,	  C.	  P.,	  Bronson,	  S.	  L.,	  Revello,	  S.	  &	  Bale,	  T.	  L.	  Paternal	  stress	  exposure	  alters	  sperm	  microRNA	  content	  and	  reprograms	  offspring	  HPA	  stress	  axis	  regulation.	  J	  Neurosci	  33,	  9003-­‐9012,	  doi:10.1523/JNEUROSCI.0914-­‐13.2013	  (2013).	  206	   Kaiser,	  T.	  &	  Feng,	  G.	  Modeling	  psychiatric	  disorders	  for	  developing	  effective	  treatments.	  Nat	  Med	  21,	  979-­‐988,	  doi:10.1038/nm.3935	  (2015).	  207	   Parks,	  C.	  L.,	  Robinson,	  P.	  S.,	  Sibille,	  E.,	  Shenk,	  T.	  &	  Toth,	  M.	  Increased	  anxiety	  of	  mice	  lacking	  the	  serotonin1A	  receptor.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  
95,	  10734-­‐10739	  (1998).	  208	   Porsolt,	  R.	  D.,	  Anton,	  G.,	  Blavet,	  N.	  &	  Jalfre,	  M.	  Behavioural	  despair	  in	  rats:	  a	  new	  model	  sensitive	  to	  antidepressant	  treatments.	  Eur	  J	  Pharmacol	  47,	  379-­‐391	  (1978).	  209	   Bortolozzi,	  A.	  et	  al.	  Selective	  siRNA-­‐mediated	  suppression	  of	  5-­‐HT1A	  autoreceptors	  evokes	  strong	  anti-­‐depressant-­‐like	  effects.	  Mol	  Psychiatry	  
17,	  612-­‐623,	  doi:10.1038/mp.2011.92	  (2012).	  210	   Toyooka,	  Y.	  et	  al.	  Expression	  and	  intracellular	  localization	  of	  mouse	  Vasa-­‐homologue	  protein	  during	  germ	  cell	  development.	  Mech	  Dev	  93,	  139-­‐149	  (2000).	  211	   Chen,	  Q.	  et	  al.	  Untargeted	  plasma	  metabolite	  profiling	  reveals	  the	  broad	  systemic	  consequences	  of	  xanthine	  oxidoreductase	  inactivation	  in	  mice.	  
PLoS	  One	  7,	  e37149,	  doi:10.1371/journal.pone.0037149	  (2012).	  212	   Ismailoglu,	  I.	  et	  al.	  Huntingtin	  protein	  is	  essential	  for	  mitochondrial	  metabolism,	  bioenergetics	  and	  structure	  in	  murine	  embryonic	  stem	  cells.	  
Developmental	  biology	  391,	  230-­‐240,	  doi:10.1016/j.ydbio.2014.04.005	  (2014).	  213	   Chan,	  R.	  B.	  et	  al.	  Comparative	  lipidomic	  analysis	  of	  mouse	  and	  human	  brain	  with	  Alzheimer	  disease.	  J	  Biol	  Chem	  287,	  2678-­‐2688,	  doi:10.1074/jbc.M111.274142	  (2012).	  214	   Dumont,	  M.	  et	  al.	  Bezafibrate	  administration	  improves	  behavioral	  deficits	  and	  tau	  pathology	  in	  P301S	  mice.	  Hum	  Mol	  Genet	  21,	  5091-­‐5105,	  doi:10.1093/hmg/dds355	  (2012).	  
	  192	  
215	   Weinstock,	  M.	  The	  potential	  influence	  of	  maternal	  stress	  hormones	  on	  development	  and	  mental	  health	  of	  the	  offspring.	  Brain,	  behavior,	  and	  
immunity	  19,	  296-­‐308	  (2005).	  216	   Humphreys,	  K.	  L.	  &	  Zeanah,	  C.	  H.	  Deviations	  from	  the	  expectable	  environment	  in	  early	  childhood	  and	  emerging	  psychopathology.	  
Neuropsychopharmacology	  :	  official	  publication	  of	  the	  American	  College	  of	  
Neuropsychopharmacology	  40,	  154-­‐170	  (2015).	  217	   Moses-­‐Kolko,	  E.	  L.	  et	  al.	  Serotonin	  1A	  receptor	  reductions	  in	  postpartum	  depression:	  a	  positron	  emission	  tomography	  study.	  Fertil	  Steril	  89,	  685-­‐692	  (2008).	  218	   Neumeister,	  A.	  et	  al.	  Reduced	  serotonin	  type	  1A	  receptor	  binding	  in	  panic	  disorder.	  J	  Neurosci	  24,	  589-­‐591	  (2004).	  219	   Savitz,	  J.,	  Lucki,	  I.	  &	  Drevets,	  W.	  C.	  5-­‐HT(1A)	  receptor	  function	  in	  major	  depressive	  disorder.	  Progress	  in	  neurobiology	  88,	  17-­‐31	  (2009).	  220	   Toth,	  M.	  5-­‐HT1A	  receptor	  knockout	  mouse	  as	  a	  genetic	  model	  of	  anxiety.	  
Eur	  J	  Pharmacol	  463,	  177-­‐184	  (2003).	  221	   Enayati,	  M.	  et	  al.	  Maternal	  infection	  during	  late	  pregnancy	  increases	  anxiety-­‐	  and	  depression-­‐like	  behaviors	  with	  increasing	  age	  in	  male	  offspring.	  Brain	  research	  bulletin	  87,	  295-­‐302	  (2012).	  222	   Guha,	  M.	  et	  al.	  Lipopolysaccharide	  activation	  of	  the	  MEK-­‐ERK1/2	  pathway	  in	  human	  monocytic	  cells	  mediates	  tissue	  factor	  and	  tumor	  necrosis	  factor	  alpha	  expression	  by	  inducing	  Elk-­‐1	  phosphorylation	  and	  Egr-­‐1	  expression.	  
Blood	  98,	  1429-­‐1439	  (2001).	  223	   Girard,	  S.,	  Tremblay,	  L.,	  Lepage,	  M.	  &	  Sebire,	  G.	  IL-­‐1	  receptor	  antagonist	  protects	  against	  placental	  and	  neurodevelopmental	  defects	  induced	  by	  maternal	  inflammation.	  J	  Immunol	  184,	  3997-­‐4005	  (2010).	  224	   Olsavsky,	  A.	  K.	  et	  al.	  Indiscriminate	  amygdala	  response	  to	  mothers	  and	  strangers	  after	  early	  maternal	  deprivation.	  Biological	  psychiatry	  74,	  853-­‐860	  (2013).	  225	   Chugani,	  H.	  T.	  et	  al.	  Local	  brain	  functional	  activity	  following	  early	  deprivation:	  a	  study	  of	  postinstitutionalized	  Romanian	  orphans.	  
NeuroImage	  14,	  1290-­‐1301	  (2001).	  226	   Laudenslager,	  M.	  L.,	  Reite,	  M.	  &	  Harbeck,	  R.	  J.	  Suppressed	  immune	  response	  in	  infant	  monkeys	  associated	  with	  maternal	  separation.	  
Behavioral	  and	  neural	  biology	  36,	  40-­‐48	  (1982).	  227	   Romeo,	  R.	  D.	  et	  al.	  Anxiety	  and	  fear	  behaviors	  in	  adult	  male	  and	  female	  C57BL/6	  mice	  are	  modulated	  by	  maternal	  separation.	  Hormones	  and	  
behavior	  43,	  561-­‐567	  (2003).	  228	   Beydoun,	  H.	  &	  Saftlas,	  A.	  F.	  Physical	  and	  mental	  health	  outcomes	  of	  prenatal	  maternal	  stress	  in	  human	  and	  animal	  studies:	  a	  review	  of	  recent	  evidence.	  Paediatr	  Perinat	  Epidemiol	  22,	  438-­‐466	  (2008).	  229	   Davis,	  E.	  P.	  et	  al.	  Prenatal	  exposure	  to	  maternal	  depression	  and	  cortisol	  influences	  infant	  temperament.	  J	  Am	  Acad	  Child	  Adolesc	  Psychiatry	  46,	  737-­‐746	  (2007).	  
	  193	  
230	   Halligan,	  S.	  L.,	  Murray,	  L.,	  Martins,	  C.	  &	  Cooper,	  P.	  J.	  Maternal	  depression	  and	  psychiatric	  outcomes	  in	  adolescent	  offspring:	  a	  13-­‐year	  longitudinal	  study.	  J	  Affect	  Disord	  97,	  145-­‐154	  (2007).	  231	   Klein,	  D.	  N.	  et	  al.	  Early	  adversity	  in	  chronic	  depression:	  clinical	  correlates	  and	  response	  to	  pharmacotherapy.	  Depress	  Anxiety	  26,	  701-­‐710	  (2009).	  232	   Mueller,	  B.	  R.	  &	  Bale,	  T.	  L.	  Sex-­‐specific	  programming	  of	  offspring	  emotionality	  after	  stress	  early	  in	  pregnancy.	  J	  Neurosci	  28,	  9055-­‐9065	  (2008).	  233	   Weaver,	  I.	  C.	  et	  al.	  Epigenetic	  programming	  by	  maternal	  behavior.	  Nature	  
neuroscience	  7,	  847-­‐854,	  doi:10.1038/nn1276	  (2004).	  234	   Weaver,	  I.	  C.	  et	  al.	  Reversal	  of	  maternal	  programming	  of	  stress	  responses	  in	  adult	  offspring	  through	  methyl	  supplementation:	  altering	  epigenetic	  marking	  later	  in	  life.	  J	  Neurosci	  25,	  11045-­‐11054	  (2005).	  235	   Radtke,	  K.	  M.	  et	  al.	  Transgenerational	  impact	  of	  intimate	  partner	  violence	  on	  methylation	  in	  the	  promoter	  of	  the	  glucocorticoid	  receptor.	  
Translational	  Psychiatry	  Published	  online	  19	  July	  (2011).	  236	   Whitelaw,	  N.	  C.	  &	  Whitelaw,	  E.	  Transgenerational	  epigenetic	  inheritance	  in	  health	  and	  disease.	  Curr	  Opin	  Genet	  Dev	  18,	  273-­‐279	  (2008).	  237	   Cedar,	  H.	  &	  Bergman,	  Y.	  Linking	  DNA	  methylation	  and	  histone	  modification:	  patterns	  and	  paradigms.	  Nat	  Rev	  Genet	  10,	  295-­‐304	  (2009).	  238	   Jacome,	  L.	  F.,	  Burket,	  J.	  A.,	  Herndon,	  A.	  L.	  &	  Deutsch,	  S.	  I.	  Genetically	  inbred	  Balb/c	  mice	  differ	  from	  outbred	  Swiss	  Webster	  mice	  on	  discrete	  measures	  of	  sociability:	  relevance	  to	  a	  genetic	  mouse	  model	  of	  autism	  spectrum	  disorders.	  Autism	  research	  :	  official	  journal	  of	  the	  International	  Society	  for	  
Autism	  Research	  4,	  393-­‐400	  (2011).	  239	   Rice,	  M.	  C.	  &	  O'Brien,	  S.	  J.	  Genetic	  variance	  of	  laboratory	  outbred	  Swiss	  mice.	  Nature	  283,	  157-­‐161	  (1980).	  240	   Mitchell,	  E.	  et	  al.	  Propagation	  of	  Anxiety	  Traits	  through	  the	  Maternal	  
Line	  via	  Segregated	  and	  Parallel	  Epigenetic	  Mechanisms.	  submitted	  (2015).	  241	   Agid,	  O.	  et	  al.	  Environment	  and	  vulnerability	  to	  major	  psychiatric	  illness:	  a	  case	  control	  study	  of	  early	  parental	  loss	  in	  major	  depression,	  bipolar	  disorder	  and	  schizophrenia.	  Mol	  Psychiatry	  4,	  163-­‐172	  (1999).	  242	   Kessler,	  R.	  C.,	  Davis,	  C.	  G.	  &	  Kendler,	  K.	  S.	  Childhood	  adversity	  and	  adult	  psychiatric	  disorder	  in	  the	  US	  National	  Comorbidity	  Survey.	  Psychol	  Med	  
27,	  1101-­‐1119	  (1997).	  243	   Cruz,	  F.	  C.,	  Quadros,	  I.	  M.,	  Planeta,	  C.	  a.	  S.	  &	  Miczek,	  K.	  A.	  Maternal	  separation	  stress	  in	  male	  mice:	  long-­‐term	  increases	  in	  alcohol	  intake.	  
Psychopharmacology	  (Berl)	  201,	  459-­‐468,	  doi:10.1007/s00213-­‐008-­‐1307-­‐4	  (2008).	  244	   Moffett,	  M.	  C.	  et	  al.	  Maternal	  separation	  alters	  drug	  intake	  patterns	  in	  adulthood	  in	  rats.	  Biochem	  Pharmacol	  73,	  321-­‐330,	  doi:10.1016/j.bcp.2006.08.003	  (2007).	  
	  194	  
245	   Moy,	  S.	  S.	  et	  al.	  Sociability	  and	  preference	  for	  social	  novelty	  in	  five	  inbred	  strains:	  an	  approach	  to	  assess	  autistic-­‐like	  behavior	  in	  mice.	  Genes	  Brain	  
Behav	  3,	  287-­‐302,	  doi:10.1111/j.1601-­‐1848.2004.00076.x	  (2004).	  246	   Brown,	  A.	  S.	  Epidemiologic	  studies	  of	  exposure	  to	  prenatal	  infection	  and	  risk	  of	  schizophrenia	  and	  autism.	  Developmental	  neurobiology	  72,	  1272-­‐1276	  (2012).	  247	   Chess,	  S.	  Follow-­‐up	  report	  on	  autism	  in	  congenital	  rubella.	  J	  Autism	  Child	  
Schizophr	  7,	  69-­‐81	  (1977).	  248	   Bannerman,	  D.	  M.	  et	  al.	  Ventral	  hippocampal	  lesions	  affect	  anxiety	  but	  not	  spatial	  learning.	  Behav	  Brain	  Res	  139,	  197-­‐213	  (2003).	  249	   Gordon,	  J.	  A.,	  Lacefield,	  C.	  O.,	  Kentros,	  C.	  G.	  &	  Hen,	  R.	  State-­‐dependent	  alterations	  in	  hippocampal	  oscillations	  in	  serotonin	  1A	  receptor-­‐deficient	  mice.	  J	  Neurosci	  25,	  6509-­‐6519	  (2005).	  250	   Adhikari,	  A.,	  Topiwala,	  M.	  A.	  &	  Gordon,	  J.	  A.	  Single	  units	  in	  the	  medial	  prefrontal	  cortex	  with	  anxiety-­‐related	  firing	  patterns	  are	  preferentially	  influenced	  by	  ventral	  hippocampal	  activity.	  Neuron	  71,	  898-­‐910	  (2011).	  251	   Wang,	  H.	  Q.,	  Tuominen,	  L.	  K.	  &	  Tsai,	  C.	  J.	  SLIM:	  a	  sliding	  linear	  model	  for	  estimating	  the	  proportion	  of	  true	  null	  hypotheses	  in	  datasets	  with	  dependence	  structures.	  Bioinformatics	  27,	  225-­‐231,	  doi:10.1093/bioinformatics/btq650	  (2011).	  252	   Koleske,	  A.	  J.	  Molecular	  mechanisms	  of	  dendrite	  stability.	  Nature	  reviews.	  
Neuroscience	  14,	  536-­‐550	  (2013).	  253	   Okano,	  M.,	  Bell,	  D.	  W.,	  Haber,	  D.	  A.	  &	  Li,	  E.	  DNA	  methyltransferases	  Dnmt3a	  and	  Dnmt3b	  are	  essential	  for	  de	  novo	  methylation	  and	  mammalian	  development.	  Cell	  99,	  247-­‐257	  (1999).	  254	   Altman,	  J.	  &	  Bayer,	  S.	  A.	  Migration	  and	  distribution	  of	  two	  populations	  of	  hippocampal	  granule	  cell	  precursors	  during	  the	  perinatal	  and	  postnatal	  periods.	  J	  Comp	  Neurol	  301,	  365-­‐381	  (1990).	  255	   Olshausen,	  B.	  A.	  &	  Field,	  D.	  J.	  Sparse	  coding	  of	  sensory	  inputs.	  Current	  
opinion	  in	  neurobiology	  14,	  481-­‐487,	  doi:10.1016/j.conb.2004.07.007	  (2004).	  256	   Samuelsson,	  A.	  M.,	  Jennische,	  E.,	  Hansson,	  H.	  A.	  &	  Holmang,	  A.	  Prenatal	  exposure	  to	  interleukin-­‐6	  results	  in	  inflammatory	  neurodegeneration	  in	  hippocampus	  with	  NMDA/GABA(A)	  dysregulation	  and	  impaired	  spatial	  learning.	  American	  journal	  of	  physiology.	  Regulatory,	  integrative	  and	  
comparative	  physiology	  290,	  R1345-­‐1356	  (2006).	  257	   Sakic,	  B.	  et	  al.	  Disturbed	  emotionality	  in	  autoimmune	  MRL-­‐lpr	  mice.	  
Physiology	  &	  behavior	  56,	  609-­‐617	  (1994).	  258	   Duman,	  C.	  H.	  et	  al.	  Peripheral	  insulin-­‐like	  growth	  factor-­‐I	  produces	  antidepressant-­‐like	  behavior	  and	  contributes	  to	  the	  effect	  of	  exercise.	  
Behav	  Brain	  Res	  198,	  366-­‐371	  (2009).	  259	   Chen,	  J.	  et	  al.	  Maternal	  deprivation	  in	  rats	  is	  associated	  with	  corticotrophin-­‐releasing	  hormone	  (CRH)	  promoter	  hypomethylation	  and	  enhances	  CRH	  transcriptional	  responses	  to	  stress	  in	  adulthood.	  Journal	  of	  
neuroendocrinology	  24,	  1055-­‐1064	  (2012).	  
	  195	  
260	   Elliott,	  G.	  et	  al.	  Intermediate	  DNA	  methylation	  is	  a	  conserved	  signature	  of	  genome	  regulation.	  Nature	  communications	  6,	  6363	  (2015).	  261	   Maunakea,	  A.	  K.,	  Chepelev,	  I.,	  Cui,	  K.	  &	  Zhao,	  K.	  Intragenic	  DNA	  methylation	  modulates	  alternative	  splicing	  by	  recruiting	  MeCP2	  to	  promote	  exon	  recognition.	  Cell	  research	  23,	  1256-­‐1269,	  doi:10.1038/cr.2013.110	  (2013).	  262	   Bird,	  A.	  DNA	  methylation	  patterns	  and	  epigenetic	  memory.	  Genes	  Dev	  16,	  6-­‐21	  (2002).	  263	   Ntanasis-­‐Stathopoulos,	  J.,	  Tzanninis,	  J.	  G.,	  Philippou,	  A.	  &	  Koutsilieris,	  M.	  Epigenetic	  regulation	  on	  gene	  expression	  induced	  by	  physical	  exercise.	  
Journal	  of	  musculoskeletal	  &	  neuronal	  interactions	  13,	  133-­‐146	  (2013).	  264	   Cortes-­‐Mendoza,	  J.,	  Diaz	  de	  Leon-­‐Guerrero,	  S.,	  Pedraza-­‐Alva,	  G.	  &	  Perez-­‐Martinez,	  L.	  Shaping	  synaptic	  plasticity:	  the	  role	  of	  activity-­‐mediated	  epigenetic	  regulation	  on	  gene	  transcription.	  International	  journal	  of	  
developmental	  neuroscience	  :	  the	  official	  journal	  of	  the	  International	  Society	  
for	  Developmental	  Neuroscience	  31,	  359-­‐369,	  doi:10.1016/j.ijdevneu.2013.04.003	  (2013).	  265	   Barreto,	  G.	  et	  al.	  Gadd45a	  promotes	  epigenetic	  gene	  activation	  by	  repair-­‐mediated	  DNA	  demethylation.	  Nature	  445,	  671-­‐675	  (2007).	  266	   Rai,	  K.	  et	  al.	  DNA	  demethylation	  in	  zebrafish	  involves	  the	  coupling	  of	  a	  deaminase,	  a	  glycosylase,	  and	  gadd45.	  Cell	  135,	  1201-­‐1212	  (2008).	  267	   Werner,	  E.	  E.	  Children	  and	  war:	  risk,	  resilience,	  and	  recovery.	  Development	  
and	  psychopathology	  24,	  553-­‐558,	  doi:10.1017/S0954579412000156	  (2012).	  268	   Essex,	  M.	  J.,	  Klein,	  M.	  H.,	  Cho,	  E.	  &	  Kalin,	  N.	  H.	  Maternal	  stress	  beginning	  in	  infancy	  may	  sensitize	  children	  to	  later	  stress	  exposure:	  effects	  on	  cortisol	  and	  behavior.	  Biological	  psychiatry	  52,	  776-­‐784	  (2002).	  269	   Caldji,	  C.	  et	  al.	  Maternal	  care	  during	  infancy	  regulates	  the	  development	  of	  neural	  systems	  mediating	  the	  expression	  of	  fearfulness	  in	  the	  rat.	  Proc	  
Natl	  Acad	  Sci	  U	  S	  A	  95,	  5335-­‐5340	  (1998).	  270	   Careau,	  V.,	  Buttemer,	  W.	  A.	  &	  Buchanan,	  K.	  L.	  Early-­‐developmental	  stress,	  repeatability,	  and	  canalization	  in	  a	  suite	  of	  physiological	  and	  behavioral	  traits	  in	  female	  zebra	  finches.	  Integrative	  and	  comparative	  biology	  54,	  539-­‐554,	  doi:10.1093/icb/icu095	  (2014).	  271	   Dantzer,	  B.	  et	  al.	  Density	  triggers	  maternal	  hormones	  that	  increase	  adaptive	  offspring	  growth	  in	  a	  wild	  mammal.	  Science	  340,	  1215-­‐1217,	  doi:10.1126/science.1235765	  (2013).	  272	   Weaver,	  I.	  C.,	  Meaney,	  M.	  J.	  &	  Szyf,	  M.	  Maternal	  care	  effects	  on	  the	  hippocampal	  transcriptome	  and	  anxiety-­‐mediated	  behaviors	  in	  the	  offspring	  that	  are	  reversible	  in	  adulthood.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  103,	  3480-­‐3485	  (2006).	  273	   Downing,	  C.	  et	  al.	  Subtle	  decreases	  in	  DNA	  methylation	  and	  gene	  expression	  at	  the	  mouse	  Igf2	  locus	  following	  prenatal	  alcohol	  exposure:	  effects	  of	  a	  methyl-­‐supplemented	  diet.	  Alcohol	  45,	  65-­‐71,	  doi:10.1016/j.alcohol.2010.07.006	  (2011).	  
	  196	  
 
